UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER THE
THE
SECURITIES EXCHANGE ACT OF 1934
Date:
June 10, 2019
Commission
File No. 0-53646
Grown
Rogue International, Inc. (formerly Novicius Corp)
(Translation
of Registrant’s name into English)
340
Richmond Street West
Toronto,
Ontario, Canada M5V 1X2
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes
☐ No ☒
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes
☐ No ☒
TABLE
OF CONTENTS
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
Dated:
June 10, 2019
|
GROWN ROGUE INTERNATIONAL, INC.
|
|
(FORMERLY:
NOVICIUS CORP.)
|
|
|
|
|
By:
|
/s/
Obie
Strickler
|
|
Name:
|
Obie
Strickler
|
|
Title:
|
President
& Chief Executive Officer
|
May 27, 2019
|
F
iled Via SEDAR
|
TO ALL APPLICABLE EXCHANGES
AND COMMISSIONS:
Subject:
|
GROWN ROGUE INTERNATIONAL INC.
|
|
Confirmation of Notice of Record and Meeting Dates
|
Dear Sirs:
We advise the following with respect to the upcoming
Annual & Special Meeting of Security Holders for the subject issuer:
1.
|
CUSIP Number
|
ISIN Number
|
|
39986R106
|
CA39986R1064
|
|
|
|
2.
|
Meeting Type:
|
Annual & Special
|
3.
|
Record Date:
|
May 31, 2019
|
4.
|
Beneficial Ownership Date:
|
May 31, 2019
|
5.
|
Mail Date:
|
June 17, 2019
|
6.
|
Meeting Date:
|
July 8, 2019
|
|
|
|
7.
|
Classes or Series of Securities that entitle the holder to receive
Notice of the Meeting:
|
COMMON
|
|
|
|
8.
|
Classes or Series of Securities that entitle the holder to vote at the meeting:
|
COMMON
|
|
|
|
9.
|
Business to be conducted at the meeting:
|
Annual & Special
|
|
|
|
10.
|
Notice-and-Access:
|
|
|
Registered Shareholders:
|
No
|
|
Beneficial Holders:
|
No
|
|
Stratification Level:
|
Not Applicable
|
|
E-Delivery
|
No
|
|
|
|
11.
|
Reporting issuer is sending proxy-related Materials directly to Non-Objecting Beneficial Owners:
|
No
|
|
|
|
12.
|
Issuer paying for delivery to Objecting Beneficial Owners:
|
Yes
|
|
|
|
13.
|
Issuer paying for delivery to US Non-Objecting Beneficial Owners:
|
No
|
In accordance with applicable securities regulations
we are filing this information with you in our capacity as agent of the Corporation.
Sincerely,
Capital Transfer Agency
Agent for Grown Rogue International Inc.
390 Bay Street, Suite 920, Toronto, ON
M5H 2Y2
Tel: 416-350-5007 Fax
416-350-5008
Website: www.capitaltransferagency.com
email: info@capitaltransferagency.com
Form 51-102F3
Material Change Report
|
Item 1
|
Name and Address of Company
|
Grown Rogue International Inc. (the “
Corporation
”
or “
Company
”)
340 Richmond Street West
Toronto, Ontario
M5V 1X2
|
Item 2
|
Date of Material Change
|
May 7, 2019
A news release was issued by
the Corporation on May 7, 2019 through the facilities of Cision and was subsequently filed on SEDAR.
|
Item 4
|
Summary of Material Change
|
On May 7, 2019, the Corporation
announced the closing of a non-brokered private placement of secured convertible debentures with an aggregate principal amount
of $1,500,000 and the issuance of 3,409,091 common share purchase warrants.
|
Item 5.1
|
Full Description of Material Change
|
On May 7, 2019, the Corporation
announced the closing of a non-brokered private placement (the “
Offering
”) of secured convertible debentures
with an aggregate principal amount of $1,500,000 (the “
Convertible Debentures
”). The Convertible Debentures
bear an interest at a rate of 2% per calendar quarter and mature on August 10, 2020. The lead investor in the Offering is an experienced
private equity cannabis investment fund.
The principal use of funds will
be continued expansion investment in the Michigan assets, namely one cultivation center, and two retail dispensaries - including
a midtown Detroit location. Additional funds will be dedicated to go-to-market strategies in California featuring Grown Rogue branded
products and wholesale products.
The Convertible Debentures are
convertible into common shares of the Corporation (the “
Common Shares
”) at a conversion price that is the lesser
of: (i) $0.44 per Common Share, or (ii) the lowest price for which securities of the Corporation are issued while such Convertible
Debentures remain outstanding (the “
Conversion Price
”). If, within 90 days of the issuance of the Convertible
Debentures, the Corporation fails to complete an offering of securities for gross proceeds of at least $1,000,000, then the Conversion
Price shall be reduced to $0.30 per Common Share.
On closing, the Corporation
issued to the purchasers of the Convertible Debentures 3,409,091 common share purchase warrants (the “
Warrants
”).
The Warrants are exercisable for a period of two (2) years from issuance into Common Shares at an exercise price equal to the lesser
of (i) $0.55 per Common Share; or (ii) the lowest price for which warrants of the Corporation are issued while such Warrants remain
outstanding. If, during the term of the Warrants, the Corporation issues warrants with an exercise price below $0.55 per Common
Share (the “
Other Warrants
”), the Corporation will issue to the purchasers, on the same terms and conditions
of the Other Warrants, additional warrants to equal the number of Warrants that would have been issued if the reduced offering
price was used to calculate the number of Warrants issued.
The Convertible Debentures and
Warrants issued pursuant to the Offering are subject to a statutory hold period of four months and one day from the closing date
of the Offering.
|
Item 6
|
Reliance on Subsection 7.1(2) of National Instrument 51-102
|
Not applicable.
|
Item 7
|
Omitted Information
|
Not applicable.
J. Obie Strickler
President and Chief Executive Officer
Tel: (503)
765-8108
May 17, 2019.
Cautionary Note Regarding Forward Looking Information
This
report contains statements which constitute “forward
-
looking information”
within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations
of the Company with respect to future business activities. Forward
-
looking information is
often identified by the words “may,” “would,” “could,” “should,” “will,”
“intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect”
or similar expressions and include information regarding: (i) statements regarding the future direction of the Company (ii) the
ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion of the Company
into new jurisdictions and securing applicable regulatory approvals, and (iv) expectations for other economic, business, and/or
competitive factors. Investors are cautioned that forward
-
looking information is not based
on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning
the business of the Company’s future results or events based on the opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward
-
looking
information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such
information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements
of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the
forward
-
looking information are the following: changes in general economic, business and political
conditions, including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity
capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the
prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable
laws; or adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and
related costs, and other risks described in the Company’s public disclosure available on www.sedar.com.
Should
one or more of these risks or uncertainties materialize, or should assumptions underlying the forward
-
looking
information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated,
believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which
could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or
intended. The Company does not intend, and does not assume any obligation, to update this forward
-
looking
information except as otherwise required by applicable law.
|
PRESS RELEASE
|
Grown
Rogue Announces Ticker Symbol GRUSF
on OTC Exchange
MEDFORD, OREGON
–
May 14, 2019
– Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) (the “
Company
” or “
Grown
Rogue
”) reports that the Financial Industry Regulatory Authority (FINRA) has accepted Grown Rogue’s request for
a ticker symbol change on the Over the Counter Bulletin Board (OTCBB) from “NVSIF” to “GRUSF”. The Company’s
symbol on the Canadian Securities Exchange (CSE) remains unchanged as “GRIN” for Grown Rogue International, Inc. There
is no action required by current shareholders in connection with this change.
“An increasing number
of United States based investors are looking for investment opportunities in the cannabis sector such as Grown Rogue and our symbol
name change on the OTC to GRUSF (Grown Rogue United States) provides improved clarity for US investors looking to buy shares of
Grown Rogue which are listed on the CSE,” said Obie Strickler CEO and Co-Founder of Grown Rogue. “In addition to the
CSE we are now quoted in US dollars on the OTC for US investors under our new symbol “GRUSF”.
Grown Rogue is now operating
or managing assets in three States: Oregon, California, and Michigan. The symbol name change follows the Company’s reverse
takeover in November, 2018. The Company indicated no immediate plans to establish the stock for trading on additional exchanges,
though the Company anticipates that a Frankfurt listing could soon be in the works.
“Most of our investors
are US-based, and increasingly more retail US-based investors have been reaching out through our website and social media channels
asking about how they can participate in our growth,” said Jacques Habra, Chief Strategy Officer of Grown Rogue.
Mr. Habra continued, “We
have a dedicated office to investor relations that is based in Santa Barbara, California. We expect to hold investor conference
calls and eventually an investor only conference as we continue to scale the company across the Country.”
Grown Rogue recently announced
the intent to acquire Decibel Farms, owners of the Loud Cannabis Brand, and also announced record monthly revenue of just over
$1.01 MM for April, 2019.
“Our vision is that our
brand and ticker symbol will be synonymous with a responsible cannabis company focused on value creation,” added Mr. Strickler.
About Grown Rogue
Grown Rogue International Inc.
(CSE: GRIN | OTC: GRUSF) is a vertically
-
integrated, multi
-
state
cannabis company curating innovative products to provide consumers with the right cannabis experience. Each of Grown Rogue’s
products and strains are categorized and marketed based on unique effects and designed for the full range of a consumer’s
lifestyle. Grown Rogue is scaling the vertically integrated model into multiple states by incorporating best
-
in
-
class
manufacturing facilities and a proprietary distribution platform based on Microsoft technology. Grown Rogue’s diverse cannabis
product suite includes premium flower, patent
-
pending nitrogen sealed pre
-
rolls,
oil and concentrates, and edibles featuring a partnership with world
-
renowned chocolatier,
Jeff Shepherd.
Subscribe to Grown Rogue investor news alerts.
Cautionary Note Regarding Forward-Looking Information
This press release contains
statements which constitute “forward-looking information” within the meaning of applicable securities laws (including
within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended), including all statements that are not statements
of historical fact regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business
activities. Forward-looking information is often identified by the words “may,” “would,” “could,”
“should,” “will,” “intend,” “plan,” “anticipate,” “believe,”
“estimate,” “expect” or similar expressions and include information regarding: (i) statements regarding
the future direction of the Company (ii) the ability of the Company to successfully achieve its business and financial objectives,
(iii) plans for expansion of the Company into new jurisdictions and securing applicable regulatory approvals, and (iv) expectations
for other economic, business, and/or competitive factors. Investors are cautioned that forward-looking information is not based
on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning
the business of the Company’s future results or events based on the opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking
information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such
information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements
of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking
information are the following: changes in general economic, business and political conditions, including changes in the financial
markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that
it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis
products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application
or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in
the Company’s public disclosure available on www.sedar.com or in the Company’s Form 20-F and 6-K filings with the Securities
and Exchange Commission.
The Company is indirectly
involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the
United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities
however, these activities are currently illegal under United States federal law. Additional information regarding this and other
risks and uncertainties relating to the Company’s business are disclosed in the Company’s public disclosure available
on its issuer profile on SEDAR at www.sedar.com or in the Company’s Form 20-K and 6-K filings with the Securities and Exchange
Commission.Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking
information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated,
believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which
could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or
intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as
otherwise required by applicable law, even if new information becomes available in the future.
No stock exchange, securities
commission or other regulatory authority has approved or disapproved the information contained herein.
For further information on Grown Rogue International
please visit https://www.grownrogue.com or contact:
Obie Strickler
|
Jacques Habra
|
Investor Relations Desk
|
Chief Executive Officer
|
Chief Strategy Officer
|
Inquiries
|
obie@grownrogue.com
|
jacques@grownrogue.com
|
invest@grownrogue.com
|
|
PRESS RELEASE
|
Grown
Rogue International Inc. Delivers Record Sales
in April Boosted by Bulk Orders
MEDFORD,OREGON
–
May 9, 2019
– Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) (the “
Company
”) reports record
sales of approximately US$1.0m in April, more than three times the average monthly revenue achieved during the Company’s
fiscal first quarter ended January 31, 2019. Sales were boosted by new bulk wholesale orders during its fiscal second quarter ended
April 30, 2019.
“Grown Rogue continues
to gain recognition in the hyper-competitive Oregon market at the retail dispensary level, and recently at the bulk wholesale level
as well,” explained Obie Strickler, CEO of Grown Rogue. “Bulk wholesale transactions helped boost our April sales as
market demand for quality product is beginning to outstrip supply in some regions. We are hearing from our accounts that sourcing
product is becoming the challenge in Oregon, not finding demand for it. Our recent LOI for the acquisition of Decibel Farms was
part of our solution to increase our production to meet this growing demand for our products. We believe that the previously oversupplied
Oregon market - widely considered the most competitive in North America - is reaching an equilibrium which could drive prices up.”
The Company continues to explore
bulk sales opportunities as it can drive large revenue gains with sound margin, but budgeting conservatively as the nature of the
bulk business can be inconsistent.
Through a dual strategy of organic
and acquisitive growth the Company has been expanding operations in each of the multiple States where its operations or assets
exist including Oregon, California and Michigan. Organic growth in Oregon is being complemented with attractively priced acquisition
targets such as the recently announced intent to acquire of Decibel Farms.
Grown Rogue’s Michigan
priorities are focused on establishing a presence in the adult-use marketplace with current agreements with operational partners
that include two retail dispensaries in highly coveted and limited areas (Detroit, Hazel Park) as well as a 19,000 sq ft cultivation
center in a Detroit Suburb.
The Company’s California
operations are anticipated to come online with Grown Rogue products available this summer. Grown Rogue’s operations in California
include distribution teams in northern and southern California and a 16,000 square foot multi-use (cultivation, retail, processing)
center in Eureka, California.
“Our team knows how to
navigate challenging cannabis market conditions because the early days of legalization in Oregon forced us to rapidly update strategy
and tactics to ensure success,” said Jacques Habra, Chief Strategy Officer for Grown Rogue. “As cannabis becomes legal
in new states, operators face similar challenges which is where a proven leader like Grown Rogue can excel. This is one of the
prime opportunities for our moves into new states. The timing between medical and recreational legalization, which we are now seeing
in Michigan and other states we are exploring, requires tactical and effective management.”
About Grown Rogue
Grown Rogue International Inc.
(CSE: GRIN | OTC: GRUSF) is a vertically
-
integrated, multi
-
state
cannabis company curating innovative products to provide consumers with the right cannabis experience. Each of Grown Rogue’s
products and strains are categorized and marketed based on unique effects and designed for the full range of a consumer’s
lifestyle. Grown Rogue is scaling the vertically integrated model into multiple states by incorporating best
-
in
-
class
manufacturing facilities and a proprietary distribution platform based on Microsoft technology. Grown Rogue’s diverse cannabis
product suite includes premium flower, patent
-
pending nitrogen sealed pre
-
rolls,
oil and concentrates, and edibles featuring a partnership with world
-
renowned chocolatier,
Jeff Shepherd.
Subscribe to Grown Rogue investor news alerts.
This press release contains
statements which constitute “forward-looking information” within the meaning of applicable securities laws, including
statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities.
Forward-looking information is often identified by the words “may,” “would,” “could,” “should,”
“will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,”
“expect” or similar expressions and include information regarding: (i) statements regarding the future direction of
the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion
of the Company into new jurisdictions and securing applicable regulatory approvals, and (iv) expectations for other economic, business,
and/or competitive factors. Investors are cautioned that forward-looking information is not based on historical facts but instead
reflect the Company’s management’s expectations, estimates or projections concerning the business of the Company’s
future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements
are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such
information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable
factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key
factors that could cause actual results to differ materially from those projected in the forward-looking information are the following:
changes in general economic, business and political conditions, including changes in the financial markets; and in particular in
the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in
the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the
Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws;
compliance with extensive government regulation and related costs, and other risks described in the Company’s public disclosure
available on www.sedar.com.
Should one or more of these
risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results
may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the
Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially,
there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not
assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Safe Harbor Statement:
This press release may contain
forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations
of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii)
trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and
operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,”
“expect,” “estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify forward-looking statements. Also, forward-looking statements represent
our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to
update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated
in these forward-looking statements, even if new information becomes available in the future. Investors are cautioned that any
such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are
beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking
statements as a result of various factors including the risk disclosed in the Company’s Form 20-F and 6-K filings with the
Securities and Exchange Commission.
The Company is indirectly
involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the
United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities
however, these activities are currently illegal under United States federal law. Additional information regarding this and other
risks and uncertainties relating to the Company’s business are disclosed in the Company’s public disclosure available
on its issuer profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize,
or should assumptions underlying the forward looking information or forward-looking statements prove incorrect, actual results
may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
No stock exchange, securities
commission or other regulatory authority has approved or disapproved the information contained herein.
For further information on Grown Rogue International
please visit https://www.grownrogue.com or contact:
Obie Strickler
|
Jacques Habra
|
Investor Relations Desk
|
Chief Executive Officer
|
Chief Strategy Officer
|
Inquiries
|
obie@grownrogue.com
|
jacques@grownrogue.com
|
invest@grownrogue.com
|
|
PRESS RELEASE
|
Grown
Rogue International Inc. Announces Closing of Convertible
Debenture Private Placement to Accelerate Expansion
NOT FOR DISTRIBUTION IN THE
UNITED STATES
MEDFORD, OREGON
–
May 7, 2019
– Grown Rogue International Inc. (CSE: GRIN | OTC: NVSIF) (the
“Company”)
is pleased
to announce the closing of a non-brokered private placement (the
“Offering”)
of secured convertible debentures
with an aggregate principal amount of $1,500,000 (the
“Convertible Debentures”).
The Convertible Debentures
bear an interest at a rate of 2% per calendar quarter and mature on August 10, 2020. The lead investor in the Offering is an experienced
private equity cannabis investment fund.
The principal use of funds will
be continued expansion investment in the Michigan assets, namely one cultivation center, and two retail dispensaries - including
a midtown Detroit location. Additional funds will be dedicated to go-to-market strategies in California featuring Grown Rogue branded
products and wholesale products.
The Convertible Debentures are
convertible into common shares of the Company (the
“Common Shares”)
at a conversion price that is the lesser
of: (i) $0.44 per Common Share, or (ii) the lowest price for which securities of the Company are issued while such Convertible
Debentures remain outstanding (the
“Conversion Price”).
If, within 90 days of the issuance of the Convertible
Debentures, the Company fails to complete an offering of securities for gross proceeds of at least $1,000,000, then the Conversion
Price shall be reduced to $0.30 per Common Share.
“Our growth has been ahead
of schedule on several fronts. This financing allows us to continue expansion while fulfilling all of our current obligations,”
added Obie Strickler, Co-Founder and CEO of Grown Rogue International.
On closing, the Company issued
to the purchasers of the Convertible Debentures 3,409,091 common share purchase warrants (the
“Warrants”).
The
Warrants are exercisable for a period of two (2) years from issuance into Common Shares at an exercise price equal to the lesser
of (i) $0.55 per Common Share; or (ii) the lowest price for which warrants of the Company are issued while such Warrants remain
outstanding. If, during the term of the Warrants, the Company issues warrants with an exercise price below $0.55 per Common Share
(the
“Other Warrants”),
the Company will issue to the purchasers, on the same terms and conditions of the Other
Warrants, additional warrants to equal the number of Warrants that would have been issued if the reduced offering price was used
to calculate the number of Warrants issued.
“Creating shareholder
value is our primary concern when putting investment to work and these funds will pay for immediate operations to advance our operational
launch date in Michigan and our product launch date in California,” said Jacques Habra, Chief Strategy Officer of Grown Rogue
International. “Building a responsible cannabis brand requires strategic investment,” continued Mr. Habra.
The Convertible Debentures and
Warrants issued pursuant to this Offering are subject to a statutory hold period of four months and one day from the closing date
of the Offering.
About Grown Rogue
Grown Rogue International Inc.
(CSE: GRIN | OTC: NVSIF) is a vertically integrated, multi-state cannabis company curating innovative products to provide consumers
with the right cannabis experience. Each of Grown Rogue’s products and strains are categorized and marketed based on unique
effects and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the vertically integrated model
into multiple states by incorporating best-in-class manufacturing facilities and a proprietary distribution platform based on Microsoft
technology. Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending nitrogen sealed pre-rolls,
oil and concentrates, and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.
Subscribe to Grown Rogue investor news alerts.
This press release contains
statements which constitute “forward-looking information” within the meaning of applicable securities laws, including
statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities.
Forward-looking information is often identified by the words “may,” “would,” “could,” “should,”
“will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,”
“expect” or similar expressions and include information regarding: (i) statements regarding the future direction of
the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion
of the Company into new jurisdictions and securing applicable regulatory approvals, and (iv) expectations for other economic, business,
and/or competitive factors. Investors are cautioned that forward-looking information is not based on historical facts but instead
reflect the Company’s management’s expectations, estimates or projections concerning the business of the Company’s
future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements
are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such
information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable
factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key
factors that could cause actual results to differ materially from those projected in the forward-looking information are the following:
changes in general economic, business and political conditions, including changes in the financial markets; and in particular in
the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in
the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the
Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws;
compliance with extensive government regulation and related costs, and other risks described in the Company’s public disclosure
available on www.sedar.com.
Should one or more of these
risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results
may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the
Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially,
there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not
assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Safe Harbor Statement:
This press release may contain
forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations
of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii)
trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and
operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,”
“expect,” “estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify forward-looking statements. Also, forward-looking statements represent
our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to
update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated
in these forward-looking statements, even if new information becomes available in the future. Investors are cautioned that any
such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are
beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking
statements as a result of various factors including the risk disclosed in the Company’s Form 20-F and 6-K filings with the
Securities and Exchange Commission.
The Company is indirectly
involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the
United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities
however, these activities are currently illegal under United States federal law. Additional information regarding this and other
risks and uncertainties relating to the Company’s business are disclosed in the Company’s public disclosure available
on its issuer profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize,
or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect, actual results
may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
No stock exchange, securities
commission or other regulatory authority has approved or disapproved the information contained herein.
For further information on Grown Rogue International
please visit https://www.grownrogue.com or contact:
Obie Strickler
|
Jacques Habra
|
Investor Relations Desk
|
Chief Executive Officer
|
Chief Strategy Officer
|
Inquiries
|
obie@grownrogue.com
|
jacques@grownrogue.com
|
invest@grownrogue.com
|
PRESS
RELEASE
Grown
Rogue Announces Proposed
Acquisition of Decibel Farms, Inc.
MEDFORD, OREGON
–
April
24, 2019
-- Grown Rogue International Inc. (CSE:GRIN | OTC: NVSIF) (“Grown Rogue” or the “Company”),
a vertically-integrated, multi-state cannabis company, and Decibel Farms, Inc. (“Decibel”), a fully organic and sustainable
producer and processor of fine cannabis products in southern Oregon, have executed a binding letter of intent (the “LOI”)
which sets out the general terms and conditions pursuant to which Grown Rogue will acquire the assets, including real estate, intellectual
property and other assets of Decibel for aggregate consideration of USD$3,000,000, subject to adjustment as described below (the
“Transaction”).
Decibel is a family owned and operated,
5-acre sungrown and greenhouse farm located in the Applegate Valley in the heart of Southern Oregon with a 2,500 square foot processing
center in Medford, Oregon. Decibel owners Shawn Bishop and Buddy Wilson are veterans of cannabis cultivation. Over the past 3 years,
Decibel has built a truly sustainable cultivation facility that utilizes biological cultivation practices and has garnered several
prestigious quality awards including:
|
●
|
1
st
place sungrown flower Oregon Growers Cup 2017
|
|
●
|
2
nd
place Infused Pre-roll Dope Cup 2018
|
|
●
|
3
rd
Place Sungrown Flower 2018 Oregon Growers Cup
|
|
●
|
2
nd
Place Solventless Extract 2018 Oregon Growers Cup
|
In addition to award winning flower, Decibel also distributes
award winning infused pre-rolls called “Decibel Louds” and award winning solventless extracts called “Decibel
Dabs”. All Decibel products are inline with the company’s primary ethos of clean and responsible cannabis which is
in alignment with Grown Rogue’s high standards for sustainable cultivation and environmentally responsible packaging.
Obie Strickler, CEO of Grown Rogue, explained
the value of the acquisition stating, “Grown Rogue is continuing to see significant month over month sales growth, such that
demand for our award winning products is surpassing our current capacity to deliver in Oregon. This acquisition addresses this
demand by immediately adding Decibel’s inventory valued at more than US$1 million wholesale to Grown Rogue’s supply.
The acquisition also adds another well respected brand into the Grown Rogue portfolio of brands, enabling us to continue growing
our market share. Decibel will expedite our ability to ramp up product supply by adding Decibel’s 40,000 sq ft cultivation
and manufacturing capacity, as well as a very experienced management to the Grown Rogue leadership team.”
Upon closing of the Transaction Shawn Bishop
will be appointed Vice President of Manufacturing for Grown Rogue and Buddy Wilson will lead Grown Rogue’s sales team as
Vice President of Sales.
“Merging operations with Grown Rogue
is an incredible opportunity for both companies,” said Shawn Bishop, ability to scale our collective efforts into many other
states and markets. The thoughtful approach to strategic expansion demonstrated by Obie and his team inspires great confidence.”
PRESS RELEASE
Mr. Strickler added, “There
are very good synergies between our teams. Together we are much more capable to extend the proven, vertically integrated platform
into additional regions.”
Terms of the Transaction
The Transaction will be structured
as a tax-free merger, pursuant to which Decibel will merge with and into Grown Rogue Gardens, LLC, a wholly-owned indirect subsidiary
of the Company pending final due diligence and a definitive merger agreement (the
“Definitive Agreement”).
The
real estate property of Decibel will be acquired by GRU Properties, LLC, a wholly-owned indirect subsidiary of the Company, pursuant
to a customary commercial real estate acquisition agreement.
The consideration to be paid
to the shareholders of Decibel shall consist of: (i) USD$2,000,000 of common shares of the Company, to be issued twelve months
from the signing of the Definitive Agreement with respect to the Transaction, with the number of shares to be issued to be determined
based on the volume weighted average price of the Company’s common shares as reported by the Canadian Securities Exchange
(the
“CSE”)
for the ten trading days immediately prior to the date that is twelve months from the closing date,
up to a maximum of C$1.25 per share; and (ii) up to an additional USD$1,000,000 of common shares on the same terms based on the
completion of certain business and operational milestones achieved by the Company. The issuance of the Company’s common shares
under the Transaction is subject to compliance with applicable securities laws and the policies of the CSE.
“The terms of this all
stock purchase, with share price to be set 12 months out, limits current dilution to our existing shareholders while increasing
capacity for product growth and revenue generation. These mandates have been fundamental to our company’s vision to develop
strong investor relationships that provide measurable returns,” added Mr. Strickler.
The closing of the Transaction
will be subject to, among other things, satisfactory completion of due diligence by the Company, regulatory approvals, and delivery
of a definitive merger agreement and other related transaction documents by June 30, 2019.
About Grown Rogue
Grown Rogue International (CSE:
GRIN | OTC: NVSIF) is a vertically-integrated, multi-state cannabis company curating innovative products to provide consumers with
the right cannabis experience. Each of Grown Rogue’s products and strains are categorized and marketed based on unique effects
and designed for the full range of a consumer’s lifestyle. Grown Rogue is scaling the vertically integrated model into multiple
states by incorporating best-in-class manufacturing facilities and a proprietary distribution platform based on Microsoft technology.
Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending nitrogen sealed pre-rolls, oil and concentrates,
and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.
PRESS RELEASE
Subscribe to Grown Rogue investor news alerts.
This press release contains statements
which constitute “forward-looking information” within the meaning of applicable securities laws, including statements
regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities. Forward-looking
information is often identified by the words “may,” “would,” “could,” “should,”
“will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,”
“expect” or similar expressions and include information regarding: (i) statements regarding the future direction of
the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion
of the Company into new jurisdictions and securing applicable regulatory approvals, and (iv) expectations for other economic,
business, and/or competitive factors. Investors are cautioned that forward-looking information is not based on historical facts
but instead reflect the Company’s management’s expectations, estimates or projections concerning the business of the
Company’s future results or events based on the opinions, assumptions and estimates of management considered reasonable
at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information,
as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the
combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking
information are the following: changes in general economic, business and political conditions, including changes in the financial
markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that
it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis
products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application
or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in
the Company’s public disclosure available on www.sedar.com.
Should one or more of these risks or
uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may
vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company
has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there
may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume
any obligation, to update this forward-looking information except as otherwise required by applicable law.
PRESS RELEASE
Safe Harbor Statement:
This press
release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief
or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s
financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s
growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,”
“will,” “expect,” “estimate,” “anticipate,” “believe,” “intend”
and similar expressions and variations thereof are intended to identify forward-looking statements. Also, forward-looking statements
represent our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation
to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those
anticipated in these forward-looking statements, even
if
new information becomes available
in the future. Investors are cautioned that any such forward-looking statements are not guarantees
of
future
performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual
results may differ materially from those projected in the forward-looking statements as a result of various factors including the
risk disclosed in the Company’s Form 20-F and 6-K filings with the Securities and Exchange Commission.
The Company is indirectly involved in
the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States
through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these
activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties
relating to the Company’s business are disclosed in the Company’s public disclosure available on its issuer profile
on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions
underlying the forward-looking information or forward-looking statements prove incorrect, actual results may vary materially from
those described herein as intended, planned, anticipated, believed, estimated or expected.
No stock exchange, securities commission
or other regulatory authority has approved or disapproved the information contained herein.
For further information on Grown Rogue International please
visit www.grownrogue.com or contact:
Obie Strickler
|
Jacques Habra
|
Investor Relations Desk
|
Chief Executive Officer
|
Chief Strategy Officer
|
Inquiries
|
obie@grownrogue.com
|
jacques@grownrogue.com
|
invest@grownrogue.com
|
PRESS RELEASE
Grown
Rogue Issuance of Stock Options and Shares
MEDFORD, OREGON
–
April
5, 2019
-- Grown Rogue International Inc. (CSE:GRIN | OTC: NVSIF) (“Grown Rogue” or the “Company”),
is pleased to announce today that stock options have been granted to two consultants of the Company to purchase up to an aggregate
of 650,000 common shares of the Company. The stock options are exercisable at a price of $0.44 per share with 150,000 of the options
expiring on November 30, 2021 and 500,000 options expiring on January 1, 2022. In addition, the Company also issued a total 570,500
common shares to certain directors and officers and 241,818 common shares to a consultant, in each case, as compensation for services
previously provided to the Company. The above-mentioned common shares and any common shares issued pursuant to the exercise of
the stock options will be subject to a four month hold period expiring on August 6, 2019.
About Grown Rogue
Grown Rogue International (CSE: GRIN |
OTC: NVSIF) is a vertically-integrated, multi-state cannabis company curating innovative products to provide consumers with the
right cannabis experience. Each of Grown Rogue’s products and strains are categorized and marketed based on unique effects
and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the vertically integrated model into multiple
states by incorporating best-in-class manufacturing facilities and a proprietary distribution platform based on Microsoft technology.
Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending nitrogen sealed pre-rolls, oil and concentrates,
and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.
The Company is indirectly involved in
the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States
through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these
activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties
relating to the Company’s business are disclosed in the Company’s Listing Statement filed on its issuer profile on
SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying
the forward looking information or forward-looking statements prove incorrect, actual results may vary materially from those described
herein as intended, planned, anticipated, believed, estimated or expected.
No stock exchange, securities commission or other regulatory
authority has approved or disapproved the information contained herein.
For further information on Grown Rogue International please
visit www.grownrogue.com or contact:
Obie Strickler
|
Jacques Habra
|
Investor Relations Desk
|
Chief Executive Officer
|
Chief Strategy Officer
|
Inquiries
|
obie@grownrogue.com
|
jacques@grownrogue.com
|
invest@grownrogue.com
|
PRESS RELEASE
Grown
Rogue Reports 388% Growth First Quarter F2019
Established Oregon Platform currently
in development in California and Michigan
MEDFORD, OREGON – April 2, 2019
-- Grown Rogue International Inc. (CSE:GRIN | OTC: NVSIF) (“Grown Rogue” or the “Company”), a vertically-integrated,
multi-state cannabis company, with licenses and operations in Oregon, California, and now Michigan, has released its financial
and operating results for the three months ended January 31, 2019. The Company’s financial statements and related management’s
discussion and analysis for the period are available on the Company’s SEDAR profile at www.sedar.com and on the Company’s
website at www.grownrogue.com. All amounts are expressed in United States Dollars unless otherwise indicated. Certain metrics,
including those expressed on an adjusted basis, are non-IFRS measures.
First Quarter F2019 Highlights
|
●
|
First
quarter revenue grew 388% year-over-year to $834,309 and is expected to continue as the Company proceeds with its expansion plans
in Oregon, California and Michigan.
|
|
●
|
Gross
margin improved to 31% compared to negative gross margin Q1-F2018.
|
|
●
|
Grown
Rogue products in over 220 dispensaries in Oregon.
|
|
●
|
Launched
innovative nitrogen sealed 3.5g glass jars inspired by Grown Rogue’s patent pending nitrogen sealed pre-rolls
|
|
●
|
Achieved
Oregon outdoor THC potency record and won the prestigious Growers Cup in two of three categories.
|
|
●
|
Established
partnership with international award-winning chocolatier
|
|
●
|
Management
expansion including the addition of Adam Wolf as Chief Operating Officer
|
|
●
|
Expanded
into California
|
|
●
|
Signed
MOU to expand into the Michigan market through strategic partnership
|
Grown Rogue current multi-state presence
|
●
|
Expanding
presence to its third state, the highly populated, limited-license state of Michigan through a partnership agreement
|
|
●
|
From
3 licenses in 1 state Q1-F2018, to control of assets with opportunity for 22 licenses in three states at the end of Q1-F2019.
|
Oregon Operations
|
●
|
Cultivating
90,000 sq. ft. of canopy in Oregon including two outdoor farms and a state-of-the-art indoor facility
|
|
●
|
Increased
outdoor yield from 2018 to 2019 by over 50%
|
|
●
|
Increasing
market penetration and sales revenue
|
California Operations
|
●
|
Expanding
into California with a 16,000-square-foot microbusiness facility in Eureka with retail, processing and distribution licensing
partnership spanning San Francisco to Los Angeles.
|
|
●
|
Secured
state and local approval for distribution license and type 6 manufacturing (non-volatile), and local approval for type 7 manufacturing
(volatile).
|
Michigan Operations
|
●
|
Subsequent
to the close of the first quarter a binding agreement was signed with Michigan partners and includes two strategically positioned
retail centres (“provisional licences”) in Hazel Park and Midtown Detroit as well as a 19,000-square-foot cultivation
centre in Detroit. Additional licence acquisitions under review.
|
“Our Fiscal 2019 Q1 represents the
first full quarter for Grown Rogue as a public company and marks the Company’s 5
th
consecutive quarter of revenue
growth since launching first in the state of Oregon in late 2017,” said Obie Strickler, President and CEO of Grown Rogue.
“To have gained this brand recognition and sales traction, in what is arguably the world’s most competitive legalized
cannabis market, bodes very well for our expansion into California and particularly the newly legalized market in Michigan. We’ve
grown very quickly from controlling just 3 licenses in one state a year ago to assets allowing us to have 22 licences in three
states today.”
Selected Financial Information
(Complete financial tables
have been filed on www.sedar.com)
|
|
Three Months
|
|
Period Ended January 31,
|
|
2019
|
|
|
2018
|
|
(in $000s except per share amounts)
|
|
|
|
|
|
|
Sales
|
|
|
834
|
|
|
|
171
|
|
Gross profit
|
|
|
256
|
|
|
|
(314
|
)
|
Expenses
|
|
|
|
|
|
|
|
|
Operating Expenses
|
|
|
1,191
|
|
|
|
676
|
|
Other Expenses
|
|
|
140
|
|
|
|
347
|
|
RTO Transaction
|
|
|
3,724
|
|
|
|
-
|
|
Net loss
|
|
|
(4,799
|
)
|
|
|
(1,337
|
)
|
Net loss per share
|
|
|
(0.08
|
)
|
|
|
(0.35
|
)
|
Cash & cash equivalents
|
|
|
532
|
|
|
|
1,363
|
|
Weighted Common Shares Outstanding
|
|
|
61,324
|
|
|
|
3,774
|
|
For the first quarter of fiscal 2019 Grown
Rogue revenue grew to US$834,309 (C$1.11 million), an increase of 388% from revenue of US$170,960 (C$227,592) in its fiscal first
quarter ended January 31, 2018. Since the Company’s first products began selling in late 2017, Grown Rogue has demonstrated
meaningful sales traction in one of the world’s most competitive cannabis markets. The increase is a result of continued
addition of the internal sales force, third party distribution, as well as an increase in awareness of the Grown Rogue brand.
Grown Rogue’s award winning flower
production (indoor and outdoor) represents approximately 55% of total sales with the remainder coming from concentrates (oil cartridges
and extracts), pre-rolls, 3rd party products, and a new edibles line launched in December of 2018 that is produced in partnership
with an award winning chocolatier. Demand for Grown Rogue branded products that exceed current internal production capacity, is
supplemented with quality products from other qualified purveyors and manufacturers inside of Oregon. Grown Rogue products typically
receive premium pricing at retail over the Oregon state average.
F2019 Q1 gross margin was $256,330, or
31% of revenues, a substantial improvement from negative gross margin of ($314,205) for the same period last year. A significant
component of the difference relates to a substantial adjustment related to the fair market value of the Company’s biological
assets during the quarter ended January 31, 2018. While the Company did not have such an adjustment during the quarter ended January
31, 2019, gross margin improved as a result of the efforts of the Company over the past year to refine its cultivation processes
to be more efficient resulting in lower cost of goods.
F2019 Q1 operating expenses of $4,915,040,
include non-recurring costs of $3,723,724 related to the Company’s Reverse Take-Over Transaction (the “Transaction”)
pursuant to its public listing on the Canadian Securities Exchange during the quarter. Of this transaction cost, $2,700,682 was
a non-cash component related to the fair value of shares issued to effect the Transaction.
Excluding Transaction costs, operating
expenses for the three months ended January 31, 2019 were $1,191,316, compared to expenses of $676,277 for the first quarter of
fiscal 2018. The increase in expenses was primarily related to the increased the scope of operations, resulting in increased salaries
and benefit expenses as the Company continued to increase its number of staff, marketing and promotion, capital markets and travel
expenses.
After Transaction costs, Grown Rogue’s
net loss from operations amounted to $4,798,562 for the three months ended January 31, 2019, compared to a loss from operations
of $1,337,095 for the three months ended January 31, 2018. The primary component of the loss for the three months ended January
31, 2019 are the Transaction costs of $3,723,724. These expenses are not expected to recur in the future.
The Company’s cash and cash equivalents
position was $531,908 as at January 31, 2019 and working capital of $840,575.
About Grown Rogue
Grown Rogue International (CSE: GRIN |
OTC: NVSIF) is a vertically-integrated, multi-state cannabis company curating innovative products to provide consumers with the
right cannabis experience. Each of Grown Rogue’s products and strains are categorized and marketed based on unique effects
and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the vertically integrated model into multiple
states by incorporating best-in-class manufacturing facilities and a proprietary distribution platform based on Microsoft technology.
Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending nitrogen sealed pre-rolls, oil and concentrates,
and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.
Subscribe to Grown Rogue investor news
alerts.
This press release contains statements
which constitute “forward-looking information” within the meaning of applicable securities laws, including statements
regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities. Forward-looking information is often identified by the words “may,” “would,” “could,” “should,”
“will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,”
“expect” or similar expressions and include information regarding: (i) statements regarding the future direction of
the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion
of the Company into Michigan and securing applicable regulatory approvals, and (iv) expectations for other economic, business,
and/or competitive factors. Investors are cautioned that forward-looking information is not based on historical facts but instead
reflect the Company’s management’s expectations, estimates or projections concerning the business of the Company’s
future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements
are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such
information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable
factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key
factors that could cause actual results to differ materially from those projected in the forward-looking information are the following:
changes in general economic, business and political conditions, including changes in the financial markets; and in particular in
the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in
the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the
Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws;
compliance with extensive government regulation and related costs, and other risks described in the Company’s Listing Statement
available on www.sedar.com.
Should one or more of these risks or
uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may
vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company
has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there
may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume
any obligation, to update this forward-looking information except as otherwise required by applicable law.
Safe Harbor Statement:
This press release may contain forward-looking
information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the
Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends
affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating
strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,”
“expect,” “estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify forward-looking statements. Also, forward-looking statements represent
our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to
update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated
in these forward-looking statements, even if new information becomes available in the future. Investors are cautioned that any
such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are
beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking
statements as a result of various factors including the risk disclosed in the Company’s Form 20-F and 6-K filings with the
Securities and Exchange Commission.
The Company is indirectly involved in
the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States
through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these
activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties
relating to the Company’s business are disclosed in the Company’s Listing Statement filed on its issuer profile on
SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying
the forward-looking information or forward-looking statements prove incorrect, actual results may vary materially from those described
herein as intended, planned, anticipated, believed, estimated or expected.
No stock exchange, securities commission or other regulatory
authority has approved or disapproved the information contained herein.
For further information on Grown Rogue International please
visit www.grownrogue.com or contact:
Obie Strickler
|
Jacques Habra
|
Investor Relations Desk
|
Chief Executive Officer
|
Chief Strategy Officer
|
Inquiries
|
obie@grownrogue.com
|
jacques@grownrogue.com
|
invest@grownrogue.com
|
FORM 51-102F1
GROWN
ROGUE INTERNATIONAL INC
.
(the “Company”
or
“Grown Rogue”)
MANAGEMENT
DISCUSSION & ANALYSIS
FOR
THE THREE MONTHS ENDED JANUARY 31, 2019
(the “Reporting Period”)
This Management Discussion and
Analysis (“
MD&A
”) made as of April 1, 2019, should be read in conjunction with the unaudited condensed
consolidated interim financial statements of the Company for the three months ended January 31, 2019 and the related notes thereto
(the “
Financial Statements
”). The Company’s unaudited financial statements are presented on a consolidated
basis with its wholly-owned subsidiaries: Grown Rogue Canada Corp. (“
GRC
”), Grown Rogue Unlimited, LLC (“
GR Unlimited
”) and GR Unlimited’s wholly-owned subsidiaries Grown Rogue Gardens, LLC (“
GR Gardens
”); Grown Rogue Distribution, LLC (“
GR Distribution
”); GRU Properties, LLC (“
GRU
Properties
”); GRIP, LLC (“
GRIP
”); as well as the GR Unlimited’s 60% ownership in
GRD CAli, LLC and Idalia, LLC. The Company’s reporting currency is the United States dollar and all amounts in this MD&A
are expressed in United dollars unless otherwise noted.
The Company’s comparative
information included in this MD&A has been prepared in accordance with IFRS.
Additional information relating
to the Company is also available on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com . The common
shares of GRIN are listed on the Canadian Securities Exchange under the symbol “
GRIN
”.
Management’s Responsibilities for Financial
Reporting
The Financial Statements have
been prepared by management in accordance with IFRS and have been approved by the Company’s board of directors (the “
Board
”). The integrity and objectivity of these Financial Statements are the responsibility of management. In addition, management
is responsible for ensuring that the information contained in the MD&A is consistent where appropriate, with the information
contained in the Financial Statements.
The Financial Statements may
contain certain amounts based on estimates and judgments. Management has determined such amounts on a reasonable basis to ensure
that the Financial Statements are presented fairly in all material respects.
The Board is responsible for
ensuring that management fulfills its responsibilities for financial reporting and internal control. The Board carries out this
responsibility principally through its audit committee. The members of the audit committee are appointed by the Board and have
sufficient financial expertise to assume this role with the Company. The majority of the audit committee members are independent
and not involved in the Company’s daily operations.
Forward-Looking Statements
This MD&A contains information and
projections based on current expectations. Certain statements herein may constitute “forward-looking” statements which
involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements
of the Company, or industry results, to be materially different from any future results, performance or achievements expressed
or implied by such forward-looking statements. When used in this Listing Statement, such statements use such words as “will”,
“may”, “could”, “intends”, “potential”, “plans”, “believes”,
“expects”, “projects”, “estimates”, “anticipates”, “continue”, “potential”,
“predicts” or “should” and other similar terminology. These statements reflect expectations regarding future
events and performance but speak only as of the date of this MD&A. Forward-looking statements include, among others, statements
with respect to planned acquisitions, strategic partnerships or other transactions and expansions not yet concluded; plans
to market, sell and distribute products; market competition; plans to retain and recruit personnel; the ability
to secure funding; and the ability to obtain regulatory and other approvals are all forward-looking information. These statements
should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties
and other factors that may cause actual results, performance or achievements to be materially different from those implied by such
statements.
There can be no assurance that any intended
or proposed activity or transaction will occur or that, if any such action or transaction is undertaken, it will be completed on
terms currently intended by the Company. The Company assumes no responsibility to update or revise forward-looking information to
reflect new events or circumstances unless required by law.
Although the Company believes that the
expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed
on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking
statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. The forward-looking
statements herein speak only as of the date hereof. Actual results could differ materially from those anticipated due to a number
of factors and risks including those described in this MD&A and under “Risk Factors” in section 17 of the Company’s
Listing Statement dated November 15, 2018 which can be found under the Company’s profile on www.sedar.com.
Description of Business
Grown Rogue is a vertically-integrated,
multi-state cannabis company curating innovative products to provide consumers with the right cannabis experience. Each of the Grown
Rogue’s products and strains are categorized and marketed based on unique effects and designed for the full range of a consumers’
active lifestyle from Relaxation to Energizing. Grown Rogue’s “seed to experience” positioning conveys the vision
of ensuring “the right experience, every time”. Grown Rogue’s diverse cannabis product suite includes premium
flower, patent-pending nitrogen sealed pre-rolls, oil and concentrates, dark chocolates, and a suite of edibles in development.
Grown Rogue, through its wholly owned subsidiary,
GR Gardens, operates three cultivation facilities that currently service the Oregon recreational marijuana market: Manzanita Glen,
Trail’s End, and the Medford Warehouse Project (the “
Warehouse
”). Grown Rogue through its 60% ownership
in GRDCali, LLC has a 16,000 sq ft facility located in Eureka, California (“Eureka Facility”) that once fully licensed
will have distribution, manufacturing (both volatile and non-volatile), and retail capabilities to serve the California marketplace.
Grown Rogue has signed a memorandum of understanding with Blue Zebra Community, LLC to enter the Michigan cannabis market through
partnership that will initially include two provisioning centers (retail dispensaries) and a 19,000 sq ft cultivation and processing
center. Grown Rogue intends to expand its facilities, add retail locations, and continue its multi-state expansion as a fully integrated
cannabis company.
Grown Rogue, through its subsidiaries,
GR Gardens and GR Distribution, currently holds four licenses (three producer licenses and one wholesale license) to do business
in the Oregon recreational marijuana market. Generally, there are four types of marijuana businesses regulated by the Oregon Liquor
Control Commission (“
OLCC
”). “Marijuana producers” cultivate marijuana for wholesale. “Marijuana
processors” produce marijuana extracts and products. “Marijuana wholesalers” may purchase marijuana and marijuana
products to sell to marijuana retailers and other non-consumers. Lastly, “marijuana retailers” are allowed to sell marijuana
|
●
|
Marijuana Producers can apply for two different license
types under the OLLC regulatory structure. A Tier I license allows for up to a maximum of 5,000 square feet of indoor and 20,000
square feet of outdoor flowering canopy. A Tier II license allows for a maximum of 10,000 square feet of indoor and 40,000 square
feet of outdoor flowering canopy. The differential between outdoor and indoor is if you use artificial lights during the flowering
cycle it is considered indoor under the rules. Marijuana producers can sell their products directly to marijuana processors, Marijuana
wholesalers or Marijuana retailers.
|
|
●
|
Marijuana Processors all operate under a single license.
This license type includes both volatile and non-volatile extraction, mechanical (i.e. bubble hash or rosin press), and edible
products. For each product contemplated by a processor, they must file for specific certificates in order to be legally allowed
to produce the products. Marijuana processors can sell their products directly to marijuana wholesalers and marijuana retailers.
Marijuana processors can also sell to other marijuana processor for additional processing but not for direct resale. Marijuana
processors cannot sell their products to Marijuana Producers.
|
|
●
|
Marijuana Wholesalers are responsible for supply chain
logistics and are generally responsible for taking the product from the manufacturer and getting it to a marijuana processor for
extraction or marijuana retailer for direct sale to the customer. Marijuana wholesalers can sell products to other marijuana wholesalers,
marijuana processors, or marijuana retailers. Marijuana wholesalers cannot sell their products to marijuana producers but are
allowed to return marijuana to marijuana producers from which the marijuana wholesaler originally purchased the product from.
|
|
●
|
Marijuana retailers provide the storefront for retailer
customers. Marijuana retailers are only allowed to sell to a customer who is over 21 with valid identification. Marijuana retailers
cannot sell products to any other license type. Limited delivery options are available for marijuana retailers as long as they
have license approval and stay within the jurisdiction of their license when doing the delivery and related items to individuals
21 years and older.
|
GR Gardens currently holds three producer
licenses for the three properties described above (and has submitted an additional application for a producer license to the OLCC
that is pending), and GR Distribution holds one wholesaler license. GR Distribution and GR Gardens jointly hold the producer license
and the wholesale license at the Warehouse as the licenses are co-located in the same facility. GR Distribution and GR Gardens have
also applied for a processor license for the Warehouse. Grown Rogue, through one or more of its subsidiaries, intends to acquire
one or more Oregon retail licenses in the future.
Grown Rogue is currently in the process
of licensing and constructing the Eureka Facility in California to house distribution, both volatile and non-volatile manufacturing,
and retail licensing. Grown Rogue is constructing the facility in phases with the distribution component of the business expected
to be completed in Q2 2019, the non-volatile manufacturing completed in Q3 2019, and the volatile manufacturing completed by end
of 2019. Retail is pending and is subject to local approval through a lottery system that Grown Rogue believes they hold high likelihood
of success in obtaining.
Through its partnership in Michigan, Grown
Rogue, subject to state and local regulatory approvals, will obtain a majority interest in two (2) strategically located dispensaries,
a 19,000 sq ft indoor cultivation and processing center in Detroit, Michigan, and an interest in a 28-acre parcel located in the
northern portion of the southern peninsula which has received approval for two cultivation licenses. Michigan recently passed adult
use cannabis in November 2018 with anticipated licensing for adult use beginning in early 2020. Michigan has the second largest
medical cannabis population in the United States. According to Detroitstats.com, in 2014, over 1 million people were recorded to
have used marijuana (15.6% of the population) in Michigan. Grown Rogue is in advanced discussions to acquire over a dozen additional
assets/licenses in Michigan over the course of 2019 and early 2020.
Production
GR Gardens is responsible for production
of recreational marijuana using outdoor, greenhouse, and indoor production methodologies. GR Gardens holds three Tier II producer
licenses from the OLCC. “Manzanita Glen”, an outdoor cultivation property leased in Josephine County, Oregon from its
sister company, GRU Properties, LLC (“
GRU Properties
”), has 40,000 square feet of canopy. “Trail’s
End”, an outdoor cultivation property leased from its sister company, GRU Properties in Jackson County, Oregon has 40,000
square feet of canopy. The Medford Warehouse project, an indoor cultivation property leased from its sister company, GRU Properties
is designed to have 10,000 square feet of canopy when fully constructed (the “
Warehouse
”). The Warehouse is
also the location of GR Distribution, the wholesale division of Grown Rogue and will also house the processing center for all Grown
Rogue Oregon products. The Warehouse is currently 70% constructed with full construction of the Warehouse scheduled to be completed
by end of Q2 2019. The two outdoor projects are anticipated to provide 3,000 lbs combined of cannabis annually and the Warehouse
project is estimated to produce 2,500 lbs annually when fully completed.
Grown Rogue is located in the famed Emerald
Triangle, which is well-known for the quality of its marijuana. With both indoor and outdoor operations, Grown Rogue is able to
produce the high quality indoor flower through controlled atmosphere environment (CAE) operations. By carefully controlling temperature,
humidity, C02 levels and other criteria, Grown Rogue is able to provide year-round supply of high quality marijuana flower with
multiple harvests per month.
With its location in Southern Oregon, Grown
Rogue is also able to capitalize on an ideal outdoor growing environment where it can produce high quality, low cost marijuana
to serve as feed stock for the other products Grown Rogue offers (vape cartridges, concentrates, pre-rolls, and edibles). Grown
Rogue is able to produce this feed stock at 3 to 4 times cheaper than indoor production costs and is thus able to establish competitive
market prices.
Product
The products Grown Rogue produces include
a variety of flower products (indicas, sativas, and hybrids), both high CBD and THC strains, pre-rolls, vape cartridges, and other
derivative products to establish a more diverse and full service opportunity for its dispensary customers. Grown Rogue has a suite
of “core” strains that represent the primary product line that consumers can rely upon every time they arrive at their
local dispensary. In addition to the “core” product offerings, Grown Rogue also provides seasonal strains for both
indoor and outdoor product. This variety appeals to the consumer by offering a diverse product with competitive market pricing.
Grown Rogue is establishing a unique approach
in the current cannabis industry market place by bringing a large variety of unique strains. This variety allows Grown Rogue to
meet the various demands of the consumer as well as provide a complete suite of strain specific products from the original seed
to final derivative products. This allows each customer to select their own preferred consumption method and still enjoy Grown
Rogue products. Grown Rogue flower is award winning in one of the most competitive cannabis production environments in the world.
Grown Rogue won the prestigious Growers Cup competition where a select number of reputable producers were all provided the identical
genetic which tests the growers techniques. Grown Rogue won 1
st
place for highest THC content, 1
st
place
for highest terpene content, and 3
rd
place in the growers choice category. In addition, Grown Rogue believes it has
achieved an outdoor production, potency record in the state of Oregon achieving a THC potency of 35.13% for it Monkey Train strain.
In March 2019, Grown Rogue won awards at the prestigious SunGrowers Guild for 1st place for highest Myrcene percentage for Mickey
Kush 2nd place for highest Limonene percentage for Jack Train.
Grown Rogue pre-rolls are produced only
from flower (no trim) and are packaged in a patent pending nitrogen sealed glass tube to ensure only the freshest products for
the customer.
The vape cartridges are a combination of
both pure CO2 oil extraction, which provides the best in flavor, and distillate. The distillate is carefully flavored with specific
terpene ratios to enhance the flavors and experience for the customer. Grown Rogue uses only the best hardware from reputable suppliers
to ensure limited malfunction of its products.
Grown Rogue produces a wide array of concentrate
products, including shatter, wax, live resin, and snap and pull. Only the best input material is utilized in their concentrates
resulting in the highest quality products
Grown Rogue sources all of its equipment
and materials from vendors it believes to be reliable from both cannabis centric companies (i.e. hydroponic grow stores) and conventional
agriculture solutions. Pricing is generally lower than retail pricing as Grown Rogue sources the majority of their supplies directly
from the manufacturer .
On December 10, 2018, Grown Rogue announced
the launch of an edible line through a partnership with Jeff Shepherd, a world renowned Chocolatier. The partnership will feature
TCH and CBD infused chocolate products under the GRAM and Grown Rogue brands – both whollyowned by the Company. GRAM Dark
Chocolate edibles are now available in a select number of the 221 Oregon dispensaries that carry the Grown Rogue brands. The terms
of the joint venture include a 60% ownership of the joint venture entity by Grown Rogue which will contract with Rogue Distribution
to provide distribution services for all of the products. The joint venture was formed through Idalia LLC, an Oregon limited liability
company.
Genetics
Grown Rogue previously contracted with
a geneticist to provide proprietary genetic lines into the Grown Rogue portfolio. Through the implementation of this robust breeding
and phenotype selection program, Grown Rogue is focused on identifying and capturing the specific genetic traits that consumers
are requesting. The end goal of this work is to have patented proprietary strains that Grown Rogue can license as well as work
toward establishing stable seed that can be used in Grown Rogue production.
All of Grown Rogue genetics are rigorously
tested to establish the genetic makeup of each strain in its portfolio.
Distribution and Sales
Grown Rogue distributes product through
its wholly owned subsidiary, GR Distribution, doing business as Rogue Distribution, which works directly with Oregon dispensaries
to provide quality, consistency, and product variety year-round. Grown Rogue’s sales team works directly with dispensary owners
and intake managers to provide consistent product, competitive prices, and service using sales techniques from other industries
such as pharmaceutical and liquor. Rogue Distribution has also developed relationships with many existing brands and provides exclusive
distribution services for those brands in the State of Oregon and first rights for distribution in other states that Grown Rogue
enters as part of a broader product offering. This allows Grown Rogue to rapidly expand its brand presence in new states by providing
the nexus for the best brands in the states Grown Rogue works to enter. Grown Rogue typically charges for distributing these products
a markup ranging from 15% to 45% depending on several factors. This allows Grown Rogue to increase its product offerings for dispensaries
and simplify their purchasing process by reducing the number of vendors that each dispensary needs to work with.
By way of example, Grown Rogue has developed
end user product marketing collateral and other educational information regarding Grown Rogue products as part of all sales with
dispensaries that include strain type, testing results, information on the product and specific company and other necessary information
to clearly articulate the product being provided. Each product is uniquely packaged all while maintaining brand consistency across
the product suite.
Grown Rogue works with dispensary owners
to develop promotional opportunities for the retail customers and bud tenders. This is structured in the form of providing select
“rare” strains, clothing, or other items that are provided to certain customers based on their loyalty and/or purchasing
volume. Grown Rogue provides detailed tutorials to the staff and owners of the dispensaries around the product and how it is grown,
processed, cured, packaged and other items so that they are intimately familiar with the Grown Rogue process. Grown Rogue also
provides expense paid trips for dispensary owners and operators to Grown Rogue’s operating facilities so they can see first-hand
the methods and processes used to create the product. Grown Rogue is implementing a proprietary software solution to streamline
the inventory and logistics of GR Distribution based on Microsoft Technology. This system allows Grown Rogue to provide real time
inventory analysis both internally and with dispensaries allowing for immediate re-ordering of Grown Rogue products simplifying
the supply chain logistics in the cannabis markets.
Branding
Building a cannabis brand is by far one
of the most critical aspects to a successful company in the sector. Currently, almost all cannabis brands are focused on one of
two aspects:
|
●
|
The flower and/or quality of the flower as the flower
is the raw material for all cannabis products.
|
|
●
|
The effect, mostly focused on impact of the product.
|
The above two components largely benefit
the current cannabis consumer, or legacy cannabis user, who has a solid understanding of strains and the effects they tend to generate.
While Grown Rogue prides itself on the
highest quality flower, its brand aims to penetrate into broader, mainstream markets through a promise of “enhancing consumer
life experience.” The Grown Rogue brand is focused on delivering a true “Seed to Experience” that accomplishes
several key objectives:
|
1.
|
Addresses the negative stigma attached to cannabis
at both a cultural and regulatory level.
|
|
2.
|
Establishes the company’s core values and purpose.
|
|
3.
|
Forecasts the company’s trajectory and market
positioning.
|
Everyday experiences like running, reading
a book, sharing a beverage with friends, or creative writing can be enhanced with the right strain of cannabis properly ingested
at the right dosage. Grown Rogue is deeply focused on enhancing consumer experience and thus aims to provide intelligence and education
around the various strains, genetic disposition, and the key product characteristics from profile testing. The education Grown
Rogue provides through digital channels develops best practices and community engagement as the company strives to eliminate the
“dark mystery” historically associated with cannabis. Grown Rogue attempts to provide the market with detailed knowledge
on the plant. To this end, Grown Rogue has developed proprietary classifications on how the cannabis product affects a consumer,
physically and psychologically based on analysis of THC potency, Terpene mix, user feedback, and various other internal metrics.
Within these classifications is a range of cannabis strains
that help to enhance certain types of experiences. Grown Rogue continues to study and iterate this proprietary classification
system to ensure the categories meet consumer expectations.
The brand strategy is to provide both the
experienced cannabis user and the cannabis curious, potential user with information that will guide their purchasing decisions
in the most concise and beneficial manner possible to ensure they purchase the right product for the experience they are seeking
to enhance.
From a social media standpoint,
Grown Rogue is committed to providing a universal appeal that is not specific to one market or consumer segment. Grown Rogue
has built a large social following by combining imagery and text that educates, empowers and inspires by focusing on our team
as they cultivate, trim, and package Grown Rogue products plants and life style imagery that shows consumers in settings and
situations where experiences can be enhanced with cannabis. Our brand strategy allows us to build a broad community of both
active and potential consumers who live in locations around the United States.
In
June 2018, Grown Rogue launched GRAM, its second brand into the Oregon market (after its first brand “Grown Rogue”).
GRAM is focused on providing the highest quality products at the most competitive prices. GRAM currently is focusing on pre-rolls
and shatter.
Marketing
and Advertising
Grown
Rogue’s marketing channels include a comprehensive, fully responsive (mobile) interactive website. The website has been
search engine optimized (SEO) and includes call to action (CTA) boxes that request contact information so consumers, and potential
consumers, can join our community.
Grown
Rogue is focused on providing education to the large majority of new and existing consumers. This education will be focused on
providing blogs and articles that highlight important topics and information to further enhance the public’s understanding
of the myriad of uses and benefits of cannabis.
Digital
and print advertising will be used to reach our endemic audience where Grown Rogue are selling or distributing products.
Grown
Rogue has established a social media presence that includes Facebook, Twitter, and Instagram. Grown Rogue’s social identity
will be defined by delivering fresh content and keeping interaction with followers/fans prompt and positive. Grown Rogue intends
to attract existing cannabis industry participants as well as people not familiar with the industry by creating a positive, inclusive
environment where dialogue is encouraged. The goal is to change existing stereotypes and overcome the stigmas associated with
the cannabis industry.
Trademarks
and Patents
Grown
Rogue actively seeks to protect its brand and intellectual property. Grown Rogue currently has eleven different trademarks that
have been submitted with three that have been Registered
|
●
|
Grown
Rogue was filed on September 22, 2017 and registered on August 7, 2018 under Registration No. 5537240
|
|
●
|
The
Right Experience Every Time was filed on September 29, 2017 and registered on August 7, 2018 under Registration 5537260.
|
|
●
|
Sizzleberry
was filed on September 29, 2017 and registered on August 7, 2018 under Registration 5537259.
|
|
●
|
Groove;
Relax; Optimize; Uplift; Energize, GRAM are all under review.
|
Grown
Rogue filed a patent for its nitrogen sealed glass containers on February 15, 2018. This patent application, No: 15/897,906 is
pending review by the United States Patent Office.
Social
and Environmental Policies
Grown
Rogue employs sustainable business models in all of its operations. On the cultivation side, Grown Rogue maintains the highest
standards of environmental stewardship. This includes sustainable
water sources with reclamation
and recapture as much as possible from runoff and recycling of dehumidification water. Grown Rogue uses only natural and organic
products in all of their applications from nutrients to integrated pest management. Grown Rogue has obtained the “Clean
Green” certification for its use of sustainable, natural, and organically based practices, which is generally considered
to be the highest level of sustainable cannabis practices in the US. These are standard industry best practices that have little
to no impact on capital expenditures.
Grown
Rogue hires and pays living wage to all of its employees and is very involved in each of the communities where it operates.
Expansion
into California and Michigan
On
December 5, 2018, Grown Rogue announced its expansion into California and that it secured 16,000 square feet of real estate in
California’s Humboldt County, as part of a multistate expansion of its operations into California through its subsidiary
GRD Cali, LLC. GRD Cali, LLC has received licensing approval from the City of Eureka and anticipates full distribution license
approval from the State of California shortly. In 2019, Grown Rogue plans to build out the 16,000 square feet California location
to add a manufacturing lab as well as retail operations.
Grown
Rogue has also expanded its business into California, currently the largest cannabis market in the United States with an anticipated
market of over US$7.7 billion by 2021 [Source: Report from Arcview Market Research and BDS Analytics, April 2018] by forming a
joint venture facility in northern California to position Grown Rogue in the largest production area in the United States. The
terms of the joint venture include a 60% ownership of the joint venture entity by Grown Rogue, free rent of an existing 16,000
square foot former chip manufacturing and packaging plant for 24 months, with conditional approval by the local municipality for
a microtier business that includes distribution, production, retail and manufacturing. Grown Rogue intends to use this facility
as its sourcing center for production materials that it will then sell to other distribution companies and for direct sale to
retail dispensaries through an inhouse sales team. The joint venture will be formed through GRD Cali, LLC, a California company.
Grown Rogue’s focus in California is to start with distribution, move into extraction (manufacturing), and ultimately retail.
Grown Rogue believes California will ultimately see similar price compression as other recreational states and therefore does
not anticipate constructing or operating cultivation facilities in California for several years. Grown Rogue currently has received
local approval for distribution, volatile, and nonvolatile manufacturing. Grown Rogue has received state approval for distribution
license and anticipates first sales in Q2 2019. hold any licenses to operate its business in California, and intends to obtain
such required licenses prior to entering the California market.
On
December 5, 2018, GRIN announced its expansion into Michigan and its plans to acquire operational control of the following
assets in Michigan pending Municipal and State regulatory approval:
|
●
|
Two
strategically located proposed provisioning centers (retail dispensaries) in high demand regions in Midtown Detroit and Hazel
Park where limited municipal licenses have been granted.
|
|
●
|
A
proposed 19,000 sq ft indoor cultivation and processing facility in Detroit, Michigan capable of producing 1,500,000 grams
of dried cannabis flower annually at full production; and
|
|
●
|
An
entity that has received multiple municipal cultivation licenses for a 28-acre parcel located in the northern portion of the
lower Michigan peninsula.
|
Once
fully licensed, Grown Rogue will offer consumers in California and Michigan locally produced Grown Rogue branded products. Michigan
licenses are very competitive requiring State, Municipal, and realestate approvals. Grown Rogue’s assets are all either
fully approved or in final stages of obtaining full approval further distinguishing the Grown Rogue assets as actionable and closing
the window on achieving revenue.
Economic
Outlook
Grown
Rogue will continue focusing on expanding and growing its business model both in the existing states and additional states to
establish itself as one of the premier multistate cannabis companies. The proven business model, established in Oregon, has been
successfully expanded into California and Michigan and is focused on providing consumers with best in class, innovative products.
Grown Rogue now controls assets that will allow for operation of up to 22 licenses in three states and will continue expanding
upon this foundation as the business grow. Grown Rogue will continue to look for organic and accretive growth. Accretive growth
through acquisition or merger will be a key objective for Grown Rogue in all of the states they operate or look to enter. Grown
Rogue is currently assessing additional states that meet their entry criteria and is targeting 3 additional states to enter by
end of 2020.
Grown
Rogue executives and technical staff have significant cannabis and business experience that includes extensive knowledge of indoor,
outdoor, and greenhouse growing conditions required to optimize productivity; financial; sales; marketing;
and branding. With the necessary specialized skill sets of the management team, Grown Rogue believes that all of the necessary
skill and labor is available to execute upon its multistate expansion strategy as long as Grown Rogue is able to continue attracting
and retaining top tier talent.
Grown
Rogue’s intellectual property subsidiary, GRIP, has been in operation since late 2016. GRIP focuses on all branding and
marketing, genetic research, cultivation analytics, and intellectual property protection. GRIP’s brands (Grown Rogue &
GRAM) are licensed to Grown Rogue and its other subsidiaries. GRIP will continue developing new brands and ideas to be licensed
to Grown Rogue or other cannabis based companies in the territories that Grown Rogue targets for expansion.
Grown
Rogue is also working to develop a luxury edible product line that will fall under the Grown Rogue brand that will include additional
products than just chocolate bars. These products are currently under R&D and market research with expected launch in 2019.
The
Company aims to continue to building its premier Seed to Experience brand. The Seed to Experience branding will be built through
continued focus on digital media and advertisement, social presence and search engine optimization, continuing development of
the ROGUE Study, and increasing the number of events at retail locations allowing for direct access to the consumer. The Company
currently controls premier advertising space in a number of industry magazines and will continue to increase its presence over
the next 12 months by adding to the number of advertising campaigns. Social media and website presence will increase through better
content and high resolution photography. Dispensary events provide one of the best options for connecting with the consumer and
educating them on the Grown Rogue brand. Currently Grown Rogue completes 10 to 15 events monthly at a cost of $200/event and plans
on increasing this frequency to 25 to 30 events monthly at $400 an event with an increased focus providing branded materials in
the form of hats, shirts, stickers, and other useful materials to further the brand penetration.
During
the year ended October 31, 2018, the Company entered into a technology license agreement (the “Technology License Agreement”)
pursuant to which, the Company was granted the exclusive license to certain intellectual property in the field of development,
breeding, cultivation, growing, harvesting, processing and commercializing cannabis, hemp and related plants and products (the
“Technology”).
California
Grown
Rogue’s plans in California are focused on establishing brand presence for the current portfolio of both internal and external
brands. The facility in Eureka will all the Company to source and distribute products across the state. With the manufacturing
license being obtained and construction being finished, Grown Rogue will be able to establish lower cost of goods on the manufactured
products increasing our competitive pricing in the state. With both volatile and nonvolatile licenses, edibles, cartridges, and
concentrate products will all be available. Grown Rogue anticipates first sales in California during Q2 2019.
Grown
Rogue anticipates similar price compression and supply glut as seen in Oregon and thus believes to be well positioned to navigate
these challenges based on experience in Oregon. As such, Grown Rogue does not anticipate building or operating any cultivation
facilities for at least 2 years. The Company will look to partner with select cultivators under direct purchase or contract manufacturing
where the Company can bring their awardwinning cultivation methods to ensure the highest quality products.
Michigan
Grown
Rogue views Michigan as a platform state and will be deploying considerable resources and focus in the state over the next 12
to 24 months. With the large market potential, the high barriers to entry, and the partnerships already established, Grown Rogue
is poised to capture considerable market share inside of the Michigan market. With the success created in Oregon and the understanding
of where the cannabis consumer is headed, Grown Rogue is excited to bring the future of cannabis into these new markets in the
Midwest and eastern portion of the US.
Grown
Rogue will be looking to add additional dispensaries and cultivation into the Michigan portfolio over the coming year to ensure
the correct branding and product consistency is available. Early in the life cycle of new states ensuring product supply to meet
demand is critical and that means controlling the entire supply chain through vertical integration.
Oregon
Despite
the price compression and oversupply in Oregon, Grown Rogue continues to experience outsized demand for our products. The current
infrastructure does not supply enough product inventory to meet the market demand and thus Grown Rogue will be looking to diversify
and add production capacity to our portfolio in 2019. This will be accomplished through continued sourcing of high quality products
from our partner farms, acquisition or merger of additional manufacturing capacity of existing cultivation licenses, building
additional cultivation capacity or contract management of existing operations.
The
Farm property is a 100+ acre pear orchard property with significant infrastructure and priority water rights, with a total licensable
canopy of approximately 280,000 sq feet. The Farm is anticipated to be acquired through an owner carry arrangement for Grown Rogue
to purchase the property in five years.
Grown
Rogue, through its subsidiary GR Gardens, has already submitted a Tier II producer license application to the OLCC for 40,000
sq feet of canopy at an existing 100+ acre farm in Oregon. With a total potential capacity of 280,000 sq feet of additional canopy,
this project would satisfy the Grown Rogue production requirements for the forseeable future. Execution of this project would
require purchasing the farm and spending considerable sums of money to effectuate the buildout. Grown Rogue is considering this
option as it relates to other options in Oregon and the other states.
GR
Gardens anticipates securing a processing license in Q2 2019 that would allow it to produce its own derivative products, with
expected decreases in costs and greater assurance of consistency of production. The extraction lab is anticipated to be constructed
at the Warehouse.
Grown
Rogue, through one or more of its subsidiaries, also anticipates securing retail establishments in Oregon through strategic partnerships
or acquisitions to fulfill the vertical integration strategy of Grown Rogue and to help ensure quality and consistency in the
supply chain. Grown Rogue anticipates establishing its retail presence inside of Oregon by middle of 2019.
Definitive
Transaction Agreement and Reverse Takeover Transaction
On
October 31, 2018, the GR Unlimited, Novicius Corp. (“
Novicius
”), Grown Rogue Canada Inc. and Novicius Acquisition
Corp. entered into a definitive transaction agreement which set out the terms for the reverse takeover of Novicius by GR Unlimited
and the related transactions (the “
Transaction
”). The Transaction was completed on November 15, 2018 and
the Company began trading its common shares through the facilities of the Canadian Securities Exchange under the symbol “GRIN”
on November 26, 2018.
As
part of the Transaction, the Company changed its name from “Novicius Corp.” to “Grown Rogue International Inc.”
and consolidated its existing common shares on the basis of one common share for each 1.4 existing common shares. The unitholders
of GR Unlimited exchanged their equity membership interests to GR Unlimited for common shares of the Company on a oneforone basis.
The Transaction resulted in the Company becoming the owner all of the equity membership interests in GR Unlimited. In connection
with the Transaction, GR Unlimited, directly and through Grown Rogue Canada Inc., raised approximately $6.5 million through brokered
and nonbrokered private placements.
For
further details regarding the Transaction and related financings, please refer to the Company’s Listing Statement filed
on SEDAR on November 23, 2018.
Going
Concern
The
Company’s ability to continue as a going concern is dependent upon, but not limited to, its ability to raise financing necessary
to fund its development programs and general and administrative expenses, discharge its liabilities as they become due and generate
positive cash flows from operations. There is no certainty that the Company will be successful in raising additional capital or
creating positive cash flow from operations..
Selected
Annual Information
The
following selected financial data for each of the two completed financial years are derived from the audited annual financial
statements of the Company.
Year
Ended October 31
|
|
2018
|
|
|
2017
(1)
|
|
|
|
$
|
|
|
$
|
|
Total revenue
|
|
1,932,128
|
|
|
156,066
|
|
Loss
from operations
|
|
|
(4,736,382
|
)
|
|
|
(138,854
|
)
|
Net loss
|
|
|
(6,552,856
|
)
|
|
|
(302,397
|
)
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
5,342,756
|
|
|
|
2,914,491
|
|
Total noncurrent
financial liabilities
|
|
|
2,333,894
|
|
|
|
1,069,139
|
|
Cash dividends
|
|
|
Nil
|
|
|
|
Nil
|
|
|
(1)
|
For
the period from October 31, 2016 to October 31, 2017.
|
Results
of
Operations
Grown
Rogue’s net loss from operations amounted to $4,798,562 for the three months ended January 31, 2019, an increase of $3,461,467
when compared to a loss from operations of $1,337,095 for the three months ended January 31, 2018. The main component driving
this loss for the three months ended January 31, 2019 are transaction costs of $3,723,724, the majority of which relate to the
fair value of shares issued to effect the Transaction. These expenses are not expected to recur in the future.
Revenue
for the three months ended January 31, 2019 increased by $663,349 to $834,309 from $170,960 during the three months ended January
31, 2018. The increase is a result of the addition of a sales team and third party distribution as well as an increase in awareness
of the Grown Rogue brand.
Cost
of sales for the three months ended January 31, 2019 amounted to $577,979 while cost of sales for the three months ended
January 31, 2018 were $485,165. Included in cost of sales for the three months ended January 31, 2019 is an unrealized gain
on changes in fair value of biological assets of $44,830. Cost of sales for the three months ended January 31, 2108 was
increased by an unrealized loss on changes in fair value of biological assets in the amount of $366,079. These fair
market adjustments relate to increasing the fair value (less costs to sell) of the cannabis crops in various stages of growth
prior to harvest and any further processing required to produce inventory available for sale. The valuation of Grown
Rogue’s biological assets, and the resulting fair market adjustment, includes several estimates made by management
based on inputs that, by their nature, are unobservable as at January 31, 2019 and 2018. These include the average harvest
yield, average selling prices, standard costs to bring the plants to harvest, as well as the stage of growth. Changes in
these estimates could result in changes to the fair value of the biological assets, as well as the unrealized gain on changes
in the fair value of these biological assets.
For
three months ended January 31, 2019, the Company earned a gross margin of $256,330. A negative gross margin of $314,205 was incurred
during three months ended January 31, 2018. This negative gross margin during fiscal 2018 was a function of a decrease in the
sale price of certain products and its effect on the carrying value of the Company’s biological assets and resulting inventory,
as well as higher labor costs included in cost of sales as the Company scaled up and trained its labor force in proper cultivation
and packaging processes. The higher estimated sale prices for some of the Company’s products over the course of the growth
cycle, resulted in increased values being ascribed to some of the Company’s inventory based on the valuation methodology
for the Company’s biological assets as described above. As the market price was higher during the growth process, a higher
fair value was assigned to these assets. Once the growth stage was complete, however, the market price had decreased, such that
the carrying value of the inventory was higher than the sales price at the time the product was ready for sale. The Company has
since refined its cultivation processes to be more efficient resulting in lower cost of sales and a better gross margin.
Operating
expenses for the three months ended January 31, 2019 were $4,915,040, an increase of $4,238,763 when compared to expenses of $676,277
for the three months ended January 31, 2018. Included in operating expenses for the three months ended January 31, 2019 were transactionspecific
costs of $3,723,724, as discussed previously. Expenses for the three months ended January 31, 2018 were low as the Company was
still in the process of ramping up operations. While there were overall increases among all expenses as the Company increased
the scope of its operations, the most significant areas of increased expenses relate to salaries and benefit expenses as the Company
continued to increase its number of staff, marketing and promotion, investor relations and travel expenses. Facility and utilities
expenses increased based on the continued development of the Company’s premises. The Company also incurred bad debt expenses
of $51,594 related to an increase in its allowance for doubtful accounts which is a function of having a growing customer base
and higher sales.
During
the years ended October 31, 2017 and 2018, GR Unlimited issued convertible promissory notes with an aggregate face value of $3,395,275.
While nearly all of the convertible promissory notes had been repaid or converted by January 31, 2019, the Company continued to
incur interest expense and accretion expense during the three months ended January 31, 2019. GR Unlimited also entered into two
finance leases for $268,184, in aggregate, and issued convertible debentures with aggregate principal of $1,141,060. The result
of these various debt financings is interest expense of $164,852 and accretion expense of $17,964 incurred during the three months
ended January 31, 2019. As a result of the various debt repayments and conversions into common units of GR Unlimited throughout
fiscal 2018, interest expense for the three month period had decreased by $172,658 when compared to interest expense of $172,658
incurred during the three months ended January 31, 2018.
Capital
Resources
As
at January 31, 2019, GR Unlimited had issued debt consisting of convertible and promissory notes and convertible debentures for
aggregate proceeds of $4,539,150, the proceeds of which were used to purchase property and equipment and fund working capital
requirements. In addition, GR Unlimited raised $225,000 through subscriptions for common units and $1,300,345 through subscriptions
for seed round preferred units. In connection with the Transaction, GR Unlimited and Grown Rogue Canada Inc. raised gross proceeds
of $3,338,893 through the issuance of subscription receipts that were eventually converted into common shares and warrants of
the Company upon close of the Transaction.
Summary
of Quarterly Results
The
following table sets out selected quarterly results of the Corporation for the eight quarters ended on or before January 31, 2019.
The information contained herein is drawn from the interim financial statements of the Corporation for each of the aforementioned
eight quarters.
Fiscal
Year
|
|
2019
|
|
|
2018
|
|
|
2017
|
|
Quarter
|
|
Jan
|
|
|
Oct
|
|
|
Jul
|
|
|
Apr
|
|
|
Jan
|
|
|
Oct
|
|
|
Jul
|
|
|
|
Apr
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
$
|
|
Revenue
|
|
|
834,309
|
|
|
|
790,236
|
|
|
|
679,906
|
|
|
|
291,026
|
|
|
|
170,960
|
|
|
|
145,222
|
|
|
|
10,844
|
|
|
|
Nil
|
|
Net
income (loss)
|
|
|
(4,798,562
|
)
|
|
|
(1,554,980
|
)
|
|
|
(1,460,380
|
)
|
|
|
(2,146,869
|
)
|
|
|
(1,390,627
|
)
|
|
|
95,476
|
|
|
|
(153,629
|
)
|
|
|
(244,244
|
)
|
Net
income
(loss), per unit basic and
diluted
|
|
|
(0.08
|
)
|
|
|
(0.41
|
)
|
|
|
(0.39
|
)
|
|
|
(0.57
|
)
|
|
|
(0.37
|
)
|
|
|
0.03
|
|
|
|
(0.04
|
)
|
|
|
(0.06
|
)
|
Liquidity
and Capital Resources
The
Company’s cash and cash equivalents position was $531,908 as at January 31, 2019 (October 31, 2018 - $826,643). The
Company had working capital of $840,575 as at January 31, 2019 compared to a working capital deficiency of $451,545 as at
October 31, 2018.
During the three months ended January 31, 2019, Grown Rogue spent $2,168,603 on operating activities, compared to cash spent
on similar activities of $921,157 for the three months ended January 31, 2018.
These
funds were primarily spent on operating expenses and inventory. The Company invested $84,428 in property and equipment and intangible
assets during the three months ended January 31, 2019, a decrease compared to investment in similar assets of $760,864 during
the three months ended January 31, 2018. Finally, Grown Rogue was able to generate cash of $1,955,421 through financing activities
during the three months ended January 31, 2019 by way of the issuance of subscription receipts of $3,234,893, which was offset
by other debt repayments and transaction and equity issuance costs. Cash generated during the three months ended January 31, 2018
from financing activities was $2,591,347 and was related to the issuance of members’ equity by way of partnership units
and the proceeds from long-term debt.
The
Company’s capital requirements to maintain its properties and fund exploration and general overhead expenses have been met
primarily through the completion of private placements.
Commitments
As
at January 31, 2019, Grown Rogue has commitments under operating leases for its facilities and commitments under finance lease
for equipment. The minimum lease payments due are as follows:
Fiscal
Year
|
|
Amount
|
|
2019
|
|
$
|
259,384
|
|
2020
|
|
$
|
227,772
|
|
2021
|
|
$
|
20,600
|
|
Off-Balance
Sheet Arrangements
The
Company does not have any off-balance sheet arrangements.
Outstanding
Unit Data
As
of the date of the MD&A, the Company has 71,653,598 common shares outstanding.
As
of the date of this MD&A, the Company has the following warrants outstanding:
Exercise
Price
|
|
|
Warrants
Outstanding
|
|
|
Remaining
Contractual Life
(Years)
|
|
|
Expiry
Date
|
$
|
17.50
|
|
|
|
16,883
|
|
|
|
0.42
|
|
|
August
31, 2019
|
$
|
14.00
|
|
|
|
17,183
|
|
|
|
0.66
|
|
|
November 30,
2019
|
$
|
0.44
|
|
|
|
757,125
|
|
|
|
1.62
|
|
|
November 15,
2020
|
$
|
0.55
|
|
|
|
21,253,089
|
|
|
|
1.62
|
|
|
November
15, 2020
|
|
|
|
|
|
22,044,279
|
|
|
|
1.61
|
|
|
|
Transactions
with Related Parties
During
the Reporting Period, the Company was involved in the following transactions with related parties:
|
a)
|
Through
its wholly owned subsidiary, GRU Properties, LLC leased 41.92 acres of real property
located in Trail, Oregon owned by J. Obie Strickler, the Company’s President and CEO.
The lease expires on December 31, 2020. Rent of $16,550 was included in facility expense
for the period ended January 31, 2019 (2018 - $15,500). The Company had $5,500 (October
31, 2018 $5,500) owing in accounts payable and accrued liabilities at January 31, 2019.
|
|
b)
|
The
Company incurred employee/director fees of $12,000 (2018 - $12,000) with an individual
related to J. Obie Strickler, the Company’s President and CEO. At January 31, 2019, due
to employee/ director includes $Nil (October 31, 2018 - $14,000) and accounts payable and
accrued liabilities includes $4,000 (October 31, 2018 - $12,000) payable to this individual.
|
|
c)
|
The
Company incurred fees related to marketing and promotion services of $94,292 (2018 - $87,785)
from two companies owned by Jacques Habra, the Company’s Chief Strategy Officer (“CSO”).
At January 31, 2019, accounts payable and accrued liabilities includes $24,703 (October
31, 2017 - $25,054) payable to these companies.
|
|
d)
|
Key
management personnel consists of the President and CEO; Executive Vice President,
CFO/General Counsel; and the CSO. The compensation paid or payable to key management
for services for the periods ended January 31, 2019 and 2018 is as follows:
|
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
Salaries and consulting
fees
|
|
$
|
156,792
|
|
|
$
|
147,785
|
|
Accounts
payable and accrued liabilities at January 31, 2019 includes $94,000 (October 31, 2018 - $94,000) and due to employee/directors includes $Nil (October 31, 2018 - $90,000) payable to these parties.
The
transactions are in the normal course of operations and are measured at the exchange amounts being the amounts agreed to by the
parties.
Critical
Accounting Judgments and Estimation Uncertainties
The
preparation of the consolidated financial statements in conformity with IFRS requires that the Company’s management make
critical judgments, estimates and assumptions about future events that affect the that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the
reported amounts of income and expenses during the reporting period. The estimates and associated assumptions are based on historical
experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates
and underlying assumptions are reviewed on an ongoing basis. The most significant judgments include those related to the ability
of the Company to continue as a going concern, the determination of when property and equipment are available for use, and impairment
of its financial and nonfinancial assets. The most significant estimates and assumptions include those related to the valuation
of biological assets, the collectibility of accounts receivable, the useful lives of property and equipment, inputs used in accounting
the determination of the discount rate used to estimate the fair value of the liability component of convertible promissory notes,
the inputs used in the estimate of the fair value of unit-based compensation and the inputs used in the estimate of the fair value
of the unit purchase option and warrants issued.
Newly
Adopted Accounting Pronouncements
The
Company adopted the following accounting policies as of November 1, 2018:
Financial Instruments
IFRS
9 financial instruments (“IFRS 9”) replaced IAS 39, Financial Instruments: recognition and Measurement. IFRS 9 includes
guidance on classification and measurement of financial instruments, a new expected credit loss model for calculating impairment
on financial assets and new general hedging requirements.
i)
Classification and measurement of financial assets and financial liabilities
IFRS
9 requires financial assets to be classified into three measurement categories on initial recognition: fair value through profit
and loss (“FVTPL”), fair value through other comprehensive income (“FVOCI”), and amortized cost. Investments
in equity instruments are required to be measured by default at FVTPL. IFRS 9 permit entities to elect into an irrevocable option
for equity instruments to report changes in fair value in other comprehensive income.
Classification
and measurement of financial assets is dependent on the entity’s business model for managing the financial assets and related
contractual cash flows. IFRS 9 retains most of the requirements of IAS 39 related to classification and measurement of financial
liabilities.
The
following table summarizes the impact of the adoption of IFRS 9 on the classification of the Company’s financial assets
and liabilities:
Asset/Liability
|
|
Classification
under IAS 39
|
|
Classification
under IFRS 9
|
Accounts
receivable, net
|
|
Loans
and receivables
|
|
Amortized
cost
|
Other
receivables
|
|
Loans
and receivables
|
|
Amortized
cost
|
Cash
and cash equivalents
|
|
Loans
and receivables
|
|
Amortized
cost
|
Accounts
payable and accrued liabilities
|
|
Other
liabilities at amortized cost
|
|
Amortized
cost
|
Finance
lease payable
|
|
Other
liabilities at amortized cost
|
|
Amortized
cost
|
Convertible
promissory notes
|
|
Other
liabilities at amortized cost
|
|
Amortized
cost
|
Long-term
debt
|
|
Other
liabilities at amortized cost
|
|
Amortized
cost
|
Interest
payable
|
|
Other
liabilities at amortized cost
|
|
Amortized
cost
|
Convertible
debentures
|
|
Other
liabilities at amortized cost
|
|
Amortized
cost
|
Due
to employee/director
|
|
Other
liabilities at amortized cost
|
|
Amortized
cost
|
IFRS
9 introduces a three-stage expected credit loss (“ECL”) model for determining impairment of financial assets. The expected
credit loss model does not require the occurrence of a triggering event before an entity recognizes credit losses. IFRS 9 requires
an entity to recognize expected credit losses upon initial recognition of a financial asset and to update the quantum of expected
credit losses at the end of each reporting period to reflect changes to credit risk of the financial asset. The adoption of the
ECL model did not have a material impact on the Company’s condensed consolidated interim financial statements.
Share-based
Payments (Amendments to IFRS 2)
In
June 2016, the IASB issued amendments to IFRS 2 that clarify how to account for certain types of share-based payment transactions.
The
amendments provide requirements related to accounting for:
|
●
|
the
effects of vesting and non-vesting conditions on the measurement of cash-settled share-based payments;
|
|
●
|
share-based
payment transactions with a net settlement feature for withholding tax obligations; and
|
|
●
|
the
effect of a modification of the terms and conditions of a share-based payment that changes the classification of the transaction
from cash-settled to equity settled.
|
Adoption
of the amendments to IFRS 2 as of November 1, 2018 did not have an impact on the Company’s financial statements.
Revenue
IFRS
15 Revenue from Contracts with Customers, (“IFRS 15”) replaced all preexisting guidance, including, but not limited
to IAS 11 Construction Contracts, IAS 18 Revenue, and IFRIC 15 Agreements for the Construction of Real Estate in IFRS related
to revenue. IFRS 15 contains a single control based model (the “model”) that applies to contracts with customers and
allows entities to recognize revenue at a point in time or overtime. The model consists of a 5 step analysis of transactions to
determine whether, how much, and when revenue is recognized. IFRS 15 also includes additional requirements for revenue accounted
for under the standard. Adoption of IFRS 15 as of November 1, 2018 did not have an impact on the Company’s financial statements.
Recent
Accounting Pronouncements
The
accounting pronouncements detailed below have been issued but are not yet effective.
IFRS
16, Leases (“IFRS 16”) was issued by the IASB in January 2016, and will replace IAS 17 Leases. IFRS 16 specifies the
methodology to recognize, measure, present and disclose leases. The standard provides a single lessee accounting model, requiring
lessees to recognize assets and liabilities for all leases except for short-term leases and leases with low value assets. IFRS
16 substantially carries forward the lessor accounting requirements in IAS 17. IFRS 16 is effective for annual periods beginning
on or after January 1, 2019, with early adoption permitted if IFRS 15 has also been adopted. A lessee will apply IFRS 16 to its
leases either retrospectively to each prior Reporting Period presented; or retrospectively with the cumulative effect of
initially applying IFRS 16 being recognized at the date of initial application. The Company is currently evaluating the impact
of IFRS 16 on its consolidated financial statements.
Financial
Instruments and Other Risk Factors
As at January 31, 2019,
the Company had accounts payable and accrued liabilities of CAD$100,965. The Company is exposed to the risk of fluctuation in
the rate of exchange
between the Canadian Dollar
and the United States Dollar. It is management’s opinion that this risk is not material.
At
January 31, 2019 and October 31, 2018, the Company’s exposure to interest rate risk relates to long-term debt, convertible promissory
notes, and finance lease obligations, but its interest rate risk is limited as the aforementioned financial instruments are fixed
interest rate instruments.
Credit
risk is derived from cash and trade accounts receivable. The Company places its cash in deposit with major United States financial
institutions. The Company has established a policy to mitigate the risk of loss related to granting customer credit.
The
carrying amount of cash and trade accounts receivable represents the Company’s maximum exposure to credit risk, which
amounted to $847,600 (October 31, 2018 - $1,079,551) as at January 31, 2019. The allowance for doubtful accounts at January
31, 2019 is $158,037 (October 31, 2018 - $106,443).
Liquidity
risk represents the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities.
The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities
when they become due. At January 31, 2019, the Company has current assets of $2,754,443 and current liabilities of $1,913,868,
which resulted in working capital of $840,575.
The
carrying amounts for the Company’s cash, accounts receivable, amounts due from a related company, short-term advance to a
related party, accounts payable and accrued liabilities, amounts due to employee/director, short-term advance payable, promissory
notes and convertible promissory notes approximate their fair values because of the short-term nature of these items.
A
number of the Company’s accounting policies and disclosures require the measurement of fair valued for both financial and nonfinancial
assets and liabilities. The Company has an established framework, which includes team members who have overall responsibility
for overseeing all significant fair value measurements, including Level 3 fair values. When measuring the fair value of an asset
or liability, the Company uses observable market data as far as possible. The Company regularly assesses significant unobservable
inputs and valuation adjustments. Fair values are categorized into different levels in a fair value hierarchy based on the inputs
used in the valuation techniques as follows:
Level
1: quoted prices (unadjusted) in active markets for identical assets or liabilities
Level
2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly
Level
3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).
During
the period ended January 31, 2019 there were no transfers of amounts between levels.
Regulatory
Disclosure
Grown
Rogue derives a substantial portion of its revenues from the cannabis industry in the United States, which industry is illegal
under United States federal law. Grown Rogue is indirectly involved (through subsidiaries) in the cannabis industry in the United
States where local state laws permit such activities. Currently, its subsidiaries are directly engaged in the manufacture, possession,
use, sale or distribution of cannabis in the recreational cannabis marketplace in the State of Oregon. Grown Rogue also intends
to enter the California and Michigan markets.
The
United States federal government regulates drugs through the Controlled Substances Act (the “
CSA
”), which
places controlled substances, including cannabis, in a schedule. Cannabis is classified as a Schedule I drug. Under federal law,
a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States and a lack of accepted
safety for the use of the drug under medical supervision. The United States Food and Drug Administration has not approved marijuana
as a safe and effective drug for any indication.
In
the United States cannabis is largely regulated at the state level. Notwithstanding the permissive regulatory environment of medical
cannabis at the state level, and the increasing number of states with legal recreational frameworks, cannabis continues to be
categorized as a Schedule I controlled substance under the CSA and as such, violates federal law in the United States. Senators
Elizabeth Warren and Cory Gardner have introduced a bipartisan Senate bill titled “Strengthening the Tenth Amendment Through
Entrusting States (STATES) Act” that would lift the Controlled Substance Act’s restrictions on cannabis in states
that have written their own laws. However, there can be no assurances as to when this bill will pass, or if it will pass at all.
The Supremacy Clause of the United States Constitution and United States federal laws made pursuant to it are paramount and in
case of conflict between federal and state law in the United States, the federal law shall apply.
As
a result of the conflicting views between state legislatures and the United States federal government regarding cannabis, investments
in cannabis businesses in the United States are subject to inconsistent legislation and regulation. The response to this inconsistency
was addressed in August 2013 when then Deputy Attorney General, James Cole, authored a memorandum (the “
Cole Memorandum
”)
addressed to all United States district attorneys acknowledging that notwithstanding the designation of cannabis as a controlled
substance at the federal level in the United States, several US states had enacted laws relating to cannabis for medical and recreational
purposes. The Cole Memorandum outlined certain priorities for the Department of Justice relating to the prosecution of cannabis
offenses. In particular, the Cole Memorandum noted that in jurisdictions that enacted laws legalizing cannabis in some form and
that also implemented strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale and
possession of cannabis, conduct in compliance with those laws and regulations is less likely to be a priority at the federal level.
In
March 2017, newly appointed Attorney General Jeff Sessions again noted limited federal resources and acknowledged that much of
the Cole Memorandum had merit; however, he disagreed that it had been implemented effectively and, on January 4, 2018, Attorney
General Jeff Sessions issued a memorandum (the “
Sessions Memorandum
”) that rescinded the Cole Memorandum.
As a result of the Sessions Memorandum, federal prosecutors are no longer bound by the priorities in the Cole Memorandum relating
to the prosecution of cannabis activities despite the existence of statelevel laws that may be inconsistent with federal prohibitions.
There
is no guarantee that state laws legalizing and regulating the sale and use of cannabis will not be repealed or overturned, or
that local governmental authorities will not limit the applicability of state laws within their respective jurisdictions. Unless
and until the United States Congress amends the Controlled Substances Act with respect to medical and/or adultuse cannabis (and
as to the timing or scope of any such potential amendments there can be no assurance), there is a risk that federal authorities
may enforce current federal law. If the federal government begins to enforce federal laws relating to cannabis in states where
the sale and use of cannabis is currently legal, or if existing applicable state laws are repealed or curtailed, Grown Rogue’s
business, results of operations, financial condition and prospects would be materially adversely affected. Until Congress amends
the federal law with respect to marijuana use, there is a risk that federal authorities may enforce current federal law against
companies such as Grown Rogue for violation of federal law or they may seek to bring an action or actions against Grown Rogue
and/or its investors for violation of federal law or otherwise, including, but not limited to, a claim against investors for aiding
and abetting another’s criminal activities.
In
light of the uncertainty surrounding the treatment of United States cannabisrelated activities, including the rescission of the
Cole Memorandum, the Canadian Securities Administrators published a staff notice (Staff Notice 51-352 (Revised)) on February 8,
2018 setting out certain disclosure expectations for issuers with United States cannabisrelated activities. Staff Notice 51-352
(Revised) includes additional disclosure expectations that apply to all issuers with United States cannabisrelated activities,
including those with direct and indirect involvement in the cultivation and distribution of cannabis, as well as issuers that
provide goods and services to third parties involved in the United States cannabis industry.
In
accordance with the Canadian Securities Administrators Staff Notice 51-352 (Revised) –
Issuers with U.S. MarijuanaRelated
Activities
(“Staff Notice 51-352”), below is a table of concordance that is intended to assist readers in identifying
the disclosure expectations outlined in Staff Notice 51-352.
In
accordance with Staff Notice 51-352, this section provides a discussion of the federal and statelevel U.S. regulatory regimes
in the jurisdictions where Grown Rogue is currently directly involved through its subsidiaries or is planning to be directly involved
in the future. Certain Grown Rogue subsidiaries are directly engaged in the manufacture, possession, use, sale or distribution
of cannabis in the recreational cannabis marketplace in the State of Oregon. Grown Rogue also intends to enter the California
and Michigan markets. In accordance with Staff Notice 51-352, Grown Rogue will evaluate, monitor and reassess this disclosure,
and any related risks, on an ongoing basis and the same will be supplemented and amended to investors in public filings, including
in the event of government policy changes or the introduction of new or amended guidance, laws or regulations regarding marijuana
regulation. Any non-compliance, citations or notices of violation which may have an impact on Grown Rogue’s licenses, business
activities or operations will be promptly disclosed by Grown Rogue.
All
Issuers with US
Marijuana-Related Activities
|
|
Response
|
Describe
the nature of the issuer’s involvement in the U.S. marijuana industry and include the disclosures indicates for at least
one of the direct, indirect and ancillary industry involvement types.
|
|
See above under “Description of Business”.
See below under “U.S. Regulatory Matters”
|
|
|
|
Prominently
state that marijuana is illegal under US federal law and that enforcement of relevant laws is a significant risk
|
|
See
above
|
Discuss
any statements and other available guidance made by federal authorities or prosecutors regarding the risk of enforcement action
in any jurisdiction where the issuer conducts U.S. marijuana-related activities.
|
|
See
below under “U.S. Regulatory Matters”
See
the following risk factors included in the Company’s Listing Statement available on www.SEDAR.com:
Section
17 –
Risk Factors – Grown Rogue’s Business is Illegal under U.S. Federal Law
Section
17 –
Risk Factors – Because marijuana is illegal under federal law, investing in cannabis business could be found
to violate the US Federal CSA
|
Outline
related risks including, among others, the risk that third party service providers could suspend or withdraw services and
the risk that regulatory bodies could impose certain restrictions on the issuer’s ability to operate in the U.S.
|
|
See
the following risk factors included in the Company’s Listing Statement available
on www.SEDAR.com:
Section
17 –
Risk Factors – Grown Rogue’s Business is Illegal under U.S. Federal Law
Section
17 –
Risk Factors – Because marijuana is illegal under federal law, investing in cannabis business could
be found to violate the US Federal CSA
Section
17 –
Risk Factors – Risks Relating to Other Laws and Regulations
Section
17 –
Risk Factors – Current and Future Consumer Protection Regulatory Requirements
|
|
|
Section 17 –
Risk
Factors – Operational Risks
Section 17 –
Risk
Factors – Grown Rogue will not be able to deduct many normal business expenses
Section 17 –
Risk
Factors – External Factors
Section 17 –
Risk
Factors – Failure to Protect Intellectual Property
Section 17 –
Risk
Factors – Agricultural Operations
Section 17 –
Risk
Factors – Liability, Enforcement Complaints etc.
Section 17 –
Risk
Factors – Grown Rogue’s business is highly regulated and it may not be issued necessary licenses, permits, and
cards
Section 17 –
Risk
Factors – Licenses
Section 17 –
Risk
Factors – Local Laws and Ordinances
Section 17 –
Risk
Factors – Third party service providers to Grown Rogue may withdraw or suspend their service
Section 17 –
Risk
Factors – Grown Rogue may not be able to obtain or maintain a bank account
Section 17 –
Risk
Factors – Grown Rogue’s contracts may be unenforceable and property may be subject to seizure
Section 17 –
Risk
Factors – The protections of US bankruptcy law may be unavailable
Section 17 –
Risk
Factors – Grown Rogue may have a difficult time obtaining insurance which may expose Grown Rogue to additional risk and
financial liabilities
Section 17 –
Risk
Factors – Grown Rogue’s websites are accessible in jurisdictions where medicinal or recreational use of marijuana
is not permitted and, as a result Grown Rogue may be found to be violating the laws of those jurisdictions
Section 17 –
Risk
Factors – The marijuana industry faces significant opposition in the United States
|
Given the illegality of marijuana under US federal
law, discuss the issuer’s ability to access both public and private capital and indicate what financing options are/are
not available in order to support continuing operations.
|
|
See above under “Description of Business”.
See the following risk factor included in the Company’s
Listing Statement available on www.SEDAR.com:
Section
17 –
Risk Factors – Grown Rogue may not be able to obtain or maintain a bank account
|
Quantify
the issuer’s balance sheet and operating statement exposure to U.S. marijuana-related activities.
|
|
100%
of Grown Rogue’s balance sheet and operating statements are exposed to U.S. marijuana-related activities.
|
|
|
|
Disclose
if legal advice has not been obtained, either in the form of a legal opinion or otherwise, regarding (a) compliance with applicable
state regulatory frameworks and (b) potential exposure and implications arising from U.S. federal law.
|
|
Grown
Rogue has received legal advice from multiple attorneys regarding (a) compliance with applicable state regulatory frameworks
and (b) potential exposure and implications arising from U.S. federal law.
|
|
|
|
CSA
Requirement
–
US Marijuana Issuers with direct involvement in cultivation or distribution
|
|
Response
|
|
|
|
Outline
the regulations for U.S. states in which the issuer operates and confirm how the issuer complies with applicable licensing
requirements and the regulatory framework enacted by the applicable U.S. state.
|
|
See
below under “U.S. Regulatory Matters”
|
|
|
|
Discuss
the issuer’s program for monitoring compliance with U.S. state law on an ongoing basis, outline internal compliance procedures
and provide a positive statement indicating that the issuer is in compliance with U.S. state law and the related licensing
framework. Promptly disclose any non-compliance, citations or notices of violation which may have an impact on the issuer’s
licence, business activities or operations.
|
|
See
below under “U.S. Regulatory Matters”
See
the following risk factors included in the Company’s Listing Statement available on www.SEDAR.com:
Section
17 –
Risk Factors – Grown Rogue’s Business is Illegal under U.S. Federal Law
Section
17 –
Risk Factors – Risks Relating to Other Laws and Regulations
Section
17 –
Risk Factors – Grown Rogue’s business is highly regulated and it may not be issued necessary
licenses, permits, and cards
Section
17 –
Risk Factors – Licenses
Section
17 –
Risk Factors – Liability, Enforcement Complaints etc.
|
US
Marijuana Issuers with indirect
involvement in cultivation or
distribution
|
|
Response
|
|
|
|
Outline
the regulations for U.S. states in which the issuer’s investee(s) operate.
|
|
N/A
|
|
|
|
Provide
reasonable assurance, through either positive or negative statements, that the investee’s business is in compliance with applicable
licensing requirements and the regulatory framework enacted by the applicable U.S. state. Promptly disclose any non-compliance,
citations or notices of violation, of which the issuer is aware, that may have an impact on the investee’s licence, business
activities or operations.
|
|
N/A
|
|
|
|
US
Marijuana Issuers with material
ancillary involvement
|
|
Response
|
|
|
|
Provide
reasonable assurance, through either positive or negative statements, that the applicable customer’s or investee’s business
is in compliance with applicable licensing requirements and the regulatory framework enacted by the applicable U.S. state.
|
|
N/A
|
U.S.
Regulatory Matters
Grown
Rogue (through its subsidiaries) has direct involvement in the cultivation and distribution of marijuana in the United States.
Grown Rogue and its subsidiaries are primarily involved in the U.S. marijuana industry as a seed to retail company with operations
currently in Oregon (a state that has legalized recreational marijuana). Currently Grown Rogue through its subsidiaries produces
recreational marijuana and distributes it to dispensaries throughout Oregon.
Producing,
manufacturing, processing, possessing, distributing, selling, and using marijuana is a federal crime in the United States. The
United States federal government regulates drugs through the Controlled Substances Act (the “
Federal CSA
”),
which places controlled substances, including cannabis, on one of five schedules. Cannabis is currently classified as a Schedule
I controlled substance, which is viewed as having a high potential for abuse and having no currently accepted medical use in treatment
in the United States. No prescriptions may be written for Schedule I substances, and such substances are subject to production
quotas imposed by the United States Drug Enforcement Administration (the “
DEA
”). Schedule I drugs are the most
tightly restricted category of drugs under the Federal CSA.
State
and territorial laws that allow the use of medical cannabis or legalize cannabis for adult recreational use are in conflict with
the Federal CSA, which makes cannabis use and possession illegal at the federal level. Because cannabis is a Schedule I controlled
substance, however, the development of a legal cannabis industry under the laws of these states is in conflict with the Federal
CSA, which makes cannabis use and possession illegal on a national level. Additionally, the Supremacy Clause of the United States
Constitution establishes that the Constitution, federal laws made pursuant to the Constitution, and treaties made under the Constitution’s
authority constitute the supreme law of the land. The Supremacy Clause provides that state courts are bound by the supreme law;
in case of conflict between federal and state law, including Oregon and other state law legalizing certain cannabis uses, the
federal law must be applied.
Until
Congress amends the Federal CSA with respect to marijuana use, there is a risk that federal authorities may enforce current federal
law against companies such as Grown Rogue for violation of federal law or they may seek to bring an action or actions against
Grown Rogue and/or its investors for violation of federal law or otherwise, including, but not limited to, a claim against investors
for aiding and abetting another’s criminal activities. The US federal aiding and abetting statute provides that anyone who
commits an offense against the United States or aids, abets, counsels, commands, induces or procures its commission, is punishable
as a principal. Additionally, even if the U.S. federal government does not prove a violation of the Federal CSA, the U.S. federal
government may seize, through civil asset forfeiture proceedings, certain assets such as equipment, real estate, moneys and proceeds,
or your assets as an investor in the Company, if the U.S. federal government can prove a substantial connection between these
assets or your investment and marijuana distribution or cultivation.
Because
many states in the United States have approved certain medical or recreational uses of cannabis, the U.S. Department of Justice,
through a memorandum dated August 29, 2013 and titled “Guidance Regarding Marijuana Enforcement” (the “
Cole
Memorandum
”), had previously described a set of priorities for federal prosecutors operating in states that had legalized
the medical or other adult use of cannabis. The Cole Memorandum represented a significant shift in U.S. federal government priorities
away from strict enforcement of federal cannabis prohibition.
However,
the Cole Memorandum was merely a directive regarding enforcement and did not overturn or invalidate the Federal CSA or any other
federal law or regulation.
The
Cole Memorandum was rescinded in January 2018 by Jeff Sessions, the U.S. Attorney General, who deemed it “unnecessary”.
This is based on Mr. Sessions’ belief as stated in the Cole Memorandum that each state’s federal prosecutor should
“follow the well-established principles that govern all federal prosecutions. These principles require federal prosecutors
deciding which cases to prosecute to weigh all relevant considerations, including federal law enforcement priorities set by the
Attorney General, the seriousness of the crime, the deterrent effect of criminal prosecution, and the cumulative impact of particular
crimes on the community.” The rescission of the Cole Memorandum, and comments made publicly by Mr. Sessions and other members
of the Trump Administration, signal a significant shift by the U.S. federal government back to more strict enforcement of federal
law.
In
Oregon, Billy J. Williams is the United States Attorney for the District of Oregon. He is a former Multnomah County (Oregon) Deputy
District Attorney, who handled major violent crimes and later served as a Chief of the Violent Crimes Unit and as the Indian Country
AUSA/Tribal Liaison for the Department of Justice prior to being appointed the federal prosecutor for Oregon.
On
January 4, 2018, Mr. Williams provided the below statement on marijuana enforcement in the District of Oregon: “As noted
by Attorney General Sessions, today’s memo on marijuana enforcement directs all U.S. Attorneys to use the reasoned exercise
of discretion when pursuing prosecutions related to marijuana crimes. We will continue working with our federal, state, local
and tribal law enforcement partners to pursue shared public safety objectives, with an emphasis on stemming the overproduction
of marijuana and the diversion of marijuana out of state, dismantling criminal organizations and thwarting violent crime in our
communities.”
In
an editorial published on January 12, 2018, Mr. Williams wrote: “In sum, I have significant concerns about the state’s
current regulatory framework and the resources allocated to policing marijuana in Oregon.”
At
a meeting on February 2, 2018, Mr. Williams told Oregon’s top politicians and law enforcement officials that there’s
more cannabis being produced in the state than can legally be consumed. “And make no mistake about it, we’re going
to do something,” Williams told dozens of politicians, tribal leaders, sheriffs as well as representatives of the FBI and
the U.S. Drug Enforcement Administration. “Here’s what I know, in terms of the landscape here in Oregon: We have an
identifiable and formidable marijuana over-production and diversion problem,” Williams said. “That’s the fact.
My responsibly is to work with our state partners to do something about it.”
Because
marijuana is illegal under U.S. federal law, investing in cannabis business could be found to violate the Federal CSA. As a result,
individuals involved with cannabis business, including but not limited to investors and lenders, may be indicted under U.S. federal
law. An investment in the Company may: (a) expose an investor personally to criminal liability under U.S. federal law, resulting
in monetary fines and jail time; and (b) expose any real and personal property used in connection with Grown Rogue’s
business to seizure and forfeiture to the U.S. federal government.
Active
enforcement of the current federal law on cannabis may thus directly and adversely affect revenues and profits of Grown Rogue.
The risk of strict enforcement of the Federal CSA remains uncertain.
U.S.
Federal Laws Applicable to Banking
Because
producing, manufacturing, processing, possessing, distributing, selling, and using marijuana is a crime under the Federal CSA,
most U.S. banks and other financial institutions are unwilling to provide banking services to marijuana businesses due to concerns
about criminal liability under the Federal CSA as well as concerns related to federal money laundering rules under the U.S. Bank
Secrecy Act. Canadian banks are also hesitant to deal with cannabis companies, due to the uncertain legal and regulatory framework
of the industry. Banks and other financial institutions could be prosecuted and possibly convicted of money laundering for providing
services to cannabis businesses.
Under
U.S. federal law, banks or other financial institutions that provide a cannabis business with a checking account, debit or credit
card, small business loan, or any other service could be found guilty of money laundering or conspiracy. In both Canada and the
United States transactions by cannabis businesses involving banks and other financial institutions are both difficult and unpredictable
under the current legal and regulatory landscape. Though guidelines issued in past years allow financial institutions to provide
bank accounts to certain cannabis businesses, few U.S. banks have taken advantage of those guidelines and many U. S. cannabis
businesses still operate on an all-cash basis.
Oregon
State Regulation
The
Oregon Medical Marijuana Program (“
OMMP
”) is a state registry program within the Public Health Division,
Oregon Health Authority (“
OHA
”). The role of the OHA is to administer the Oregon Medical Marijuana Act. The
OMMP allows individuals with a medical history of one or more qualifying illnesses and a doctor’s written statement to apply
for registration with the OMMP. Qualified applicants are issued a medical marijuana card that entitles them to legally possess
and cultivate cannabis, subject to certain limitations.
On
November 4, 2014, Oregon voters passed Measure 91, known as the Control, Regulation, and Taxation of Marijuana and Industrial
Hemp Act (the “
Act
”), effectively ending the state’s prohibition of recreational marijuana and legalizing
the possession, use, and cultivation of marijuana within legal limits by adults 21 years and older. The Act did not amend or effect
the Oregon Medical Marijuana Act and the OMMP. The Act empowered the Oregon Liquor Control Commission (“
OLCC
”)
with regulating sales of recreational marijuana in Oregon.
Under
current Oregon law, possession and home cultivation by adults at least 21 years old is allowed within legal limits. Public sales
of marijuana and marijuana products may be done only through licensed retailers. The OLCC has the authority to decide how many
licenses to allow in a specific area or location and may refuse granting a license if there are reasonable grounds to believe
there are sufficient licenses in the area or if the granting of a license is not demanded by public interest or convenience. The
OLCC may disqualify applicants for a number of reasons, including for lacking a good moral character, for lacking sufficient financial
resources or responsibility, for relevant past convictions, and for using marijuana, alcohol, or drugs “to excess.”
Grown
Rogue has a comprehensive compliance program administered through its Director of Compliance, which tracks all aspects of operations
through the METRC program (an online software tool mandated through the State of Oregon that tracks seed to retail purchases),
as well as compliance with all state and federal employment and other safety regulations.
Grown
Rogue is periodically advised by various outside attorneys about the requirements for compliance with Oregon law.
Grown
Rogue is in compliance with Oregon state law and its related licensing framework.
California
State Regulation
As
part of its business plan, Grown Rogue intends to enter the California market..
In
1996, California voters passed a medical marijuana law allowing physicians to recommend cannabis for an inclusive set of qualifying
conditions including chronic pain. The law established a not-for-profit patient/caregiver system but there was no state licensing
authority to oversee the businesses that emerged as a result of the system. In September of 2015, the California legislature passed
three bills, collectively known as the “Medical Marijuana Regulation and Safety Act” (“
MCRSA
”).
In 2016, California voters passed “The Adult Use of Marijuana Act” (“
AUMA
”), which legalized
adult-use cannabis for adults 21 years of age and older and created a licensing system for commercial cannabis businesses. On June
27, 2017, Governor Brown signed SB-94 into law. SB-94 combines California’s medicinal and adult-use cannabis regulatory frameworks
into one licensing structure under the Medicinal and Adult-Use of Cannabis Regulation and Safety Act (“
MAUCRSA
”).
Pursuant
to MAUCRSA: (1) the California Department of Food and Agriculture, via CalCannabis, issues licenses to cannabis cultivators: (2)
the California Department of Public Health, via the Manufactured Cannabis Safety Branch (the “
MCSB
”), issues
licenses to cannabis manufacturers and (3) the California Department of Consumer Affairs, via the Bureau of Cannabis Control (the
“
BCC
”), issues licenses to cannabis distributors, testing laboratories, retailers, and micro-businesses. These
agencies also oversee the various aspects of implementing and maintaining California’s cannabis landscape, including the
statewide track and trace system.
To
operate legally under state law, cannabis operators must obtain a state license and local approval. Local authorization is a prerequisite
to obtaining state licensure, and local governments are permitted to prohibit or otherwise regulate the types and number of cannabis
businesses allowed in their locality. The state license approval process is not competitive and there is no limit on the number
of state licenses an entity may hold. Although vertical integration across multiple license types is allowed under MAUCRSA, testing
laboratory licensees may not hold any other licenses aside from a laboratory license. There are also no residency requirements
for ownership under MAUCRSA.
California
has implemented a robust regulatory system designed to ensure, monitor, and enforce compliance with all aspects of a cannabis
operator’s licensed operations. Compliance with local law is a prerequisite to obtaining and maintaining state licensure,
and all three state regulatory agencies require confirmation from the locality that the operator is operating in compliance with
local requirements and was granted authorization to continue or commence commercial cannabis operations within the locality’s
jurisdiction.
License
types are designated into two classes: Type M (medical) or Type A (adult use). There are 20 types of licenses, and a single entity
may possess both Type M and Type A licenses, across six different categories:
|
●
|
Cultivation
Facility: license to cultivate, process and package cannabis; and to sell cannabis to cannabis distributors, but not
to consumers.
|
|
●
|
Distributor:
license to purchase cannabis from cultivators, manufacturers and other distributors; to store cannabis; to have
cannabis tested by a testing facility; to sell cannabis to other distributors and to retailers; and to transport
cannabis from a cannabis licensee’s premises to another cannabis licensee’s premises.
|
|
●
|
Product
Manufacturing Facility: license to purchase cannabis from distributors; to manufacture, process, and package cannabis
and cannabis products; and to sell cannabis and cannabis products to distributors but not to consumers. Pursuant to this
category, cannabis products include edibles, ointments, tinctures, oils and other concentrates.
|
|
●
|
Testing
Laboratory: license to test cannabis and cannabis products for potency and contaminants.
|
|
●
|
Retailer:
license to purchase cannabis and cannabis products from distributors, as well as to sell cannabis and cannabis products directly
to consumers.
|
|
●
|
Microbusiness:
license to cultivate cannabis on an area less than 10,000 square feet; to purchase cannabis from cultivators, manufacturers
and distributors; to store cannabis; to have cannabis tested by a testing facility; to sell cannabis to retailers
and distributors; to transport cannabis from one cannabis licensee’s premises to another; to manufacture,
process and package cannabis and cannabis products; and to sell cannabis and cannabis products directly to consumers.
|
The
MAUCRSA permits vertical integration by licensees to hold licenses in more than two separate licensing categories. Licensees must
conduct their commercial cannabis activity within a single-premises, which must be contiguous. Although multiple premises are allowed
on a given parcel, each premises must be sufficiently separate from any other premises, i.e., having separate entrances and exits
and no shared common areas. Importantly, licensees may not sublet any portion of their licensed premises, and therefore, a licensee
cannot lease a multi-unit building and sublease one of the units to an affiliated licensee.
Only
businesses engaged in “commercial cannabis activity” are required to have a license – ancillary services, technology,
and know-how are not included unless their interests in the licensee amount to “ownership” or a “financial interest.”
Under
MAUCRSA, an “owner” no longer distinguishes between public and private companies. An owner is: (1) anyone with an
aggregate ownership interest of 20% or more in the applicant, unless the interest is solely a security, lien, or encumbrance,
(2) the chief executive officer of a non-profit or other entity, (3) a member of the board of directors for a nonprofit, or (4)
an individual participating in the direction, control, or management of the applicant. Each owner of the entity applying for a
cannabis license is required to submit fingerprint images and background checks. Such fingerprinting requirement extends to shareholders
holding 5% or more of the equity of the applicant’s public company owner.
Under
California state law, all state licensed cannabis businesses are entitled to rely on certain transition provisions until December
6, 2018. These provisions were included to ease the transition of businesses into the new regulatory regime introduced on January
1, 2018 in California. The transition provisions grandfathered the sale of certain products compliantly produced prior to January
1, 2018, and, among other things, also allow state licensees to transact with other state licensees regardless of the parties’
Type M (medical) or Type A (adult use) license.
Retail
cannabis businesses must pay tax on gross receipts (i.e., all revenues in whatever form and before any deductions whatsoever).
A cannabis tax return is required whether or not taxes are owed during the month. Failure to submit timely tax returns and payments
result in a penalty equal to 25% of the amount of the tax in addition to the amount of the tax, plus interest on the unpaid tax
calculated from the original due date.
Zoning
and Land Use Requirements
Applicants
are required to comply with all local zoning and land use requirements and provide written authorization from the property owner
where the commercial cannabis operations are proposed to take place, which must dictate that the applicant has the property owner’s
authorization to engage in the specific statesanctioned commercial cannabis activities proposed to occur on the premises.
Record-Keeping
and Continuous Reporting Requirements
California’s
state license application process additionally requires comprehensive criminal history, regulatory history, financial and personal
disclosures, coupled with stringent monitoring and continuous reporting requirements designed to ensure only good actors are granted
licenses and that licensees continue to operate in compliance with the State regulatory program.
Operating
Procedure Requirements
Applicants
must submit standard operating procedures describing how the operator will, among other requirements, secure the facility, manage
inventory, comply with the State’s seed-to-sale tracking requirements, dispense cannabis, and handle waste, as applicable
to the license sought. Once the standard operating procedures are determined compliant and approved by the applicable state regulatory
agency, the licensee is required to abide by the processes described and seek regulatory agency approval before any changes to
such procedures may be made. Licensees are additionally required to train their employees on compliant operations and are only
permitted to transact with other legal and licensed businesses.
Site-Visits
& Inspections
All
licencees will not be able to obtain or maintain state licensure, and thus engage in commercial cannabis activities in the state
of California without satisfying and maintaining compliance with state and local law. As a condition of state licensure, operators
must consent to random and unannounced inspections of the commercial cannabis facility as well as all of the facility’s
books and records to monitor and enforce compliance with state law. Many localities have also enacted similar standards for inspections,
and the state has already commenced site-visits and compliance inspections for operators who have received state temporary or annual
licensure.
Michigan
State Regulation
As
part of its business plan, Grown Rogue intends to enter the Michigan state market.
In
November 2008, Michigan residents approved the Michigan Medical Marihuana Act20 (the “MMMA”) to provide a legal framework
for a safe and effective medical marijuana program. In September 2016, the Michigan Senate passed the Medical Marihuana Facilities
Licensing Act21 (the “MMFLA”) and the Marihuana Tracking Act (the “MTA” and together with the MMMA and
the MMFLA, the “Michigan Cannabis Regulations”) to provide a comprehensive licensing and tracking scheme, respectively,
for the medical marijuana program. Additionally, the Michigan Department of Licensing and Regulatory Affairs and its licensing
board (“LARA”) has supplemented the Michigan Cannabis Regulations with “Emergency Rules” to further clarify
the regulatory landscape surrounding the medical marijuana program. LARA is the main regulatory authority for the licensing of
marijuana businesses.
Under
the MMFLA, LARA administrates five types of “state operating licenses” for medical marijuana businesses: (a) a “grower”
license, (b) a “processor” license, (c) a “secure transporter” license, (d) a “provisioning center”
license and (e) a “safety compliance facility” license. There are no stated limits on the number of licenses that
can be made available on a state level; however, LARA has discretion over the approval of applications and municipalities
can pass additional restrictions.
On
November 6, 2018, Michigan voters approved Proposal 1, to make marihuana legal under state and local law for adults 21 years of
age or older and to control the commercial production and distribution of marihuana under a system that licenses, regulates, and
taxes the businesses involved. The act will be known as the Michigan Regulation and Taxation of Marihuana Act24. According to
Proposal 1, LARA is required to start accepting applications for retail (recreational) dispensaries within 12 months of the measure’s
effective date.
Michigan
License
State
operating licenses for marijuana businesses have a 1 year term and are annually renewable if certain conditions are met: (a) the
renewal application is submitted prior to the date the license expires, or within sixty (60) days of expiration if all other conditions
are met and a late fee is paid, (b) the licensee pays the regulatory assessment fee set by LARA and (c) the licensee continues
to meet the requirements to be a licensee under the Michigan Cannabis Regulations. Each renewal application is reviewed by LARA,
but there is no guarantee of a timely renewal. There is no ultimate expiry after which no renewals are permitted.
Michigan
Regulations
Michigan
Marijuana Products may be purchased in a retail setting from a provisioning center by a registered qualified patient or registered
primary caregivers connected to a registered qualifying patient (“Michigan Qualified Purchaser”); in each case,
Michigan Qualified Purchasers must present a valid registry identification card issued by LARA (a “Michigan Registry ID”).
For a Michigan Qualified Purchaser to receive Michigan Marijuana Products, provision centers must deploy an inventory control
and tracking system that is capable of interfacing with the statewide monitoring system to determine (a) whether a Michigan Qualified
Purchaser holds a Michigan Registry ID and (b) whether the sale or transfer will exceed the thencurrent daily and monthly purchasing
limit for the holder of the Michigan Registry ID.
In
order to receive a Michigan Registry ID, an applicant must provide: a completed application dated within one year of submission,
a written certification from a physician with a bona-fide physician-patient relationship to the underlying patient, the application
or renewal fee, contact information for the patient, caregiver (if applicable) and physician, as well as proof of Michigan residency.
For
registered qualifying patients, the daily purchasing limit is 2.5 ounces, and for registered primary caregivers, the daily purchasing
limit is 2.5 ounces per underlying registered qualifying patient that the registered primary caregiver is connected with through
the registration process. Finally, the licensee shall verify in the statewide monitoring system that the sale or transfer does
not exceed the monthly purchasing limit of ten (10) ounces of marihuana product per month to a qualifying patient, either directly
or through the qualifying patient’s registered primary caregiver.
Allowable
forms of medical marihuana includes smokable dried flower, dried flower for vaporizing and marihuanainfused products, which are
defined under the Act to include topical formulations, tinctures, beverages, edible substances or similar products containing
usable marijuana that is intended for human consumption in a matter other than smoke inhalation. Under the Michigan Cannabis Regulations,
marijuanainfused products shall not be considered food.
Qualifying
conditions for the medical marijuana program in Michigan are the following:
|
●
|
Cancer,
glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency
syndrome, hepatitis C, amyotrophic lateral sclerosis, Crohn’s disease, agitation of Alzheimer’s
disease, nail patella or the treatment of these conditions;
|
|
●
|
A
chronic or debilitating disease or medical condition or its treatment that produces 1
or more of the following: cachexia or wasting syndrome; severe and chronic pain;
severe nausea; seizures, including but not limited to those characteristic of epilepsy;
or severe and persistent muscle spasms, including but not limited to those characteristic
of multiple sclerosis;
|
|
●
|
Post-Traumatic
Stress Disorder (PTSD); and/or
|
|
●
|
Any
other medical condition or its treatment approved by the department under the Michigan
Cannabis Regulations.
|
Reporting
Requirements
Pursuant
to the requirements of the MTA, Michigan selected Franwell’s METRC software as the state’s thirdparty solution for
integrated marijuana industry verification. Using METRC, regulators are able to track third party inventory, permissible sales
and seed-to-sale information. Additionally, provisioning centers can use the METRC API to connect their own inventory management
and/or point-of-sale systems to verify the identity as well as permissible sales for Michigan Qualified Purchasers.
Storage
and Security
To
ensure the safety and security of cannabis business premises and to maintain adequate controls against the diversion, theft, and
loss of cannabis or cannabis products, a provisioning center is required to:
Maintain
and submit a security operations plan that includes the following at a minimum:
|
●
|
Escorts
for all nonemployee personnel in limited access areas.
|
|
●
|
Secure
locks for all interior rooms, windows and points of entry and exits with commercial grade, nonresidential door locks.
|
|
●
|
An
alarm system. Licensees will make all information related to the alarm system including
monitoring and alarm activity available to LARA.
|
|
●
|
A
video surveillance system that, at a minimum, consists of digital or network video recorders,
cameras, video monitors, digital archiving devices and a color printer capable of delivering
still photos.
|
|
●
|
24-hour
surveillance footage with fixed, mounted cameras, tamper/theft proof secured storage mediums and a notification system for
interruption or failure of surveillance footage or storage of surveillance footage. All surveillance footage must be of sufficient
resolution to identify individuals, have accurate time/date stamps and be stored for a minimum of 14 days unless state regulators
notify that such recordings may be destroyed.
|
|
●
|
State
access to view and obtain copies of any surveillance footage through LARA or related
investigators, agents, auditors and/or state police. A facility shall also provide copies
of recordings to LARA upon request.
|
|
●
|
Logs
of the following: the identities of the employee or employees responsible for monitoring the video surveillance system, the
identity of the employee who removed the recording from the video surveillance system storage device and the time and date
removed and the identity of the employee who destroyed any recording.
|
Maintain
marijuana storage plan for provisioning centers that includes the following at a minimum:
|
●
|
A
secured limited access area for inventories of Michigan Marijuana Products.
|
|
●
|
Clearly
labeled containers (a) marked, labeled or tagged, (b) enclosed on all sides and (c) latched or locked to keep all contents
secured within. All such containers must be identified and tracked in accordance with the MTA.
|
|
●
|
A
locked area for chemical and solvents separate from Michigan Marijuana Products.
|
|
●
|
Separation
of marijuana-infused products from toxic or flammable materials.
|
|
●
|
A
sales or transfer counter or barrier separated from stock rooms to ensure registered qualifying patients or registered primary
caregivers do not have direct access to Michigan Marijuana Products.
|
There
are significant risks associated with the business of the Company, as described above and in Section 17 –
Risk Factors
of the Company’s Listing Statement as filed on www.sedar.com. Readers are strongly encouraged to carefully read all
of the risk factors contained in Section 17 –
Risk Factors
of the Company’s Listing Statement.
Internal
Control over Financial Reporting and Disclosure Controls
Management,
including the President and Chief Executive Officer (“
CEO
”) and the Chief Financial Officer (“
CFO
”), is responsible for designing, establishing, and maintaining a system of internal controls over financial reporting
(“
ICFR
”) to provide reasonable assurance that all information prepared by the Company for external purposes
is reliable and timely. Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of the consolidated financial statements for external purposes in accordance with IFRS.
The
Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance
of records that, in reasonable detail, accurately reflect the transactions of the Company; (ii) provide reasonable assurance
that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS, and that receipts
and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company;
and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition
of the Company’s assets that could have a material effect on the Company’s consolidated Financial Statements. Due
to its inherent limitations, internal control over financial reporting and disclosure may not prevent or detect all misstatements.
The
CEO and CFO have evaluated whether there were changes to the ICFR during the year ended October 31, 2018 that have materially
affected, or are reasonably likely to materially affect, the ICFR. As a result, no such significant changes were identified through
their evaluation.
There
have been no material changes in the Company’s internal control over financial reporting during the period ended January
31, 2019 that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.
Unaudited
Condensed Consolidated Interim Financial Statements
Grown
Rogue International Inc.
For
the Three Month Periods ended January 31, 2019 and 2018
(Expressed in United States Dollars)
NOTICE
TO READER
The
accompanying unaudited condensed consolidated interim financial statements have been prepared by the Company’s management and
the Company’s independent auditors have not performed a review of these interim financial statements.
Grown
Rogue International Inc.
Unaudited
Condensed Consolidated Interim Statements of Financial Position
Expressed in United States Dollars
|
|
January
31,
2019
(Unaudited)
|
|
|
October
31,
2018
(Audited)
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
Current Assets
|
|
|
|
|
|
|
Cash
|
|
$
|
531,908
|
|
|
$
|
826,643
|
|
Accounts receivable, net
|
|
|
315,692
|
|
|
|
252,908
|
|
Other receivable
|
|
|
68,183
|
|
|
|
52,843
|
|
Biological assets (note 7)
|
|
|
129,399
|
|
|
|
149,617
|
|
Inventory (note 8)
|
|
|
1,503,504
|
|
|
|
1,380,101
|
|
Prepaid expenses and other assets
|
|
|
205,757
|
|
|
|
207,582
|
|
|
|
|
2,754,443
|
|
|
|
2,869,694
|
|
Property and equipment
(note 9)
|
|
|
1,496,159
|
|
|
|
1,575,921
|
|
Intangible Assets
(note 10)
|
|
|
66,117
|
|
|
|
64,974
|
|
Technology License
(note 15(xix))
|
|
|
2,199,667
|
|
|
|
-
|
|
Deferred transaction costs
|
|
|
-
|
|
|
|
855,679
|
|
|
|
$
|
6,516,386
|
|
|
$
|
5,366,268
|
|
Liabilities
|
|
|
|
|
|
|
|
|
Current Liabilities
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
1,565,495
|
|
|
$
|
2,382,694
|
|
Finance lease payable (note 11)
|
|
|
103,371
|
|
|
|
99,134
|
|
Convertible promissory notes (note 13)
|
|
|
42,368
|
|
|
|
265,277
|
|
Due to employee/director (note 19)
|
|
|
-
|
|
|
|
104,000
|
|
Interest payable (note 12, 13)
|
|
|
202,634
|
|
|
|
470,134
|
|
|
|
|
1,913,868
|
|
|
|
3,321,239
|
|
Finance lease payable
(note 11)
|
|
|
70,194
|
|
|
|
97,680
|
|
Convertible promissory notes
(note 13)
|
|
|
-
|
|
|
|
1,034,099
|
|
Convertible debentures
(note 14)
|
|
|
957,360
|
|
|
|
931,099
|
|
Long-term debt
(note 12)
|
|
|
50,000
|
|
|
|
50,000
|
|
Deferred rent
(note 22)
|
|
|
28,444
|
|
|
|
31,256
|
|
Derivative liabilities
|
|
|
24,500
|
|
|
|
148,500
|
|
|
|
|
3,044,366
|
|
|
|
5,613,873
|
|
Equity Holders’ Deficit
|
|
|
|
|
|
|
|
|
Members’ Capital (note 15)
|
|
|
-
|
|
|
|
4,701,773
|
|
Share Capital (note 16)
|
|
|
13,269,391
|
|
|
|
-
|
|
Subscriptions Payable (note 1)
|
|
|
85,136
|
|
|
|
720,516
|
|
Equity Component of Convertible Debentures (note 14)
|
|
|
132,000
|
|
|
|
132,000
|
|
Contributed Surplus (notes 17 and 19)
|
|
|
2,596,438
|
|
|
|
2,010,489
|
|
Accumulated Deficit
|
|
|
(12,610,945
|
)
|
|
|
(7,812,383
|
)
|
|
|
|
3,472,020
|
|
|
|
(247,605
|
)
|
|
|
$
|
6,516,386
|
|
|
$
|
5,366,268
|
|
The
accompanying notes form an integral part of these condensed consolidated interim financial statements.
Approved on behalf of the
Board of Directors
Signed “J. Obie Strickler”
|
, Director
|
Signed “Abhilash Patel”
|
,
Director
|
Grown
Rogue International Inc.
Unaudited
Condensed Consolidated Interim Statements of Operations
For the three month periods ended January 31
Expressed
in United States Dollars
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
834,309
|
|
|
$
|
170,960
|
|
|
|
|
|
|
|
|
|
|
Cost of Goods Sold
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) on changes in fair value of biological assets (note 7)
|
|
|
(44,830
|
)
|
|
|
366,079
|
|
Cost of goods sold (note 8)
|
|
|
622,809
|
|
|
|
119,086
|
|
Cost of goods sold (recovery to cost of sales), net of the unrealized gain on changes in fair value of biological assets
|
|
|
577,979
|
|
|
|
485,165
|
|
|
|
|
|
|
|
|
|
|
Gross profit (loss)
|
|
|
256,330
|
|
|
|
(314,205
|
)
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative (note 24)
|
|
|
1,007,305
|
|
|
|
617,643
|
|
Amortization of intangible assets (note 10)
|
|
|
7,233
|
|
|
|
|
|
Amortization of property and equipment (note 9)
|
|
|
158,814
|
|
|
|
58,634
|
|
Accretion expense (notes 13 and 14)
|
|
|
17,964
|
|
|
|
|
|
Transaction costs (note 2)
|
|
|
3,723,724
|
|
|
|
|
|
|
|
|
4,915,040
|
|
|
|
676,277
|
|
Loss from operations
|
|
|
(4,658,710
|
)
|
|
|
(990,482
|
)
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(164,852
|
)
|
|
|
(337,510
|
)
|
Other income
|
|
|
10,000
|
|
|
|
-
|
|
Gain on derecognition of derivative liability
|
|
|
15,000
|
|
|
|
-
|
|
Loss on disposal of property and equipment
|
|
|
-
|
|
|
|
(9,103
|
)
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(4,798,562
|
)
|
|
$
|
(1,337,095
|
)
|
|
|
|
|
|
|
|
|
|
Income per Share - basic and diluted
|
|
$
|
(0.08
|
)
|
|
$
|
(0.35
|
)
|
|
|
|
|
|
|
|
|
|
Weighted Average Number of Common Shares Outstanding - basic and diluted
|
|
|
61,324,047
|
|
|
|
3,773,689
|
|
The
accompanying notes form an integral part of these condensed consolidated interim financial statements.
Grown
Rogue International Inc.
Unaudited
Condensed Consolidated Interim Statements of Changes in Members’ Deficit
Expressed in United States Dollars
|
|
Common Units
|
|
|
Incentive
Units
|
|
|
Seed
Round
Preferred
Units
|
|
|
Total
Members’
Capital
|
|
|
Subscriptions Payable
|
|
|
Equity
Component
of
Convertible
Debentures
|
|
|
Contributed Surplus
|
|
|
Accumulated Deficit
|
|
|
Total Equity
Holders’
Deficit
|
|
Balance - October 31, 2017
|
|
$
|
100
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
100
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(302,397
|
)
|
|
$
|
(302,297
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common units issued pursuant to conversion of notes payable (note 14)
|
|
|
2,152,134
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,152,134
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,152,134
|
|
Seed Round Preferred Units issued for cash (note 14)
|
|
|
-
|
|
|
|
-
|
|
|
|
1,300,345
|
|
|
|
1,300,345
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,300,345
|
|
Common units issued for cash (note 14)
|
|
|
225,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
225,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
225,000
|
|
Common units issued to service providers (note 14)
|
|
|
1,049,595
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,049,595
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,049,595
|
|
Unit purchase options granted (note 16)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,510,489
|
|
|
|
-
|
|
|
|
1,510,489
|
|
Unit purchase option purchased (note 16)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
500,000
|
|
|
|
-
|
|
|
|
500,000
|
|
Issuance of convertible debentures (note 13)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
132,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
132,000
|
|
Subscription
proceeds (note 15)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
720,516
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
720,516
|
|
Issuance costs
|
|
|
-
|
|
|
|
-
|
|
|
|
(25,401
|
)
|
|
|
(25,401
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(25,401
|
)
|
Net loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(7,509,986
|
)
|
|
|
(7,509,986
|
)
|
Balance - October 31, 2018
|
|
$
|
3,426,829
|
|
|
$
|
-
|
|
|
$
|
1,274,944
|
|
|
$
|
4,701,773
|
|
|
$
|
720,516
|
|
|
$
|
132,000
|
|
|
$
|
2,010,489
|
|
|
$
|
(7,812,383
|
)
|
|
$
|
(247,605
|
)
|
The
accompanying notes form an integral part of these condensed consolidated interim financial statements.
Grown
Rogue International Inc.
Unaudited
Condensed Consolidated Interim Statements of Changes in Members’ Deficit
Expressed in United States Dollars
|
|
Number
of
Common
Shares
|
|
|
Share
Capital
|
|
|
Common
Units
|
|
|
Incentive
Units
|
|
|
Seed
Round
Preferred
Units
|
|
|
Total
Members’
Capital
|
|
|
Subscriptions
Payable
|
|
|
Equity
Component
of
Convertible
Debentures
|
|
|
Contributed
Surplus
|
|
|
Accumulated
Deficit
|
|
|
Total
Equity
Holders’
Deficit
|
|
Balance
- October 31, 2018
|
|
|
-
|
|
|
$
|
-
|
|
|
$
|
3,426,829
|
|
|
$
|
-
|
|
|
$
|
1,274,944
|
|
|
$
|
4,701,773
|
|
|
$
|
720,516
|
|
|
$
|
132,000
|
|
|
$
|
2,010,489
|
|
|
$
|
(7,812,383
|
)
|
|
$
|
(247,605
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
units issued pursuant to conversion of notes payable (note 15)
|
|
|
-
|
|
|
|
-
|
|
|
|
1,374,317
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,374,317
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,374,317
|
|
Common
units issued pursuant to technology license agreement(note 15)
|
|
|
-
|
|
|
|
-
|
|
|
|
2,199,667
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,199,667
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,199,667
|
|
Common
units issued pursuant to exercise of purchase option (note 15)
|
|
|
-
|
|
|
|
-
|
|
|
|
1,258,784
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,258,784
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,218,784
|
)
|
|
|
-
|
|
|
|
40,000
|
|
Subscription
receipts (note 18)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
554,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
554,000
|
|
Common
units issued pursuant to subscription receipts (note 15)
|
|
|
-
|
|
|
|
-
|
|
|
|
913,698
|
|
|
|
-
|
|
|
|
-
|
|
|
|
913,698
|
|
|
|
(1,274,516
|
)
|
|
|
-
|
|
|
|
360,818
|
|
|
|
-
|
|
|
|
-
|
|
Exchange
of Units for common shares pursuant to the Transaction (note 16)
|
|
|
60,746,202
|
|
|
|
10,448,239
|
|
|
|
(9,173,295
|
)
|
|
|
-
|
|
|
|
(1,274,944
|
)
|
|
|
(10,448,239
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Common
units issued to existing shareholders of the Company pursuant to the Transaction (note 16)
|
|
|
3,773,689
|
|
|
|
1,257,706
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,257,706
|
|
Common
shares issued to former debt holders of the Company (note 16)
|
|
|
839,790
|
|
|
|
279,888
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
279,888
|
|
Common
shares pursuant to acquisition of Grown Rogue Canada (note 16)
|
|
|
100,000
|
|
|
|
33,328
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
33,328
|
|
Common
shares issued pursuant to subscription receipts (note 16)
|
|
|
6,193,917
|
|
|
|
1,479,947
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
584,430
|
|
|
|
-
|
|
|
|
2,064,377
|
|
Fair
value of broker warrants (note 16)
|
|
|
-
|
|
|
|
(85,931
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
85,931
|
|
|
|
-
|
|
|
|
-
|
|
Issuance
costs (note 16)
|
|
|
-
|
|
|
|
(143,786
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(56,781
|
)
|
|
|
-
|
|
|
|
(200,567
|
)
|
Fair
value of warrants issued to debenture holders (note 16)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
830,335
|
|
|
|
-
|
|
|
|
830,335
|
|
Debt
settlements
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
85,136
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
85,136
|
|
Net
loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,798,562
|
)
|
|
|
(4,798,562
|
)
|
Balance
- January 31, 2019
|
|
|
71,653,598
|
|
|
$
|
13,269,391
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
85,136
|
|
|
$
|
132,000
|
|
|
$
|
2,596,438
|
|
|
$
|
(12,610,945
|
)
|
|
$
|
3,472,020
|
|
The
accompanying notes form an integral part of these condensed consolidated interim financial statements.
Grown
Rogue International Inc.
Unaudited
Condensed Consolidated Interim Cash Flow Statements
For
the three month periods ended January 31
Expressed
in United States Dollars
|
|
2019
|
|
|
2018
|
|
Cash provided by (used in)
|
|
|
|
|
|
|
Operating Activities
|
|
|
|
|
|
|
Net loss
|
|
$
|
(4,798,562
|
)
|
|
$
|
(1,337,095
|
)
|
Adjustments for non-cash items in net loss
|
|
|
|
|
|
|
|
|
Amortization of property and equipment
|
|
|
158,814
|
|
|
|
58,634
|
|
Amortization of intangible assets
|
|
|
7,233
|
|
|
|
|
|
Unrealized gain on changes in fair value of biological assets
|
|
|
(44,830
|
)
|
|
|
366,079
|
|
Unit-based compensation
|
|
|
-
|
|
|
|
|
|
Accretion expense
|
|
|
17,964
|
|
|
|
|
|
Finance charge expense
|
|
|
-
|
|
|
|
-
|
|
Loss on disposal of property and equipment
|
|
|
-
|
|
|
|
-
|
|
Transaction costs
|
|
|
3,723,724
|
|
|
|
-
|
|
Gain on recognition of derivative liability
|
|
|
(15,000
|
)
|
|
|
-
|
|
|
|
|
(950,657
|
)
|
|
|
(912,382
|
)
|
Changes in non-cash working capital (note 20)
|
|
|
(1,217,946
|
)
|
|
|
(8,775
|
)
|
Net cash used in operating activities
|
|
|
(2,168,603
|
)
|
|
|
(921,157
|
)
|
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
Purchase of intangible asset
|
|
|
(8,376
|
)
|
|
|
(40,921
|
)
|
Purchase of property and equipment
|
|
|
(79,052
|
)
|
|
|
(719,943
|
)
|
Cash acquired upon close of Transaction
|
|
|
5,875
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(81,553
|
)
|
|
|
(760,864
|
)
|
|
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
|
|
|
Members contributions
|
|
|
-
|
|
|
|
1,416,012
|
|
Subscriptions receivable
|
|
|
(720,516
|
)
|
|
|
-
|
|
Option proceeds
|
|
|
40,000
|
|
|
|
-
|
|
Proceeds from long-term debt
|
|
|
-
|
|
|
|
1,196,387
|
|
Repayment of long-term debt
|
|
|
(231,026
|
)
|
|
|
(21,052
|
)
|
Proceeds of subscription receipts
|
|
|
3,234,893
|
|
|
|
-
|
|
Payment of equity issuance costs
|
|
|
(200,567
|
)
|
|
|
-
|
|
Transaction costs
|
|
|
(167,363
|
)
|
|
|
-
|
|
Net cash provided by financing activities
|
|
|
1,955,421
|
|
|
|
2,591,347
|
|
|
|
|
|
|
|
|
|
|
Change in cash
|
|
|
(294,735
|
)
|
|
|
909,326
|
|
|
|
|
|
|
|
|
|
|
Cash - beginning of period
|
|
|
826,643
|
|
|
|
453,199
|
|
|
|
|
|
|
|
|
|
|
Cash - end of period
|
|
$
|
531,908
|
|
|
$
|
1,362,525
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow disclosure
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
163,746
|
|
|
$
|
52,254
|
|
Purchase of property and equipment on account
|
|
|
-
|
|
|
|
103,655
|
|
Property and equipment acquired through finance leases (note 9)
|
|
|
-
|
|
|
|
158,193
|
|
Conversion of notes payable to common units
|
|
|
1,063,360
|
|
|
|
181,458
|
|
The
accompanying notes form an integral part of these condensed consolidated interim financial statements.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
Grown
Rogue International Inc. (the “Company”), formerly “Novicius Corp.”, was amalgamated under the Business
Corporations Act (Ontario) on November 30, 2009 (the “Company”). The Company’s registered office is located at 340
Richmond Street West, Toronto, Ontario, M5V 1X2. The Company’s common shares trade on the Canadian Securities Exchange (“CSE”)
under the symbol GRIN.
These
unaudited condensed consolidated interim financial statements for the three months ended January 31, 2019 and 2018, include the
Company, its wholly-owned subsidiaries Grown Rogue Canada Corp. (“GRC”), and Grown Rogue Unlimited, LLC (“GR Unlimited”)
and GR Unlimited’s wholly-owned subsidiaries (collectively referred to as the “Subsidiaries”) and joint-venture interests.
GR Unlimited’s wholly-owned subsidiaries include Grown Rogue Gardens, LLC; Grown Rogue Distribution, LLC; GRU Properties, LLC;
and GRIP, LLC. GR Unlimited also has 60% ownership interests in two joint ventures GRD Cali, LLC and Idalia, LLC (the “Joint
Ventures”).
Grown
Rogue Gardens, LLC is engaged in cannabis cultivation activities. Grown Rogue Distribution, LLC is engaged in wholesale activities;
GRU Properties, LLC is engaged in real estate activities; and GRIP, LLC is engaged in intellectual property activities.
The
Company entered into a definitive transaction agreement (the “Definitive Agreement”) dated October 31, 2018 with GR
Unlimited and Grown Rogue Canada Inc. (“Grown Rogue Canada”) and Novicius Acquisition Corp. (“Novicius Subco”)
which resulted, through a series of transactions, in the acquisition of all of the equity interests of GR Unlimited and Grown
Rogue Canada by the Company (the “Transaction”), such that, immediately following completion of the Transaction, approximately
86% of the issued and outstanding shares of the Company were owned by the former unitholders of GR Unlimited. Prior to close of
the Transaction the Company completed a consolidation of its common shares on the basis of 1.4 pre-consolidated common shares
for 1 post-consolidated common share. Upon close of the Transaction, the Company issued, in aggregate, 60,746,202 common shares
to the GR Unlimited unitholders for all of the outstanding units of GR Unlimited, 100,000 common shares to a director of Grown
Rogue Canada and 839,790 common shares to former debtholders of the Company. Holders of warrants and convertible debentures of
GR Unlimited and Grown Rogue Canada exchanged such securities for warrants and convertible debentures, with substantially the
same terms, of the Company on a one for one basis.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
2.
|
Business
Acquisition (continued)
|
For
accounting purposes, GR Unlimited is the deemed acquirer and the Company the deemed acquired company, and accordingly, the Company’s
balances are accounted for at cost and GR Unlimited is accounted for at fair value. Since the Company’s operations do not
constitute a business, this transaction has been accounted for as a reverse takeover that is not a business combination. Therefore,
the Company’s share capital, deficit, and contributed surplus will be eliminated, the consideration transferred by the Company
will be allocated to share capital, and the transaction costs will be expensed.
The
allocation of the consideration transferred is as follows:
3,773,689 shares at a price of CAD$0.44 per share
|
|
$
|
1,257,706
|
|
Net assets (liabilities) of the Company acquired
|
|
|
(604,107
|
)
|
Transaction costs
|
|
$
|
1,861,813
|
|
The
acquisition-date fair value of the consideration transferred by the Company for its interest in GR Unlimited is based on the number
of equity interests GR Unlimited would have had to issue to give the owners of the Company the same percentage equity interest
in the combined entity that results from the transaction described above. The fair value of the number of equity interests calculated
in that way is used as the fair value of consideration transferred in exchange for GR Unlimited. An adjustment has been booked
to adjust the fair market value of the Company’s equity interest in GR Unlimited accordingly.
Upon
completion of the Transaction, the former shareholder of Grown Rogue Canada controlled less than 1% of the issued and outstanding
common shares of the Company (not including holders of subscription receipts of Grown Rogue Canada). For accounting purposes,
the Company has been identified as the acquirer and Grown Rogue Canada the acquired company. Since Grown Rogue Canada’s operations
do not constitute a business, this transaction has been accounted for as a share-based payment. As such, Grown Rogue Canada’s
balances are accounted for at fair value, with the balance of the purchase price in excess of the fair value of the acquired assets
and liabilities of Grown Rogue Canada accounted for as transaction costs. Grown Rogue Canada’s historical share capital, deficit
and contributed surplus have been eliminated.
The
allocation of the consideration transferred is as follows:
100,000 common shares at a price of CAD$0.44 per share
|
|
$
|
33,328
|
|
Fair value of warrants of the Company issued
|
|
|
830,335
|
|
Total consideration transferred
|
|
|
863,663
|
|
Net assets of Grown Rogue Canada acquired
|
|
|
61,447
|
|
Transaction costs
|
|
$
|
802,216
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
a)
|
Statement
of Compliance
|
The
Company’s unaudited condensed consolidated interim financial statements have been prepared in accordance with International
Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board.
These
consolidated financial statements hve not been subject to audit and were approved and authorized for issuance by the Company’s
Board of Directors on April 1, 2019.
The
comparative figures presented throughout these condensed consolidated financial statements are the historical results of GR Unlimited.
The
condensed consolidated interim financial statements have been prepared on a historical cost basis except for certain financial
instruments and biological assets, which are measured at fair value as described herein.
|
c)
|
Functional
and Presentation Currency
|
The
Company and its affiliates’ functional currency is the United States (“U.S.”) dollar. These condensed consolidated
interim financial statements are presented in U.S. dollars.
|
d)
|
Basis
of Consolidation
|
The
Subsidiaries and Joint Ventures are controlled by the Company, as the Company is exposed, or has rights, to variable returns from
its involvement with the Subsidiaries and Joint Ventures and has the ability to affect those returns through its power over the
Subsidiaries and Joint Ventures by way of its ownership of all of the issued and outstanding common shares. The financial statements
of subsidiaries are included in these condensed consolidated interim financial statements from the date that control commences
until the date control ceases. All significant inter-company balances and transactions have been eliminated upon consolidation.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies
|
The
Company records revenue when it has transferred the risks and rewards of ownership of the goods to the purchaser, when it has
no continuing managerial involvement over the goods, when it is probable the Company will receive the consideration, and when
it can reliably measure the amount of revenue and costs associated with the transaction.
Inventory
is valued at the lower of cost and net realizable value. Harvested cannabis included in inventory is recognized at the fair value
of the biological asset at the point of harvest. Manufactured inventory and work-in-progress includes an allocation of production
overhead, which is based on normal operating capacity. The Company reviews inventories for obsolete, redundant and slow moving
goods and any such inventories identified are written down to net realizable value.
Cost
of goods sold includes the cost of finished goods inventory sold during the period, revaluations of biological assets at the point
of harvest, and inventory write-downs during the period.
The
Company measures biological assets consisting of cannabis plants at fair value less costs to sell up-to the point of harvest.
Subsequent to harvest, the recognized biological asset amount becomes the cost basis of finished goods inventory. Seeds are measured
at fair value. Unrealized gains or losses arising from changes in fair value less costs to sell during the period are included
in the consolidated results of operations of the appropriate period.
|
e)
|
Accounts
Payable and Accrued Liabilities
|
Liabilities
are recognized for amounts to be paid in the future for goods or services received, whether billed by the supplier or not. Provisions
are recognized when the Company has an obligation (legal or constructive) arising from a past event, and the costs to settle this
obligation are both probable and able to be reliably measured.
|
f)
|
Related
Party Transactions
|
Parties
are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operating decisions. Parties are also considered to be related if they
are subject to common control or common significant influence. Related parties may be individuals or corporate entities. A transaction
is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies (continued)
|
|
g)
|
Property
and Equipment
|
Property
and equipment are stated at cost less accumulated amortization and accumulated impairment losses, if any. Costs include borrowing
costs for assets that require a substantial period of time to become ready for use.
Amortization
is recognized so as to write off the cost of assets less their residual values over their useful lives, using the straight-line
method. Amortization begins when an asset is available for use, meaning that it is in the location and condition necessary for
it to be used in the manner intended by management. The estimated useful lives, residual values and method of amortization are
reviewed at each period end, with the effect of any changes in estimated useful lives and residual values accounted for on a prospective
basis.
As
at January 31, 2019, the Company was in the process of completing construction of its warehouse facility in order to expand its
cultivation and wholesale activities. The Company has capitalized the costs incurred to date on the construction-in-process asset,
but as the assets were not available for use as intended by management as at January 31, 2019, amortization expense was not recorded.
Amortization
is calculated applying the following useful lives:
Furniture
and fixtures
|
7
- 10
|
years
on a straight line basis
|
Computer and office
equipment
|
3
- 5
|
years
on a straight line basis
|
Production equipment
and other
|
5
- 10
|
years
on a straight line basis
|
Leasehold improvements
|
15
- 40
|
years
on a straight line basis
|
The
carrying values of property and equipment are reviewed for impairment when events or changes in circumstances indicate that the
carrying value may not be recoverable. If any such indication exists, and where the carrying values exceed the estimated recoverable
amount, the assets are written down to their recoverable amount, being the higher of their fair value less costs of disposal and
their value in use. Fair value is the price at which the asset could be bought or sold in an orderly transaction between market
participants. In assessing value in use, the estimated cash flows are discounted to their present value using a pre-tax discount
rate that reflects the current market assessments of the time value of money and the risks specific to the asset.
Leases
are classified as finance leases whenever substantially all the risks and rewards of ownership of the leased asset are transferred
to the Company. Leased assets are measured initially at an amount equal to the lower of fair value and present value of minimum
lease payments. Subsequent to initial recognition, the assets are accounted for in accordance with the accounting policy applicable
to the asset.
Assets
held under other leases, where the risks and rewards of ownership are not transferred are classified as operating leases and are
not recognized on the Company’s consolidated statement of financial position.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies (continued)
|
Intangible
assets are initially measured at cost. The useful life of intangible assets is assessed as either finite or indefinite. Following
the initial recognition, intangible assets with finite useful lives are carried at cost less accumulated amortization and accumulated
impairment losses, if any. If impairment indicators are present, these assets are subject to an impairment review. Amortization
is calculated using the straight-line method over the estimated useful lives of the intangible assets of two to three years.
|
j)
|
Impairment
of Long-lived Assets
|
For
all long-lived assets, except for intangible assets with indefinite useful lives and intangible assets not yet available for use,
the Company reviews its carrying amount at the end of each reporting period to determine whether there is any indication that
those assets have suffered an impairment loss. Where such impairment exists, the recoverable amount of the asset is estimated
in order to determine the extent of the impairment loss.
An
impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable
amount is the greater of fair value less costs of disposal and value in use. In assessing value in use, estimated future cash
flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time
value of money and the risks specific to the asset. Impairment losses are recognized in the consolidated statement of operations.
Impairment
losses may be reversed in a subsequent period where the impairment no longer exists or has decreased. The carrying amount after
a reversal must not exceed the carrying amount (net of depreciation) that would have been determined had no impairment loss been
recognized. A reversal of impairment loss is recognized in profit or loss.
|
k)
|
Deferred
transaction costs
|
Deferred
transaction costs represents professional fees incurred with respect to a contemplated transaction that is to be completed in
a future period. The transaction costs will be recognized in profit and loss in the period in which the transaction is completed.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies (continued)
|
The
effective interest method is used to calculate the amortized cost of a financial asset or liability and allocates interest income
over the corresponding period. The effective interest rate is the rate that is used to discount estimated future cash receipts
or payments over the expected life of the financial asset or liability, or, where appropriate, a shorter period, to the net carrying
amount on initial recognition.
Compound
financial instruments issued by the Company comprise convertible promissory notes that are convertible to share capital at either
the option of the holder or upon consummation of a qualifying go-public transaction. The number of shares to be issued will depend
on the conversion price, which will be agreed to by the Company and the purchaser of the note. The liability component of a compound
financial instrument would be recognized initially at the fair value of a similar liability that does not have an equity conversion
option. The equity component would be recognized initially at the difference between the fair value of the compound financial
instrument as a whole and the fair value of the liability component. Any directly attributable transaction costs are allocated
to the liability and equity components in proportion to the initial carrying amounts.
Subsequent
to initial recognition, the liability component of a compound financial instrument is measured at amortized cost using the
effective interest method. The equity component of a compound financial instrument would not be re-measured subsequent to
initial recognition.
|
m)
|
Impairment
of Financial Assets
|
An
impairment loss in respect of a financial asset measured at amortized cost, such as accounts receivable and other receivable,
is calculated as the difference between its carrying amount and the present value of the estimated future cash flows discounted
at the asset’s original effective interest rate. Losses are recognized in profit or loss and reflected in an allowance account
against the corresponding asset.
|
n)
|
Unit/
Share Based Compensation
|
Unit/ Share Based Payment Transactions
Transactions
with non-employees that are settled in equity instruments of the Company are measured at the fair value of the services rendered.
In situations where the fair value of the goods or services received by the entity as consideration cannot be reliably measured,
transactions are measured at fair value of the equity instruments granted. The fair value of the share based payments is recognized
together with a corresponding increase in equity over a period that services are provided or goods are received.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies (continued)
|
|
n)
|
Unit/
Share Based Compensation (continued)
|
Equity Settled Transactions
The
costs of equity settled transactions with employees are measured by reference to the fair value of the equity instruments at the
date on which they are granted, using the Black-Scholes option pricing model.
The
costs of equity settled transactions are recognized, together with a corresponding increase in equity, over the period in which
the performance and/or service conditions are fulfilled, ending on the date on which the relevant employees become fully entitled
to the award (“the vesting date”). The cumulative cost is recognized for equity-settled transactions at each reporting
date until the vesting date reflects the Company’s best estimate of the number of equity instruments that will ultimately
vest. The profit or loss charge or credit for a period represents the movement in cumulative expense recognized as at the beginning
and end of that period and the corresponding amount is represented in contributed surplus.
No
expense is recognized for awards that do not ultimately vest.
The
dilutive effect of outstanding options, if any, is reflected as additional dilution in the computation of loss per unit.
Unit/
Share Issuance Costs
Costs
incurred in connection with the issuance of members’ equity are netted against the proceeds received net of tax. Costs related
to the issuance of members’ equity and incurred prior to issuance are recorded as deferred members’ equity issuance costs and
subsequently netted against proceeds when they are received.
Members’
capital consisted of common units, incentive units and seed round preferred units which are classified as equity on the statements
of financial position. Incremental costs attributable directly to the issuance of member’s capital are recognized as deduction
from equity, net of any tax effects.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies (continued)
|
No
provision for federal or state income taxes is included in the Company’s consolidated financial statements because the tax effects
of GR Unlimited’s income or loss for the period from inception to December 31, 2017 were passed on to the Members. Effective January
1, 2018, Grown Rogue Gardens, LLC and Grown Rogue Distribution, LLC elected to be taxed as corporations. Following the Transaction,
GR Unlimited also elected to be taxed as a corporation. As such, these three entities will follow the asset and liability method
of accounting for income taxes. Under this method, deferred income tax assets and liabilities are determined based on the differences
between the carrying amount of assets and liabilities on the statement of financial position and their corresponding tax value,
using the substantively enacted tax rates expected to apply when these temporary differences are reversed. Deferred income tax
assets are recorded to recognize tax benefits only to the extent that, based on available evidence, it is probable that they will
be realized. Income tax expense is recognized in profit or loss except to the extent that it relates to a business combination,
or items recognized directly in equity.
Deferred
tax liabilities are recognized for all temporary differences except when the deferred income tax liability arises from the initial
recognition of goodwill or of an asset or liability in a transaction that is not a business combination and, at the time of the
transaction, affects neither the accounting profit nor taxable profit or loss.
|
q)
|
Newly
Adopted Accounting Policies
|
The
Company adopted the following accounting policies as of November 1, 2018:
Financial Instruments
IFRS
9 financial instruments (“IFRS 9”) replaced IAS 39, Financial Instruments: recognition and Measurement. IFRS 9 includes
guidance on classification and measurement of financial instruments, a new expected credit loss model for calculating impairment
on financial assets and new general hedging requirements.
i)
Classification and measurement of financial assets and financial liabilities
IFRS
9 requires financial assets to be classified into three measurement categories on initial recognition: fair value through profit
and loss (“FVTPL”), fair value through other comprehensive income (“FVOCI”), and amortized cost. Investments
in equity instruments are required to be measured by default at FVTPL. IFRS 9 permit entities to elect into an irrevocable option
for equity instruments to report changes in fair value in other comprehensive income.
Classification
and measurement of financial assets is dependent on the entity’s business model for managing the financial assets and
related contractual cash flows. IFRS 9 retains most of the requirements of IAS 39 related to classification and measurement
of financial liabilities.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies (continued)
|
|
q)
|
Newly
Adopted Accounting Policies (continued)
|
Financial Instruments (continued)
The
following table summarizes the impact of the adoption of IFRS 9 on the classification of the Company’s financial assets
and liabilities:
Asset/Liability
|
|
Classification under IAS 39
|
|
Classification under IFRS 9
|
Accounts receivable, net
|
|
Loans and receivables
|
|
Amortized cost
|
Other receivables
|
|
Loans and receivables
|
|
Amortized cost
|
Cash and cash equivalents
|
|
Loans and receivables
|
|
Amortized cost
|
Accounts payable and accrued liabilities
|
|
Other liabilities at amortized cost
|
|
Amortized cost
|
Finance lease payable
|
|
Other liabilities at amortized cost
|
|
Amortized cost
|
Convertible promissory notes
|
|
Other liabilities at amortized cost
|
|
Amortized cost
|
Long-term debt
|
|
Other liabilities at amortized cost
|
|
Amortized cost
|
Interest payable
|
|
Other liabilities at amortized cost
|
|
Amortized cost
|
Convertible debentures
|
|
Other liabilities at amortized cost
|
|
Amortized cost
|
Due to employee/ director
|
|
Other liabilities at amortized cost
|
|
Amortized cost
|
ii)
Impairment
IFRS
9 introduces a three-stage expected credit loss (“ECL”) model for determining impairment of financial assets. The
expected credit loss model does not require the occurrence of a triggering event before an entity recognizes credit losses. IFRS
9 requires an entity to recognize expected credit losses upon initial recognition of a financial asset and to update the quantum
of expected credit losses at the end of each reporting period to reflect changes to credit risk of the financial asset. The adoption
of the ECL model did not have a material impact on the Company’s condensed consolidated interim financial statements.
Share-based
Payments (Amendments to IFRS 2)
In
June 2016, the IASB issued amendments to IFRS 2 that clarify how to account for certain types of share-based payment transactions.
The
amendments provide requirements related to accounting for:
|
●
|
the
effects of vesting and non-vesting conditions on the measurement of cash-settled share-based
payments;
|
|
●
|
share-based
payment transactions with a net settlement feature for withholding tax obligations; and
|
|
●
|
the
effect of a modification of the terms and conditions of a share-based payment that changes the classification of the transaction
from cash-settled to equity settled.
|
Adoption
of the amendments to IFRS 2 as of November 1, 2018 did not have an impact on the Company’s financial statements.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
4.
|
Significant
Accounting Policies (continued)
|
|
q)
|
Newly
Adopted Accounting Policies (continued)
|
Revenue
IFRS
15 Revenue from Contracts with Customers, (“IFRS 15”) replaced all preexisting guidance, including, but not limited
to IAS 11 Construction Contracts, IAS 18 Revenue, and IFRIC 15 Agreements for the Construction of Real Estate in IFRS related
to revenue. IFRS 15 contains a single control based model (the “model”) that applies to contracts with customers and
allows entities to recognize revenue at a point in time or overtime. The model consists of a 5 step analysis of transactions to
determine whether, how much, and when revenue is recognized. IFRS 15 also includes additional requirements for revenue accounted
for under the standard. Adoption of IFRS 15 as of November 1, 2018 did not have an impact on the Company’s financial statements.
|
r)
|
Future
Accounting Pronouncements
|
IFRS
16 Leases (“Leases”) was issued in January 2016 and replaces IAS 17 Leases. Under IAS 17, lessees were required to make
a distinction between a finance lease and an operating lease. If the lease was classified as a finance lease, a lease liability
was included on the statement of financial position. IFRS 16 now requires lessees to recognize a right of use asset and lease
liability reflecting future lease payments for virtually all lease contracts. The right of use asset is treated similarly to other
non-financial assets and depreciated accordingly. The lease liability accrues interest. The IASB has included an optional exemption
for certain short term leases and leases of low value assets; however, this exemption can only be applied by lessees. Under IFRS
16, a contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period
of time in exchange for consideration. Control is conveyed where the customer has both the right to direct the identified asset’s
use and obtain substantially all the economic benefits from that use. IFRS 16 is effective for annual periods beginning on or
after January 1, 2019 with early adoption permitted if IFRS 15, Revenue from Contracts with Customers, is also applied. The Company
is currently evaluating the impact adopting IFRS 16 will have on its consolidated financial statements.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
5.
|
Liquidity
and Capital Resources
|
The
Company has incurred significant losses from operations. The Company’s management continues to finance its cash needs through
promissory and convertible promissory notes, and the issuance of membership units and common shares. If management is unsuccessful
in its efforts to generate profitable operations and/or continue to receive financial support, the Company may not be able to
continue as a going concern. The ability of the Company to continue as a going concern and to meet its obligations will be dependent
upon successful sales of product and a return to successful operations and cash flows as well as the potential issuance of members’
capital. The accompanying consolidated financial statements do not reflect any adjustment that might result from the outcome of
this uncertainty.
|
6.
|
Significant
Accounting Judgments, Estimates and Assumptions
|
The
preparation of these consolidated financial statements in conformity with IFRS requires management to make judgments, estimates
and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities
at the date of the consolidated financial statements and the reported amounts of income and expenses during the reporting period.
The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant.
Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. The
most significant judgments include those related to the ability of the Company to continue as a going concern, the determination
of when property and equipment are available for use, and impairment of its financial and non-financial assets. The most significant
estimates and assumptions include those related to the valuation of biological assets, the collectibility of accounts receivable,
the useful lives of property and equipment, inputs used in accounting the determination of the discount rate used to estimate
the fair value of the liability component of convertible promissory notes, the inputs used in the estimate of the fair value of
unit-based compensation and the inputs used in the estimate of the fair value of the unit purchase options and warrants issued.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
Biological
assets consists of cannabis seeds and cannabis plants. The reconciliation of changes in the carrying amount of biological assets
as at January 31, 2019 and October 31, 2018 is as follows:
Balance - October 31, 2017
|
|
$
|
10,436
|
|
Add: Purchased cannabis plants
|
|
|
521,949
|
|
Change in fair value less costs to sell due to biological transformation
|
|
|
541,352
|
|
Transferred to inventory upon harvest
|
|
|
(924,120
|
)
|
|
|
|
|
|
Balance - October 31, 2018
|
|
|
149,617
|
|
Add: Purchased cannabis plants
|
|
|
124,711
|
|
Change in fair value less costs to sell due to biological transformation
|
|
|
44,830
|
|
Transferred to inventory upon harvest
|
|
|
(189,759
|
)
|
|
|
|
|
|
Balance - January 31, 2019
|
|
$
|
129,399
|
|
When
determining the fair value of biological assets, the Company makes estimates and uses assumptions as follows:
|
●
|
Expected costs required to grow the cannabis up to
the point of harvest
|
|
●
|
Expected costs associated with harvesting and selling
|
|
●
|
Expected yield from the cannabis plants and selling
price.
|
The
estimates and assumptions used are subject to volatility in uncontrollable market conditions, may significantly impact the fair
value of biological assets. Biological assets represent a level 3 assets in the fair value hierarchy.
As
at January 31, 2019, the Company’s inventory consists of 1,356kg (October 31, 2018 - 638 kg) of harvested cannabis.
Balance - October 31, 2018
|
|
$
|
1,380,101
|
|
|
|
|
|
|
Balance - January 31, 2019
|
|
$
|
1,503,504
|
|
The
cost of inventories included as an expense and included in cost of goods sold, excluding amortization expense was $622,809 (2018
- $119,086).
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
9.
|
Property
and Equipment
|
|
|
Furniture and
Fixtures
|
|
|
Computer and
Office
Equipment
|
|
|
Production
Equipment and
Other
|
|
|
Construction in
Progress -
Warehouse
|
|
|
Leasehold
Improvements
|
|
|
Total
|
|
Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2017
|
|
$
|
750
|
|
|
$
|
2,230
|
|
|
$
|
169,403
|
|
|
$
|
536,008
|
|
|
$
|
326,731
|
|
|
$
|
1,035,122
|
|
Additions
|
|
|
-
|
|
|
|
73,653
|
|
|
|
199,827
|
|
|
|
772,746
|
|
|
|
740,994
|
|
|
|
1,787,220
|
|
Disposals
|
|
|
(750
|
)
|
|
|
-
|
|
|
|
(12,115
|
)
|
|
|
(730,596
|
)
|
|
|
-
|
|
|
|
(743,461
|
)
|
Balance - October 31, 2018
|
|
$
|
-
|
|
|
$
|
75,883
|
|
|
$
|
357,115
|
|
|
$
|
578,158
|
|
|
$
|
1,067,725
|
|
|
$
|
2,078,881
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions
|
|
|
3,964
|
|
|
|
13,922
|
|
|
|
12,543
|
|
|
|
42,662
|
|
|
|
53,565
|
|
|
|
126,656
|
|
Disposals
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(47,604
|
)
|
|
|
-
|
|
|
|
(47,604
|
)
|
Balance -January 31, 2019
|
|
$
|
3,964
|
|
|
$
|
89,805
|
|
|
$
|
369,658
|
|
|
$
|
573,216
|
|
|
$
|
1,121,290
|
|
|
$
|
2,157,933
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2017
|
|
$
|
6
|
|
|
$
|
145
|
|
|
$
|
13,133
|
|
|
$
|
-
|
|
|
$
|
32,642
|
|
|
$
|
45,926
|
|
Transfers
|
|
|
(6
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
6
|
|
|
|
-
|
|
Amortization for the period
|
|
|
-
|
|
|
|
1,762
|
|
|
|
61,036
|
|
|
|
-
|
|
|
|
397,248
|
|
|
|
460,046
|
|
Disposals
|
|
|
-
|
|
|
|
-
|
|
|
|
(3,012
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(3,012
|
)
|
Balance - October 31, 2018
|
|
|
-
|
|
|
|
1,907
|
|
|
|
71,157
|
|
|
|
-
|
|
|
|
429,896
|
|
|
|
502,960
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transfers
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Amortization for the period
|
|
|
94
|
|
|
|
695
|
|
|
|
17,183
|
|
|
|
-
|
|
|
|
140,842
|
|
|
|
158,814
|
|
Disposals
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Balance - January 31, 2019
|
|
$
|
94
|
|
|
$
|
2,602
|
|
|
$
|
88,340
|
|
|
$
|
-
|
|
|
$
|
570,738
|
|
|
$
|
661,774
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Book Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at October 31, 2018
|
|
$
|
-
|
|
|
$
|
73,976
|
|
|
$
|
285,958
|
|
|
$
|
578,158
|
|
|
$
|
637,829
|
|
|
$
|
1,575,921
|
|
As at January 31, 2019
|
|
$
|
3,870
|
|
|
$
|
87,203
|
|
|
$
|
281,318
|
|
|
$
|
573,216
|
|
|
$
|
550,552
|
|
|
$
|
1,496,159
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
The
Company’s intangible asset included amounts charged to develop the Company’s website and brand positioning. The Company determined
the useful lives of the assets to be 2 and 3 years, respectively. Amortization is calculated on a straight-line basis over the
respective useful lives.
|
|
Website
|
|
|
Branding
|
|
|
Total
|
|
Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2017
|
|
$
|
29,405
|
|
|
$
|
9,968
|
|
|
$
|
39,373
|
|
Additions
|
|
|
41,971
|
|
|
|
2,392
|
|
|
|
44,363
|
|
Balance - October 31, 2018
|
|
|
71,376
|
|
|
|
12,360
|
|
|
|
83,736
|
|
Additions
|
|
|
13,480
|
|
|
|
-
|
|
|
|
13,480
|
|
Disposals
|
|
|
-
|
|
|
|
(5,104
|
)
|
|
|
(5,104
|
)
|
Balance -January 31, 2019
|
|
$
|
84,856
|
|
|
$
|
7,256
|
|
|
$
|
92,112
|
|
Accumulated Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2017
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
Additions
|
|
|
15,862
|
|
|
|
2,900
|
|
|
|
18,762
|
|
Balance - October 31, 2018
|
|
|
15,862
|
|
|
|
2,900
|
|
|
|
18,762
|
|
Amortization for the period
|
|
|
5,980
|
|
|
|
1,253
|
|
|
|
7,233
|
|
Balance -January 31, 2019
|
|
$
|
21,842
|
|
|
$
|
4,153
|
|
|
$
|
25,995
|
|
Net Book Value
|
|
|
|
|
|
|
|
|
|
|
|
|
As at October 31, 2018
|
|
$
|
55,514
|
|
|
$
|
9,460
|
|
|
$
|
64,974
|
|
As at January 31, 2019
|
|
$
|
63,014
|
|
|
$
|
3,103
|
|
|
$
|
66,117
|
|
|
11.
|
Finance
lease liabilities
|
|
i)
|
Effective
July 11, 2017, and as amended on July 28, 2017, the Company entered into an agreement with a third party to lease equipment at
a cost $134,289 over a thirty-six month period for monthly payments of $4,778. The terms and conditions of the lease predicate
that substantially all of the risks and rewards of ownership of the leased asset transfer to the Company. Therefore, the Company
has classified the agreement as a finance lease.
|
|
ii)
|
Effective
November 8, 2017, the Company entered into an agreement with a third party to lease equipment at a cost $158,193 over a thirty-six
month period for monthly payments of $5,630. The terms and conditions of the lease predicate that substantially all of the risks
and rewards of ownership of the leased asset transfer to the Company. Therefore, the Company has classified the agreement as a
finance lease.
|
As
at January 31, 2019, the related lease liabilities are payable as follows:
|
|
Future minimum
lease payments
|
|
|
Interest
|
|
|
Total
|
|
Less than one year
|
|
$
|
103,371
|
|
|
$
|
21,513
|
|
|
$
|
124,884
|
|
Between one and five years
|
|
|
70,194
|
|
|
|
4,358
|
|
|
|
74,552
|
|
|
|
$
|
173,565
|
|
|
$
|
25,871
|
|
|
$
|
199,436
|
|
As
at January 31, 2019, the net book value of the growing equipment under finance lease is $.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
Transactions
related to GR Unlimited’s unsecured promissory notes during the period ended January 31, 2019, include the following:
|
|
Face
value
|
|
|
Carrying
amount
|
|
|
Interest
payable
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
$
|
50,000
|
|
|
$
|
50,000
|
|
|
$
|
10,444
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settled in exchange for convertible
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense on long-term debt
|
|
|
-
|
|
|
|
-
|
|
|
|
1,500
|
|
Debt repayments
|
|
|
-
|
|
|
|
-
|
|
|
|
(6,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
|
50,000
|
|
|
|
50,000
|
|
|
|
5,944
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: current portion
|
|
|
-
|
|
|
|
-
|
|
|
|
5,944
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - January 31, 2019 net of current portion
|
|
$
|
50,000
|
|
|
$
|
50,000
|
|
|
$
|
-
|
|
Transactions
related to GR Unlimited’s unsecured promissory notes during the period ended October 31, 2018, include the
following:
|
|
Face
value
|
|
|
Carrying
amount
|
|
|
Interest
payable
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2017
|
|
$
|
552,173
|
|
|
$
|
552,173
|
|
|
$
|
14,860
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred financing costs
|
|
|
642
|
|
|
|
642
|
|
|
|
-
|
|
Settled in exchange for convertible promissory note (note )
|
|
|
(500,000
|
)
|
|
|
(500,000
|
)
|
|
|
(10,416
|
)
|
Interest expense on long-term debt
|
|
|
-
|
|
|
|
-
|
|
|
|
6,000
|
|
Debt repayments
|
|
|
(2,815
|
)
|
|
|
(2,815
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
|
50,000
|
|
|
|
50,000
|
|
|
|
10,444
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: current portion
|
|
|
-
|
|
|
|
-
|
|
|
|
10,444
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018 net of current portion
|
|
$
|
50,000
|
|
|
$
|
50,000
|
|
|
$
|
-
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
12.
|
Long-term
Debt (continued)
|
|
i)
|
On
February 1, 2017: Principal of $50,000 with simple interest accrued at a rate of 12% per annum. Interest only payments due on
the following: (i) $6,000 on each of July 1, 2018 and July 1, 2019 and interest and principal payment, $56,000 due on July 1,
2020. As at January 31, 2019, accrued interest of $5,944 (October 31, 2018 - $10,444) was incurred.
|
|
ii)
|
On
October 1, 2017: Principal of $500,000 with simple interest accrued at a rate of 25% per annum. During the period ended October
31, 2018, this Company formalized this debt by way of a convertible promissory note (see note 13 (iii)).
|
|
13.
|
Convertible
Promissory Notes
|
Transactions
related to GR Unlimited’s convertible promissory notes during the period ended January 31, 2019, include the following:
|
|
Face
value
|
|
|
Carrying
amount
|
|
|
Interest
payable
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
$
|
1,343,171
|
|
|
$
|
1,299,376
|
|
|
$
|
454,775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50% - November 7, 2017 (i)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
25% - December 15, 2017 (iii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
12.5% - August 1, 2018 (vii)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
1,343,171
|
|
|
|
1,299,376
|
|
|
|
454,775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred financing costs
|
|
|
6,974
|
|
|
|
8,627
|
|
|
|
-
|
|
Interest expense on long-term debt
|
|
|
-
|
|
|
|
-
|
|
|
|
69,650
|
|
Interest accretion
|
|
|
-
|
|
|
|
5,502
|
|
|
|
-
|
|
Repaid
|
|
|
(207,777
|
)
|
|
|
(207,777
|
)
|
|
|
(141,559
|
)
|
Converted to common units
|
|
|
(1,100,000
|
)
|
|
|
(1,063,360
|
)
|
|
|
(194,313
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - January 31, 2019
|
|
|
42,368
|
|
|
|
42,368
|
|
|
|
188,553
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: current portion
|
|
|
42,368
|
|
|
|
42,368
|
|
|
|
188,553
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - net of current portion
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
Transactions
related to GR Unlimited’s convertible promissory notes during the year ended October 31, 2018, include the following:
|
|
Face
value
|
|
|
Carrying
amount
|
|
|
Interest
payable
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2017
|
|
$
|
1,518,391
|
|
|
$
|
1,394,582
|
|
|
$
|
140,118
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50% - November 7, 2017 (i)
|
|
|
300,000
|
|
|
|
300,000
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
190,000
|
|
|
|
190,000
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
125,000
|
|
|
|
125,000
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
90,000
|
|
|
|
90,000
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
25,000
|
|
|
|
25,000
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
70,000
|
|
|
|
70,000
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
25,000
|
|
|
|
25,000
|
|
|
|
-
|
|
50% - November 14, 2017 (ii)
|
|
|
25,000
|
|
|
|
25,000
|
|
|
|
-
|
|
25% - December 15, 2017 (iii)
|
|
|
1,000,000
|
|
|
|
1,000,000
|
|
|
|
-
|
|
12.5% - August 1, 2018 (vii)
|
|
|
57,500
|
|
|
|
57,500
|
|
|
|
-
|
|
|
|
|
3,425,891
|
|
|
|
3,302,082
|
|
|
|
140,118
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred financing costs
|
|
|
(55,008
|
)
|
|
|
(55,008
|
)
|
|
|
-
|
|
Amortization of deferred financing costs
|
|
|
52,286
|
|
|
|
52,286
|
|
|
|
-
|
|
Interest expense on long-term debt
|
|
|
-
|
|
|
|
-
|
|
|
|
822,165
|
|
Fair value of conversion option
|
|
|
-
|
|
|
|
(298,000
|
)
|
|
|
-
|
|
Interest accretion
|
|
|
-
|
|
|
|
284,042
|
|
|
|
-
|
|
Exchanged
|
|
|
(50,000
|
)
|
|
|
(50,000
|
)
|
|
|
(7,500
|
)
|
Repaid
|
|
|
(492,223
|
)
|
|
|
(492,223
|
)
|
|
|
(205,678
|
)
|
Converted to common units
|
|
|
(1,537,775
|
)
|
|
|
(1,443,803
|
)
|
|
|
(294,330
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
|
1,343,171
|
|
|
|
1,299,376
|
|
|
|
454,775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: current portion
|
|
|
265,277
|
|
|
|
265,277
|
|
|
|
454,775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - net of current portion
|
|
$
|
1,077,894
|
|
|
$
|
1,034,099
|
|
|
$
|
-
|
|
During
the period ended October 31, 2018, GR Unlimited issued the following unsecured convertible promissory notes:
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
|
i)
|
Effective
November 7, 2017, the GR Unlimited entered into an agreement with GR Unlimited’s Marketing Consultant (the “Consultant”)
whereby the Consultant purchased a convertible promissory note for the total principal of $300,000 with simple interest accrued
at a rate of 50%. Accrued interest shall be paid in monthly installments of $12,500 until maturity. A balloon interest payment
of $15,000 was due to the Consultant on day 180 and has been accrued as of July 31, 2018. The note, which includes any unpaid
principal and accrued interest, unless converted in accordance with provisions stated in the agreement shall be due and payable
on the earlier of the following: (a) 12 months from the effective date of the note; or (b) the occurrence of a change of control
of the Company. The note does not have a prepayment option under the agreement, unless agreed to in writing by the purchaser.
|
At
any time prior to the maturity of the agreement, the Consultant has the right to convert all (but not less than all) of the outstanding
principal amount and all accrued and unpaid interest into the number of fully paid and non-assessable common units of GR Unlimited
at a price per unit equal to the applicable conversion price calculated immediately before the closing of a going public event
or qualified transaction.
The
conversion price represents an amount equal to the applicable conversion valuation divided by the number of units outstanding
at the time of conversion. The Conversion valuation represents the following a) $15,000,000 if the holder converts the note within
6 months of the effective date of the note and b) $18,000,000 if the holder converts the note after 6 months of the effective
date of the note, but prior to the note’s maturity. On June 1, 2018, the principle of $300,000 was converted into 285.70
common units of GR Unlimited as described in note 15(xvi).
|
ii)
|
Effective
November 14, 2017, GR Unlimited entered into an agreement with certain purchasers (collectively the “Purchasers” and
individually the “Purchaser”), to issue a series of notes with substantially similar terms, including maturity, interest
rates, and conversion terms. Under the agreements, the Purchasers purchased convertible promissory notes with aggregate principal
of $550,000. The notes accrue simple interest as follows:
|
|
a)
|
Interest
will accrue on the outstanding principal at an annual rate of 50% calculated on the basis of a year of 365 days.
|
|
b)
|
Should
the Purchasers extend the maturity date due to a public event prior to the end of the period, the Purchaser has the right to extend
the Maturity date by up to 3 months after the consummation of the public event at an annual rate of 0% following the initial period.
|
|
c)
|
Should
purchasers extend the Maturity Date by 6 months on all but not less than all of the then-outstanding principal; provided, however
GR Unlimited shall pay Holder all principal not so extended, and all accrued but unpaid interest at the end of the initial period
at an annual rate of 30% calculated on the basis of a year of 365 days.
|
|
d)
|
Should
the Purchaser extend the maturity date of this note by 18 months on not less than $10,000 of the then-outstanding principal and
unpaid interest accrued under the Note at the end of the initial period; provided, however GR Unlimited shall pay Purchaser all
principal and/or interest for which the maturity date is not so extended at an annual rate of 20% calculated on the basis of a
year of 365 days.
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
The
notes, which includes any unpaid principal and accrued interest, unless converted in accordance with provisions stated in the
agreement shall be due and payable on the earlier of the following: (a) the date on which the initial period ends (the Maturity
Date) unless the Maturity Date is extended by Purchaser by 3, 6, or 18 months after the Public Event. The notes may not be prepaid,
in whole or in part, prior to the Maturity Date without the prior written consent of a majority in interest of a Purchaser.
If
at any time prior to the maturity of the notes and qualified equity financing occurs, the Purchaser has the right to convert not
less than $10,000 of the outstanding principal amount and all accrued and unpaid interest into the number of fully paid and non-assessable
common membership units of GR Unlimited at a price per unit equal to the applicable conversion price. If the Purchaser has extended
the maturity date and the qualified equity financing occurs during the 18 months following the initial period, the Purchaser shall
have the obligation to convert all of the outstanding principal amount and all accrued and unpaid interest into the number of
fully paid and non-assessable common membership until of GR Unlimited at a price per unit equal to the applicable conversion price.
The conversion price represents the following:
|
a)
|
In
the event of a qualified equity financing, the lower of (i) the valuation cap divided by issued and outstanding share count immediately
prior to the qualified equity financing, or (ii) eighty percent (80%) of the price per unit paid in cash by purchasers of New
Units issued in such qualified equity financing; provided, however, that such percentage shall decline by two percent (2%) for
each month an event of default occurs and is continuing after the end of the initial period, up to a maximum of ten percent (10%)
(e.g., if such an event of default continues for five months, the conversion price under this paragraph (a) will be a price equal
to seventy (70%) of the applicable price set forth in clause (ii) above); or
|
|
b)
|
In
the event of a public event the lower of (i) the valuation cap divided by the issued and outstanding share count immediately prior
to the public event, or (ii) eighty percent (80%) of the price per unit paid in cash by purchasers of new units issued in such
Public Event; provided, however, that such percentage shall decline by two percent (2%) for each month an event of default occurs
and is continuing after the end of the Initial Period, up to a maximum of ten percent (10%) (
e.g.
, if such an event of
default continues for five months, the conversion Price under this paragraph (b) will be a price equal to seventy (70%) of the
applicable price set forth in clause (ii) above); or
|
|
c)
|
In
the event of a change of control transaction, the lower of (i) the valuation cap divided by the change of control issued and outstanding
share count immediately prior to the qualified equity financing, or (ii) eighty percent (80%) of the price per unit paid by the
purchaser(s) in such change of control transaction; provided, however, that such percentage shall decline by two percent (2%)
for each month an event of default occurs and is continuing after the end of the initial period, up to a maximum of ten percent
(10%) (
e.g.
, if such an event of default continues for five months, the conversion price under this paragraph (c) will
be a price equal to seventy (70%) of the applicable price set forth in clause (ii) above); provided, further, that if a transaction
or event can be characterized both as a public event and as a change of control transaction, the conversion price shall be established
as if such transaction or event were a change of control transaction; or
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
|
d)
|
In
the event of a nonqualified equity financing, the lower of (i) the valuation cap divided by Issued and outstanding share count
immediately prior to the nonqualified equity financing, or (ii) eighty percent (80%) of the price per unit paid in cash by purchasers
of new units issued in such nonqualified equity financing; provided, however, that such percentage shall decline by two percent
(2%) for each month an event of default occurs and is continuing after the end of the initial period, up to a maximum of ten percent
(10%) (e.g., if such an event of default continues for five months, the conversion price under this paragraph (a) will be a price
equal to seventy (70%) of the applicable price set forth in clause (ii) above). During the year ended October 31, 2018, GR Unlimited
made aggregate principal repayments of $442,223. During the three months ended January 31, 2019, GR Unlimited repaid the remaining
aggregate principal of $107,777. As at October 31, 2018, accrued interest of $127,915 remained unpaid which was paid during the
three months ended January 31, 2019.
|
|
iii)
|
Effective
December 15, 2017, GR Unlimited entered into an agreement whereby the holder purchased a convertible promissory note for the total
principal of $1,000,000 with simple interest accrued at a rate of 25%, payable as follows:
|
|
a)
|
As
at October 31, 2018 interest accrued to $105,556 on the sum of $500,000, of debt previously held by the holder.
|
|
b)
|
Interest
shall accrue from the effective date of the note on the total sum of $1,000,000 and paid in monthly installments of $20,833.33
to the holder beginning on January 15, 2018. As at October 31, 2018 none of the monthly instalments had been paid.
|
|
c)
|
A
one-time additional interest payment equal to 5% of the unpaid principal balance payable concurrent with the 12
th
scheduled
monthly installment payment is otherwise due. In the event the holder completed a full or partial conversion within 12 months
of the effective date, the one-time interest payment shall be pro-rated as at the date of the full or partial conversion.
|
The
note, which includes any unpaid principal and accrued interest, unless converted in accordance with provisions stated in the agreement
shall be due and payable on the earlier of the following: (a) 36 months from the effective date of the note; or (b) the occurrence
of a change of control of GR Unlimited. Within the first 24 months from the effective date of the note, no prepayment will occur,
except for payments of accrued interest or other payments as outlined above.
At
any time prior to the 24 month anniversary of the effective date of the note, the holder has the right to fully or partially convert
the outstanding principal and all accrued and unpaid interest into the number of fully paid and non-assessable common membership
units of GR Unlimited at a price per unit equal to the applicable conversion price. The Conversion price represents an amount
equal to the applicable conversion valuation divided by the number of issued and outstanding units ofGR Unlimited at the time
of conversion calculated immediately before the closing of a qualified equity financing event if the conversion is in conjunction
with a qualified equity financing event.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
If
the Company consummates a going public event within the 12 months anniversary date of the note, the holder has the right to fully
or partially convert the total principal outstanding at a price per unit equal to the applicable conversion price by providing
written notice to GR Unlimited of its election to convert within 7 days after receipt from GR Unlimited of the financing notice.
If the holder so converts, GR Unlimited will offer the holder a position as a strategic advisor toGR Unlimited for a 12 month
term, which commences on the date of conversion. The holder will receive gross monthly compensation equal to $10,000 if the holder
fully converts or a portion of the $10,000 equal to the ratio of the amount converted.
The
conversion valuation represents the following a) $20,000,000 if the holder converts the note within 12 months of the effective
date of the note and b) $40,000,000 if the holder converts the note after 12 months of the effective date of the note, but before
24 months of the effective date of the note. As at October 31, 2018, accrued interest of $248,958 was incurred. During the three
months ended January 31, 2019, the principle of $1,000,000 and unpaid interest of $171,875 were converted into 1,144.15 common
units of GR Unlimited as described in note 15 (xxi)
During
the period ended October 31, 2017, GR Unlimited issued the following unsecured convertible promissory notes:
|
iv)
|
Effective
February 1, 2017: Principal of $100,000 with simple interest accrued at a rate of 15%. Principal and interest due and payable
on the three year anniversary of the promissory note, February 1, 2020. In the event GR Unlimited completes a qualified equity
financing transaction on or before the maturity date of the promissory note, the holder has the right to convert in whole or in
part the unpaid principal and interest balance into fully paid non-assessable shares of common stock of GR Unlimited. The conversion
price per unit will equal 80% of the price per unit paid in cash by purchasers of new units in a qualified equity transaction.
As at October 31, 2018, accrued interest of $26,219 was incurred. The fair value of the conversion option was estimated as $Nil.
During the three months ended January 31, 2019, the principle of $100,000 and unpaid interest of $22,438 were converted into 126.13
common units of GR Unlimited as described in note 15(xx)
|
|
v)
|
Effective
February 1, 2017: Principal of $100,000 with simple interest accrued at a rate of 15%. Principal and interest due and payable
on the three year anniversary of the promissory note, February 1, 2020. In the event GR Unlimited completes a qualified equity
financing transaction on or before the maturity date of the promissory note, the holder has the right to convert in whole or in
part the unpaid principal and interest balance into fully paid non-assessable shares of common stock of GR Unlimited. The conversion
price per unit will equal 80% of the price per unit paid in cash by purchasers of new units in a qualified equity transaction.
As at October 31, 2018, accrued interest of $22,438 (2017 - $11,209) was incurred. The fair value of the conversion option was
estimated as $Nil. On June 15, 2018, the principle of $100,000 and unpaid interest of $20,465 were converted into 115 common units
of GR Unlimited as described in note 15(xviii).
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
|
vi)
|
Effective
June 1, 2017: GR Unlimited entered into an agreement with its President and CEO and the President and CEO’s spouse (the
“Holder”), whereby the Holder purchased a convertible nonnegotiable promissory note for total principal of $637,775
with simple interest calculated at a rate of 25% per annum. The note, which includes any unpaid principal and accrued interest,
unless converted in accordance with provisions stated in the agreement shall be due and payable on the earlier of the following:
(a) 36 months from the effective date of the note; or (b) the occurrence of a change of control of GR Unlimited. A balloon interest
payment of $30,000 was due to the Holder on June 1, 2018. On June 1, 2018, the principle of $637,775 and unpaid interest of $146,157
(which included the $30,000 balloon interest payment) were converted into 922.70 common units of GR Unlimited as described in
note 15(xv).
|
In
the event GR Unlimited completes a qualified equity financing transaction on or before the maturity date of the promissory note,
the holder has the right to convert in whole or in part the unpaid principal and interest balance into fully paid non-assessable
shares of common stock of GR Unlimited at a price per unit equal to the applicable conversion price calculated immediately before
the closing of a going public event or qualified transaction. At any time prior to the maturity of the agreement, the Holder has
the right to convert a portion of the outstanding principal amount and all accrued and unpaid interest into the number of fully
paid and non-assessable common membership units of GR Unlimited.
The
conversion price represents an amount equal to the applicable conversion valuation divided by the number of units outstanding
at the time of conversion. The Conversion valuation represents the following a) $10,000,000 if the holder converts the note within
12 months of the effective date of the note and b) $15,000,000 if the holder converts the note after 12 months of the effective
date of the note, but prior to the note’s maturity.
The
fair value of the conversion option was estimated as $54,000 using the following inputs, assumptions and estimates:
Risk-free interest rate
|
|
|
1.68%
|
|
Expected life
|
|
|
2.6 years
|
|
Expected volatility
|
|
|
70%
|
|
Share price
|
|
|
$612
|
|
Units outstanding at time of conversion
|
|
|
10,000
|
|
Conversion price at time of conversion
|
|
|
$
1,000 - $1,500
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
|
vii)
|
Effective
July 26, 2017, GR Unlimited through its wholly owned subsidiary GRU Properties, LLC entered into an agreement whereby the holder
purchased a convertible promissory note for the total principal of $100,000 with simple interest calculated at a rate of 50% per
annum for the first 6 months. The note became due on February 1, 2018 and was extendable for another 6 months at the holder’s
option. If the holder extends the term an additional 6 months the rate of simple interest will change to 30%, such that at the
end of the 12 month period, the total outstanding principal and interest amount would not exceed $140,000.
|
The
holder of the convertible promissory note has the unrestricted right, at the holder’s option to convert a maximum of $125,000
of the outstanding balances into common units of GR Unlimited at a price per unit agreed upon by GR Unlimited and the holder,
or if a conversion price per unit cannot be agreed upon, the price per unit will be determined by appraisal. The right to convert
may be exercised after the extended maturity date of the convertible promissory note. The number of common shares into which the
convertible promissory notes may or will be converted shall be determined by dividing the unpaid principal balance, together with
all accrued and unpaid interest thereon, by the conversion price. On January 31, 2018, $50,000 of the outstanding principal was
repaid and the remaining principal of $50,000 was extended to August 1, 2018. In addition, $25,000 of accrued and unpaid interest
was converted into common units of GR Unlimited as described in note 15(x)(iii). On August 1, 2018, the holder of the convertible
promissory note accepted a new convertible promissory note in the amount of $57,500 in exchange for the current note and $7,500
of accrued interest. The new convertible promissory note has a maturity date to August 1, 2019, with interest at 12.5% per annum,
payable monthly. As at October 31, 2018, accrued interest of $1,197 (2017 - $13,185) was incurred.
The
fair value of the conversion option was estimated as $23,000 using the following inputs, assumptions and estimates:
Risk-free interest rate
|
|
|
1.36%
|
|
Expected life
|
|
|
0.75 years
|
|
Expected volatility
|
|
|
70%
|
|
Share price
|
|
|
$612
|
|
Conversion price at time of conversion
|
|
|
$612
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
|
viii)
|
Effective
July 26, 2017, GR Unlimited through its wholly owned subsidiary GRU Properties, LLC entered into an agreement whereby the holder
purchased a convertible promissory note for the total principal of $100,000 with simple interest calculated at a rate of 50% per
annum for the first 6 months. The note became due on February 1, 2018 and was extendable for another 6 months at the holder’s
option. If the holder extends the term an additional 6 months the rate of simple interest will change to 30%, such that at the
end of the 12 month period, the total outstanding principal and interest amount would not exceed $140,000.
|
The
holder of the convertible promissory note has the unrestricted right, at the holder’s option to convert a maximum of $125,000
of the outstanding balances into common units of GR Unlimited at a price per unit agreed upon by GR Unlimited and the holder,
or if a conversion price per unit cannot be agreed upon, the price per unit will be determined by appraisal. The right to convert
may be exercised after the extended maturity date of the convertible promissory note. The number of common shares into which the
convertible promissory notes may or will be converted shall be determined by dividing the unpaid principal balance, together with
all accrued and unpaid interest thereon, by the conversion price. As at October 31, 2017, accrued interest of $13,185 was incurred.
On January 31, 2018, the principle of $100,000 and unpaid interest of $25,000 were converted into 89.8 common units of GR Unlimited
as described in note 15(x)(iii).
The
fair value of the conversion option was estimated as $23,000 using the following inputs, assumptions and estimates:
Risk-free interest rate
|
|
|
1.36%
|
|
Expected life
|
|
|
0.75 years
|
|
Expected volatility
|
|
|
70%
|
|
Share price
|
|
|
$612
|
|
Conversion price at time of conversion
|
|
|
$612
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
|
ix)
|
Effective
July 26, 2017: Principal of $100,000 with simple interest calculated at a rate of 50% per annum for the first 6 months. The note
becomes due and payable on the earlier of a) February 1, 2018 unless extended for another 6 months at the holder’s option
and b) the occurrence of a change of control of GR Unlimited. At the maturity date, the holder has the right to either a) convert
the total unpaid principal and accrued interest balance into other convertible notes then being offered or b) extend the original
term of the note for an additional 6-month period. If the holder extends the term an additional 6-months the rate of simple interest
will change to 30% per annum. As at October 31, 2017, accrued interest of $13,185 was incurred. Effective January 31, 2018, the
principal and unpaid interest of $25,000 were converted into 74.8 common units of GR Unlimited as describedin note 15(ix).
|
The
fair value of the conversion option was estimated as $15,000 using the following inputs, assumptions and estimates:
Risk-free interest rate
|
|
|
1.15%
|
|
Expected life
|
|
|
0.25 years
|
|
Expected volatility
|
|
|
60%
|
|
Share price
|
|
|
$612
|
|
Conversion price at time of conversion
|
|
|
$612
|
|
|
x)
|
Effective
October 1, 2017: GR Unlimited entered into an agreement with its President and CEO and the President and CEO’s spouse (the
“Holder”), whereby the Holder purchased two convertible non-negotiable promissory note for total principal of $250,000
with simple interest calculated at a rate of 50% per annum. The note, which includes any unpaid principal and accrued interest,
unless converted in accordance with provisions stated in the agreement shall be due and payable on the earlier of the following:
(a) 12 months from the effective date of the note; or (b) the occurrence of a change of control of the Company. A balloon interest
payment of $15,000 is due to the Holder on day 180. The note does not have a prepayment option under the agreement, unless agreed
to in writing by the Holder. Effective March 31, 2018, the principal and unpaid interest of $46,250 were converted into 332.4
common units of GR Unlimited as describedin note 15(xiv).
|
At
any time prior to the maturity of the agreement, the Holder had the right to convert a portion of the outstanding principal amount
and all accrued and unpaid interest into the number of fully paid and non-assessable common membership units of GR Unlimited at
a price per unit equal to the applicable conversion price calculated immediately before the closing of a going public event or
qualified transaction.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
The
conversion price represents an amount equal to the applicable conversion valuation divided by the number of units outstanding
at the time of conversion. The Conversion valuation represents the following a) $10,000,000 if the holder converts the note within
6 months of the effective date of the note and b) $15,000,000 if the holder converts the note after 6 months of the effective
date of the note, but prior to the note’s maturity. As at October 31, 2017, accrued interest of $10,274 was incurred.
The
fair value of the conversion option was estimated as $8,000 using the following inputs, assumptions and estimates:
Risk-free interest rate
|
|
|
1.41%
|
|
Expected life
|
|
|
0.92 years
|
|
Expected volatility
|
|
|
70%
|
|
Share price
|
|
|
$612
|
|
Units outstanding at time of conversion
|
|
|
10,000
|
|
Conversion price at time of conversion
|
|
|
$
1,000 - $1,500
|
|
|
xi)
|
Effective
October 20, 2017, Principal of $100,000 with simple interest accrued at a rate of 50% per annum. All unpaid principal and accrued
interest become due and payable on the earlier of a) the 6 month anniversary of the note, unless extended at the sole discretion
of the holder and b) the occurrence of a change in control of GR Unlimited. At the Maturity date, the holder has the right to
either a) convert the total unpaid principal and accrued interest into other convertible notes then being offered by GR Unlimited
or b) extend the maturity of the note by 6 months. Should the holder extend the note, interest will accrue on the original principal
at a rate of 30% per annum. As of the maturity date, October 20, 2017, the maturity date was extended by 6 months and fully matured
on April 20, 2018. On April 20, 2018, the maturity was extended by 6 months to October 20, 2018 with interest accrued at a rate
of 30% during the extension period. The maturity date was then extended further to November 8, 2018. During the three months ended
January 31, 2019, GR Unlimited repaid the principal of $100,000. As at January 31, 2019, and October 31, 2018, accrued interest
of $40,000 was outstanding.
|
The
fair value of the conversion option was estimated as $23,000 using the following inputs, assumptions and estimates:
Risk-free interest rate
|
|
|
1.27%
|
|
Expected life
|
|
|
0.47 years
|
|
Expected volatility
|
|
|
70%
|
|
Share price
|
|
|
$612
|
|
Conversion price at time of conversion
|
|
|
$612
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
13.
|
Convertible
Promissory Notes (continued)
|
|
xii)
|
On
October 23, 2017, Principal of $50,000 with simple interest accrued at a rate of 50% per annum. All unpaid principal and accrued
interest become due and payable on the earlier of a) the 6 month anniversary of the note, unless extended at the sole discretion
of the holder and b) the occurrence of a change in control of GR Unlimited. At the Maturity date, the holder has the right to
either a) convert the total unpaid principal and accrued interest into other convertible notes then being offered by GR Unlimited
or b) extend the maturity of the note by 6 months. Should the holder extend the note, interest will accrue on the original principal
at a rate of 30% per annum. As at October 31, 2017, accrued interest of $548 was incurred. On January 26, 2018, the holder converted
the original principal amount and accrued and unpaid interest of $6,458 into 34 uncertified common units of GR Unlimited as describedin
note 15(viii).
|
The
fair value of the conversion option was estimated as $11,000 using the following inputs, assumptions and estimates:
Risk-free interest rate
|
|
|
1.27%
|
|
Expected life
|
|
|
0.48 years
|
|
Expected volatility
|
|
|
70%
|
|
Share price
|
|
|
$612
|
|
Conversion price at time of conversion
|
|
|
$612
|
|
|
14.
|
Convertible
Debentures
|
Transactions
related to GR Unlimited’s convertible debentures during the period ended January 31, 2019, include the following:
|
|
Face
value
|
|
|
Carrying
amount
|
|
|
Interest
payable
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
$
|
1,029,314
|
|
|
$
|
931,099
|
|
|
$
|
7,758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of issuance costs
|
|
|
-
|
|
|
|
13,799
|
|
|
|
-
|
|
Interest accretion
|
|
|
-
|
|
|
|
12,462
|
|
|
|
-
|
|
Interest expense
|
|
|
-
|
|
|
|
-
|
|
|
|
22,566
|
|
Interest payments
|
|
|
-
|
|
|
|
-
|
|
|
|
(22,187
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
|
1,029,314
|
|
|
|
957,360
|
|
|
|
8,137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: current portion
|
|
|
-
|
|
|
|
-
|
|
|
|
8,137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - net of current portion
|
|
$
|
1,029,314
|
|
|
$
|
957,360
|
|
|
$
|
-
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
14.
|
Convertible
Debentures (continued)
|
Transactions
related to GR Unlimited’s convertible debentures during the year ended October 31, 2018, include the following:
|
|
Face
value
|
|
|
Carrying
amount
|
|
|
Interest
payable
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2016 and 2017
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued during the year
|
|
|
1,141,060
|
|
|
|
1,141,060
|
|
|
|
7,758
|
|
Fair value of conversion option
|
|
|
-
|
|
|
|
(132,000
|
)
|
|
|
-
|
|
Interest accretion
|
|
|
-
|
|
|
|
33,785
|
|
|
|
-
|
|
Less: issuance costs
|
|
|
(111,746
|
)
|
|
|
(111,746
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - October 31, 2018
|
|
|
1,029,314
|
|
|
|
931,099
|
|
|
|
7,758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: current portion
|
|
|
-
|
|
|
|
-
|
|
|
|
7,758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - net of current portion
|
|
$
|
1,029,314
|
|
|
$
|
931,099
|
|
|
$
|
-
|
|
(i)
During the period ended October 31, 2018, GR Unlimited issued a series of secured convertible debentures with aggregate principal
of CAD$1,500,000 ($1,141,060). This series of convertible debentures bear interest at 2% quarterly payable on the last day of
March, June, September, and December. The convertible debentures mature twenty four months from the effective date of the agreement
or December 1, 2018 if a change in ownership has not occurred. The debentures will be secured by a general security agreement
granting a security interest in all of GR Unlimited’s property and assets. The debentures can be converted by the holder
into common units of the company at a conversion price of CAD$0.44 per Unit. In the event of a default, the Conversion Price shall
be reduced to CAD$0.05 per Unit. In connection with the issuance of the convertible debentures, GR Unlimited incurred issuance
costs of $111,746.
GR
Unlimited has allocated the proceeds from the issuance of the convertible debentures as follows:
Convertible debentures, principal
|
|
$
|
1,009,060
|
|
Conversion option
|
|
|
132,000
|
|
|
|
$
|
1,141,060
|
|
The
value of the conversion option was calculated by subtracting the net present value of the debenture from the face value of the
convertible debentures. The net present value of the debenture was calculated using a discount rate of 15% over a period of 24
months.
Upon
close of the Transaction, these debentures were replaced by convertible debentures of the Company with similar terms.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
GR
Unlimited is authorized to issue up to 20,000 common units, up to 750 Seed Round Preferred Units and up to 3,000 Incentive Units.
The
following table summarizes the common unit activities of GR Unlimited for the periods ended January 31, 2019 and October 31, 2018:
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
Seed Round
|
|
|
|
|
|
|
Common
|
|
|
Incentive
|
|
|
Preferred
|
|
|
Member’s
|
|
|
|
Units
|
|
|
Units
|
|
|
Units
|
|
|
Capital
|
|
Balance, October 31, 2017 (i)
|
|
7,000
|
|
|
-
|
|
|
-
|
|
|
$100
|
|
Issued pursuant to conversion of promissory notes
|
|
|
1,854
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,152,134
|
|
Issued for cash proceeds
|
|
|
191
|
|
|
|
-
|
|
|
|
733
|
|
|
|
1,525,345
|
|
Issued as employee compensation (ii)
|
|
|
-
|
|
|
|
300
|
|
|
|
-
|
|
|
|
-
|
|
Issued to service providers (xiii)
|
|
|
1,500
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,049,595
|
|
Issuance costs
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(25,401
|
)
|
Balance, October 31, 2018
|
|
|
10,545
|
|
|
|
300
|
|
|
|
733
|
|
|
|
4,701,773
|
|
Issued pursuant to conversion of promissory notes
|
|
|
1,322
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,374,317
|
|
Issued in connection with Technology License Agreement
(xix)
|
|
|
6,600,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,199,667
|
|
Issued upon exercise of unit purchase options
|
|
|
4,202,429
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,258,784
|
|
Issued pursuant to Subscription Receipts
|
|
|
3,771,023
|
|
|
|
-
|
|
|
|
-
|
|
|
|
913,698
|
|
Exchange of incentive units for common units (ii)
|
|
|
150
|
|
|
|
(300
|
)
|
|
|
-
|
|
|
|
-
|
|
Balance, January 31, 2019
|
|
|
14,585,469
|
|
|
|
-
|
|
|
|
733
|
|
|
$
|
10,448,239
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
15.
|
Members’
Capital (continued)
|
|
i)
|
During
the period ended October 31, 2017, GR Unlimited issued 7,000 common units to GR Unlimited’s CEO and President for proceeds
of $100.
|
|
ii)
|
On
November 27, 2017, GR Unlimited issued 300 Incentive Units to an employee of GR Unlimited. Immediately prior to the Transaction,
these Incentive Units were exchnaged for 150 common units.
|
|
iii)
|
Effective
December 11, 2017, GR Unlimited entered into a Seed Round Preferred Unit Subscription Agreement whereby GR Unlimited will issue
up to 621 Seed Round Preferred Units (the “Units”) at a purchase price of $1,773.05 per Unit. Under the Agreement
GR Unlimited issued 253 Units for total proceeds of $448,581. Each Unit will have one vote per unit and will be subject to automatic
conversion into common units rounded to the nearest whole common unit, at the then effective conversion rate immediately prior
to the closing of a public event. The conversion rate shall be determined by dividing the original issue price for a single Unit
by the conversion price effective at the time of conversion. The Conversion price will change upon the occurrence of an event
which changes the number of outstanding and issued common units at the time of conversion.
|
|
iv)
|
Effective
December 11, 2017, GR Unlimited entered into a Seed Round Preferred Unit Subscription Agreement whereby GR Unlimited will issue
up to 621 Seed Round Preferred Units (the “Units”) at a purchase price of $1,773.05 per Unit. Under the Agreement
GR Unlimited issued 56 Units for a total purchase price of $99,291. Each Unit will have one vote per unit and will be subject
to automatic conversion into common units rounded to the nearest whole common unit, at the then effective conversion rate immediately
prior to the closing of a public event. The conversion rate shall be determined by dividing the original issue price for a single
Unit by the conversion price effective at the time of conversion. The Conversion price will change upon the occurrence of an event
which changes the number of outstanding and issued common units at the time of conversion.
|
|
v)
|
Effective
December 11, 2017, GR Unlimited entered into a Seed Round Preferred Unit Subscription Agreement whereby GR Unlimited will issue
up to 621 Seed Round Preferred Units (the “Units”) at a purchase price of $1,773.05 per Unit. Under the Agreement
GR Unlimited issued 139 Units for a total purchase price of $246,454. Each Unit will have one vote per unit and will be subject
to automatic conversion into common units rounded to the nearest whole common unit, at the then effective conversion rate immediately
prior to the closing of a public event. The conversion rate shall be determined by dividing the original issue price for a single
Unit by the conversion price effective at the time of conversion. The Conversion price will change upon the occurrence of an event
which changes the number of outstanding and issued common units at the time of conversion.
|
|
vi)
|
Effective
December 15, 2017, GR Unlimited entered into a Seed Round Preferred Unit Subscription Agreement whereby GR Unlimited will issue
up to 621 Seed Round Preferred Units (the “Units”) at a purchase price of $1,773.05 per Unit. Under the Agreement
GR Unlimited issued 3 Units for a total purchase price of $5,319. Each Unit will have one vote per unit and will be subject to
automatic conversion into common units rounded to the nearest whole common unit, at the then conversion rate immediately prior
to the closing of a public event. The conversion rate shall be determined by dividing the original issue price for a single Unit
by the conversion price effective at the time of conversion. The conversion price will change upon the occurrence of an event
which changes the number of outstanding and issued common units at the time of conversion.
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
15.
|
Members’
Capital (continued)
|
|
vii)
|
Effective
January 5, 2018, GR Unlimited entered into a Seed Round Preferred Unit Subscription Agreement whereby GR Unlimited will issue
up to 621 Seed Round Preferred Units (the “Units”) at a purchase price of $1,773.05 per Unit. Under the Agreement
GR Unlimited issued 170 Units for a total purchase price of $301,418. Each Unit will have one vote per unit and will be subject
to automatic conversion into common units rounded to the nearest whole common unit, at the then conversion rate immediately prior
to the closing of a public event. The conversion rate shall be determined by dividing the original issue price for a single Unit
by the conversion price effective at the time of conversion. The conversion price will change upon the occurrence of an event
which changes the number of outstanding and issued common units at the time of conversion.
|
|
viii)
|
Effective
January 26, 2018, the holder of a convertible promissory note converted the original principal amount of $50,000 and all accrued
and unpaid interest of $6,458 into 34 uncertified common units of GR Unlimited.
|
|
ix)
|
Effective
January 31, 2018, the holder of a note payable assigned 100% principal and accrued and unpaid interest to a limited liability
company (the “Entity”), which is wholly owned by the holder. Through the execution of the assignment agreement, the
terms within, the Entity converted the original principal amount of $100,000 and all accrued and unpaid interest of $25,000 into
74.8 uncertified common units of GR Unlimited.
|
|
x)
|
Effective
January 31, 2018, the holder of two convertible promissory notes in the original principal amount of $100,000 took the following
actions:
|
|
(i)
|
Received
a return of principal of $50,000 from one of the convertible promissory notes.
|
|
(ii)
|
Extended
the maturity date of the continuing convertible promissory not for the principal amount of $50,000 to August 1, 2018 with a coupon
interest rate of 30% per annum. All principal and accrued and unpaid interest, shall become due on the earlier of a) August 1,
2018 or b) the occurrence of a change of control of GR Unlimited; and
|
|
(iii)
|
Converted
the original principal of the second convertible promissory note and accrued and unpaid interest of $50,000 into 89.8 uncertified
common units of GR Unlimited.
|
|
xi)
|
Effective
February 9, 2018, GR Unlimited entered into a Seed Round Preferred Unit Subscription Agreement whereby GR Unlimited will issue
up to 750 Seed Round Preferred Units (the “Units”) at a purchase price of $1,773.05 per Unit. Under the Agreement
GR Unlimited issued 56 Units for a total purchase price of $99,291. Each Unit will have one vote per unit and will be subject
to automatic conversion into common units rounded to the nearest whole common unit, at the then effective conversion rate immediately
prior to the closing of a public event. The conversion rate shall be determined by dividing the original issue price for a single
Unit by the conversion price effective at the time of conversion. The conversion price will change upon the occurrence of an event
which changes the number of outstanding and issued common units at the time of conversion.
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
15.
|
Members’
Capital (continued)
|
|
xii)
|
Effective
February 9, 2018, GR Unlimited entered into a Seed Round Preferred Unit Subscription Agreement whereby GR Unlimited will issue
up to 750 Seed Round Preferred Units (the “Units”) at a purchase price of $1,773.05 per Unit. Under the Agreement
GR Unlimited issued 56 Units for a total purchase price of $99,291. Each Unit will have one vote per unit and will be subject
to automatic conversion into common units rounded to the nearest whole common unit, at the then effective conversion rate immediately
prior to the closing of a public event. The conversion rate shall be determined by dividing the original issue price for a single
Unit by the conversion price effective at the time of conversion. The conversion price will change upon the occurrence of an event
which changes the number of outstanding and issued common units at the time of conversion.
|
|
xiii)
|
Effective
March 1, 2018, GR Unlimited issued 750 common units to GR Unlimited’s CFO/ general counsel and 750 common units to GR Unlimited’s
marketing consultant. The fair value of these units was estimated to be $1,049,595 and has been expensed as unit-based compensation
expense.
|
|
xiv)
|
Effective
March 31, 2018, the holder of a convertible promissory note converted the original principal amount of $250,000 and all accrued
and unpaid interest of $46,250 into 332.4 uncertified common units of GR Unlimited.
|
|
xv)
|
Effective
June 1, 2018, the holder of a convertible promissory note converted the original principal amount of $637,775 and all accrued
and unpaid interest of $146,157 into 922.70 uncertified common units of GR Unlimited.
|
|
xvi)
|
Effective
June 1, 2018, the holder of a convertible promissory note converted the original principal amount of $300,000 into 285.70 uncertified
common units of GR Unlimited.
|
|
xvii)
|
Between
June 13, 2018 and June 15, 2018, GR Unlimited issued 190.8 common units of GR Unlimited for proceeds of $225,000.
|
|
xviii)
|
Effective
June 15, 2018, the holder of a convertible promissory note converted the original principal amount of $100,000 and all accrued
and unpaid interest of $20,465 into 115 uncertified common units of GR Unlimited.
|
|
xix)
|
During
the period ended October 31, 2018, GR Unlimited entered into a technology license agreement pursuant to which, GR Unlimited was
granted the exclusive license to certain intellectual property in the field of development, breeding, cultivation, growing, harvesting,
processing and commercializing cannabis, hemp and related plants and products (the “Technology”) in exchange for 6,600,000
common units of GR Unlimited. Immediately prior to the Transaction disclosed in note 2, GR Unlimited issued the common units.
|
|
xx)
|
Immediately
prior to the Transaction disclosed in note 2, the holder of a convertible promissory note converted the original principal amount
of $100,000 and all accrued and unpaid interest of $22,438 into 126.13 uncertified common units of GR Unlimited.
|
|
xxi)
|
Immediately
prior to the Transaction disclosed in note 2, the holder of a convertible promissory note converted the original principal amount
of $1,000,000 and accrued and unpaid interest of $171,875 into 1,144.15 uncertified common units of GR Unlimited.
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
15.
|
Members’
Capital (continued)
|
|
xxii)
|
Immediately
prior to the Transaction disclosed in note 2, the holder of a convertible promissory note converted the original principal amount
of $50,000 and accrued and unpaid interest of $7,644 into 52.06 uncertified common units of GR Unlimited.
|
|
xxiii)
|
Immediately
prior to the Transaction disclosed in note 2, GR Unlimited issued 1,475,179 common units pursuant to the exercise of the unit
purchase option disclosed in note 19(ii).
|
|
xxiv)
|
Immediately
prior to the Transaction disclosed in note 2, GR Unlimited issued 2,000,000 common units pursuant to the exercise of the unit
purchase option disclosed in note 19(iii).
|
|
xxv)
|
Immediately
prior to the Transaction disclosed in note 2, GR Unlimited issued 727,250 common units pursuant to a partial exercise of the unit
purchase option disclosed in note 19(i).
|
|
xxvi)
|
In
connection with the Transaction, GR Unlimited issued and sold on a subscription receipt basis, 3,771,023 units (the “GR
Units”) containing one Common Unit and one GR Unlimited purchase warrant (the “GR Warrant”) for gross proceeds
of CAD$1,646,050 ($1,274,516), of which $360,818 was allocated to the GR Warrants. Upon close of the Transaction, the GR Units
were automatically converted into 3,771,023 common units of GR Unlimited and 3,771,023 warrants of GR Unlimited.
|
The
Company is authorized to issue an unlimited number of common shares at no par value and an unlimited number of preferred shares
issuable in series.
During
the three months ended January 31, 2019, the following share transactions occurred:
|
i)
|
In
connection with the Transaction disclosed in note 2, the Company completed a consolidation of its common shares on the basis of
1.4 pre-consolidated common shares for 1 post-consolidated common shares. Following this consolidation, the Company had 3,773,689
common shares outstanding.
|
|
ii)
|
In
connection with the Transaction disclosed in note 2, the Company issued 60,746,202 common shares in exchange for the issued and
outstanding common units and seed round preferred units of GR Unlimited.
|
|
iii)
|
In
connection with the Transaction disclosed in note 2, the Company assigned CAD$369,508 ($279,888) of indebtedness to Novicius Subco
which was subsequently converted (the “Debt Conversion”) into 839,790 units of Novicius Subco at CAD$0.44 per unit
(the “Debt Conversion Units”). Each Debt Conversion Unit was comprised of one common share of Novicius Subco (a “Debt
Conversion Share”) and one Novicius Subco purchase warrant (“Novicius Subco Warrants”). In accordance with the
Definitive Agreement, upon close of the Transaction, the Debt Conversion Shares were exchanged for 839,790 common shares of the
Company and the 839,790 Novicius Subco Warrants were exchanged, without additional consideration or action, for the same number
of warrants of the Company. Of the deemed proceeds of the Debt Conversion Units of $279,888 related to the assigned indebtedness,
$206,651 were assigned to the common shares of Novicius Subco and $73,237 were allocated to the Novicius Subco Warrants.
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
16.
|
Share
Capital (continued)
|
|
iv)
|
In
connection with the Transaction disclosed in note 2, Grown Rogue Canada, completed a brokered private placement of 6,193,917 subscription
receipts (the “Brokered Subscription Receipts”) for gross proceeds of CAD$2,725,323 ($2,064,378). Under its terms,
each Brokered Subscription Receipt is automatically converted and immediately cancelled, without any further action by the holder
of such Brokered Subscription Receipt, and for no additional consideration, into one unit of Grown Rogue Canada (the “Grown
Rogue Canada Units”) upon the satisfaction of the following conditions, among others: (a) the completion of the acquisition
of all outstanding units of Grown Rogue by the Company; (b) requisite shareholder and regulatory approvals of the Transaction
including, but not limited to, conditional approval of the Exchange for the listing of the Shares issuable in connection thereto;
and (c) all documents and instruments have been tabled for the concurrent closing of the Transaction (the “Closing”).
Each Grown Rogue Canada Unit consists of one share in the capital of Grown Rogue Canada (the “Grown Rogue Canada Shares”)
and one Grown Rogue Canada common share purchase warrant (the “Grown Rogue Canada Warrants”).The Grown Rogue Canada
Shares and Grown Rogue Canada Warrants issued upon conversion of the Brokered Subscription Receipts were immediately exchanged,
without additional consideration or action, for common shares and warrants of the Company upon close of the Transaction. Of the
gross proceeds of $2,064,378, $584,430 was allocated to the Grown Rogue Canada Warrants.
|
The
fair value of the Grown Rogue Canada Warrants of $584,430 was estimated at the grant date based on the Black-Scholes pricing model,
using the following assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
*
Based on the volatility of comparable publicly traded companies
|
|
|
|
|
In
connection with the issuance of the Grown Rogue Canada Units, Grown Rogue Canada paid cash commissions and expenses of $200,567,
of which $143,786 was allocated to the Grown Rogue Canada shares and $56,781 was allocated to the Grown Rogue Canada Warrants.
Grown Rogue also issued 757,125 Grown Rogue Canada Broker Warrants with each Grown Rogue Canada Broker Warrant entitling the holder
to acquire one Grown Rogue Canada Unit at an exercise price of CAD$0.44 per Grown Rogue Canada Unit for a period of 24 months.
Of the fair value of the Grown Rogue Canada Broker Warrants of $119,864, $85,931 was allocated to the Grown Rogue Canada shares
and $33,933 was allocated to the Grown Rogue Canada Warrants.
|
v)
|
In
connection with the Transaction disclosed in note 2, the Company issued 100,000 common shares to a director of Grown Rogue Canada
a payment for services rendered. The fair value of the common shares was estimated to by $33,328
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
The
following table summarizes the warrant activities for the three months ended January 31, 2019:
|
|
Number
|
|
|
Weighted
Average
Exercise Price
|
|
Balance - November 1, 2018
|
|
|
148,722
|
|
|
$
|
7.39
|
|
|
|
|
|
|
|
|
|
|
Issued in connection with the Transaction
|
|
|
11,288,149
|
|
|
|
0.55
|
|
Issued pursuant to subscription receipts
|
|
|
9,964,940
|
|
|
|
0.55
|
|
Issued to brokers
|
|
|
757,125
|
|
|
|
0.44
|
|
Issuance costs
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Balance - January 31, 2019
|
|
|
22,158,936
|
|
|
$
|
0.60
|
|
During
the three months ended January 31, 2019, the Company:
|
i)
|
Issued
839,790 warrants in exchange for the same amount of Novicius Subco Warrants as disclosed in note 16(iii). Each Novicius Subco
Warrant was exercisable into one common share at an exercise price of CAD$0.55 per share for 24 months.
|
The
fair value of the Novicius Subco Warrants of $73,237 was estimated at the grant date based on the Black-Scholes pricing model,
using the following assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
|
ii)
|
Issued
1,675,179 warrants in exchange for the same amount of GR Unlimited warrants disclosed in note 19(ii). Each warrant shall be exercisable
period of two years following the date of option exercise (“the Expiration Date”); provided, however, that the expiration
date shall be automatically extended for an additional three years (the “Extended Period”) if, during the initial
two-year term the Company does not raise at least $18,000,000 in additional equity capital at an effective price per common unit
at or above $0.70 (a “Qualified Offering”); and provided further, that the Company has the right, only during the
Extended Period, if any, and only following the exercise of the Option, to accelerate the expiration date to forty-five days following
written notice to the holder if during the Extended Period the Company closes a Qualified Offering.
|
The
fair value of the warrants of $152,798 was estimated at the grant date based on the Black-Scholes pricing model, using the following
assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
iii)
|
Issued
3,771,023 warrants in exchange for the same amount of GR Unlimited warrants disclosed in note 15(xxvi). Each warrant allows the
holder to purchase one common share of the Company at an exercise price of CAD$0.55 per unit for a period of 24 months.
|
The
fair value of the warrants of $360,818 was estimated at the grant date based on the Black-Scholes pricing model, using the following
assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
|
iv)
|
Issued
6,193,917 warrants in exchange for the same amount of Grown Rogue Canada warrants disclosed in note 16(iv). Each warrant allows
the holder to purchase one common share of the Company at an exercise price of CAD$0.55 per unit for a period of 24 months.
|
The
fair value of the warrants of $584,430 was estimated at the grant date based on the Black-Scholes pricing model, using the following
assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
|
v)
|
Issued
757,125 broker warrants in exchange for the same amount of Grown Rogue Canada broker warrants disclosed in note 16(iv). Each warrant
allows the holder to purchase one unit of the Company at an exercise price of CAD$0.44 per unit for a period of 24 months. Each
unit contains one common share of the Company and one warrant entitling the holder to acquire one common share of the Company
at an exercise price of CAD$0.55 per unit for a period of 24 months.
|
The
fair value of the GR Broker Warrants of $119,864 was estimated at the grant date based on the Black-Scholes pricing model, using
the following assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
vi)
|
Issued
3,409,091 warrants in exchange for the same amount of Grown Rogue Canada warrants that were issued to subscribers of the GR Unlimited
convertible debenture offering disclosed in note 14. Each warrant entitles the holder to acquire one common share of the Company
at an exercise price of CAD$0.55 per unit for a period of 24 months.
|
The
fair value of the warrants of $321,654 was estimated at the grant date based on the Black-Scholes pricing model, using the following
assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
|
vii)
|
Issued
5,364,089 warrants in exchange for the same amount of Grown Rogue Canada warrants that were issued to certain investors prior
to the acquisition of Grown Rogue Canada. Each warrant entitles the holder to acquire one common share of the Company at an exercise
price of CAD$0.55 per unit for a period of 24 months. In the event that the share price of the Company closes at or above CAD$0.70
per share for a period of ten (10) consecutive trading days on the CSE, the Company has the right to accelerate the expiry of
the warrants to a date that is not less than 30 days from the date of delivery of a notice to the holder announcing the exercise
of the acceleration right.
|
The
fair value of the warrants of $506,101 was estimated at the grant date based on the Black-Scholes pricing model, using the following
assumptions:
Expected dividend yield
|
|
|
Nil
|
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
As
at January 31, 2019, the following Warrants were issued and outstanding:
Exercise Price
|
|
|
Warrants
Outstanding
|
|
|
Remaining
Contractual Life
(Years)
|
|
|
Expiry Date
|
$
|
4.90
|
|
|
|
114,656
|
|
|
|
0.08
|
|
|
March 1, 2019
|
$
|
17.50
|
|
|
|
16,883
|
|
|
|
0.58
|
|
|
August 31, 2019
|
$
|
14.00
|
|
|
|
17,183
|
|
|
|
0.83
|
|
|
November 30, 2019
|
$
|
0.44
|
|
|
|
757,125
|
|
|
|
1.79
|
|
|
November 15, 2020
|
$
|
0.55
|
|
|
|
21,253,089
|
|
|
|
1.79
|
|
|
November 15, 2020
|
|
|
|
|
|
22,158,936
|
|
|
|
1.78
|
|
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
18.
|
Subscriptions
Payable
|
During
the year ended October 31, 2018, GR Unlimited received aggregate proceeds of CAD$923,630 ($720,516) for 2,099,159 Subscription
Receipts related to the financing disclosed in note 15(xxvi). Each Subscription Receipt includes one common unit of GR Unlimited,
and one purchase warrant of GR Unlimited. Each purchase warrant is exercisable at the option of the holder to purchase one common
unit of GR Unlimited at a price of CAD$0.55 per common unit for a period of two years from the time GR Unlimited completes a transaction
whereby all of the equity instruments of the issuer are acquired by a Reporting Issuer in exchange for common shares of the Reporting
Issuer. During the period ended January 31, 2019, GR Unlimited received additional proceeds of CAD$735,620 ($554,000) in connection
with the financing. During the three months ended January 31, 2019, GR Unlimited issued the Subscription Receipts.
|
19.
|
Unit
Purchase Options
|
|
i)
|
During
the period ended October 31, 2018, GR Unlimited granted an option to purchase 2,727,250 common units of the Company for an aggregate
amount of CAD$54,545 at any point prior to December 31, 2018. The exercise of the option is contingent upon the optionee having
invested a minimum of CAD$1,050,000 of cash in securities of another party. As at October 31, 2018, this minimum investment had
been completed. During the period ended January 31, 2019,GR Unlimited issued 727,250 common units in connection with the partial
exercise of the option. The remaining portion of the option expired.
|
The
fair value of the option of $871,230 was expensed as a finance charge expense during the year ended October 31, 2018 and was estimated
at the grant date based on the Black-Scholes pricing model, using the following assumptions:
Expected dividend yield
|
|
|
Nil
|
%
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
5.5 months
|
|
Expected volatility
|
|
|
99
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
|
ii)
|
During
the period ended October 31, 2018, GR Unlimited received proceeds of CAD$649,351 ($500,000) in exchange for an option to acquire
1,475,979 common units and warrants to purchase a further 1,675,979 common units. Each warrant shall be exercisable period of
two years following the date of option exercise (“the Expiration Date”); provided, however, that the expiration date
shall be automatically extended for an additional three years (the “Extended Period”) if, during the initial two-year
term GR Unlimited does not raise at least $18,000,000 in additional equity capital at an effective price per common unit at or
above $0.70 (a “Qualified Offering”); and provided further, that GR Unlimited has the right, only during the Extended
Period, if any, and only following the exercise of the Option, to accelerate the expiration date to forty-five days following
written notice to the holder if during the Extended Period GR Unlimited closes a Qualified Offering. During the period ended January
31, 2019, GR Unlimited issued the common and units and warrants pursuant to the exercise of the option.
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
19.
|
Unit
Purchase Options (continued)
|
|
iii)
|
During
the period ended October 31, 2018, GR Unlimited granted an option to purchase 2,000,000 common units of GR Unlimited for an aggregate
amount of CAD$40,000 at any point prior to December 31, 2018. The exercise of the option is contingent upon the optionee having
invested a minimum of CAD$1,050,000 of cash in securities of another party. As at October 31, 2018, this minimum investment had
been completed. During the period ended January 31, 2019, GR Unlimited issued 2,000,000 common units pursuant to the exercise
of the option.
|
The
fair value of the option of $639,259 was expensed as a finance charge expense during the year ended October 31, 2018 and was estimated
at the grant date based on the Black-Scholes pricing model, using the following assumptions:
Expected dividend yield
|
|
|
Nil
|
%
|
Risk-free interest rate
|
|
|
1.710
|
%
|
Expected life
|
|
|
2.0 months
|
|
Expected volatility
|
|
|
100
|
%*
|
* Based on the volatility of comparable publicly traded companies
|
|
|
|
|
|
20.
|
Changes
in Non-cash Working Capital
|
The
changes to the Company’s non-cash working capital for the periods ended January 31, 2019 and 2018 are as follows:
|
|
2019
|
|
|
2018
|
|
Accounts receivable
|
|
$
|
(62,784
|
)
|
|
$
|
(52,166
|
)
|
Other receivable
|
|
|
(12,303
|
)
|
|
|
-
|
|
Inventory
|
|
|
(58,355
|
)
|
|
|
(322,245
|
)
|
Prepaid expenses and other assets
|
|
|
3,909
|
|
|
|
12,283
|
|
Accounts payable and accrued liabilities
|
|
|
(1,020,058
|
)
|
|
|
195,164
|
|
Due to employee/ director
|
|
|
-
|
|
|
|
158,189
|
|
Interest payable
|
|
|
(65,543
|
)
|
|
|
-
|
|
Deferred rent
|
|
|
(2,812
|
)
|
|
|
|
|
|
|
$
|
(1,217,946
|
)
|
|
$
|
(8,775
|
)
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
21.
|
Related
Party Transactions
|
During
the period ended January 31, 2019, the Company incurred the following related party transactions:
|
i)
|
Through
its wholly owned subsidiary, GRU Properties, LLC leased 41.92 acres of real property located in Trail, Oregon owned by the Company’s
President and CEO. The lease expires on December 31, 2020. Rent of $16,500 was included in facility expense for the period ended
January 31, 2019 (2018 - $15,500). The Company had $5,500 (October 31, 2018 - $5,500) owing in accounts payable and accrued liabilities
at January 31, 2019.
|
|
ii)
|
The
Company incurred employee/director fees of $12,000 (2018 - $12,000) with an individual related to the Company’s President
and CEO. At January 31, 2019, due to employee/ director includes $Nil (October 31, 2018 - $14,000) and accounts payable and accrued
liabilities includes $4,000 (October 31, 2018 - $12,000) payable to this individual.
|
|
iii)
|
The
Company incurred fees related to marketing and promotion services of $94,292 (2018 - $87,785) from two companies owned by the
Company’s Chief Strategy Officer (“CSO”). At January 31, 2019, accounts payable and accrued liabilities includes
$24,703 (October 31, 2018 - $25,054) payable to these companies.
|
|
v)
|
Key
management personnel consists of the President and CEO; Executive Vice President, CFO/General Counsel; and the CSO. The compensation
paid or payable to key management for services for the periods ended January 31, 2019 and 2018 is as follows:
|
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
Salaries and consulting fees
|
|
$
|
156,792
|
|
|
$
|
147,785
|
|
Accounts
payable and accrued liabilities at January 31, 2019 includes $94,000 (October 31, 2018 - $94,000) and due to employee/ directors
includes $Nil (October 31, 2018 - $90,000) payable to these parties.
Additional
related party transactions are disclosed in notes 13(vi) and 13(x)
The
transactions are in the normal course of operations and are measured at the exchange amounts being the amounts agreed to by the
parties.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
22.
|
Financial
Instruments
|
As
at January 31, 2019, the Company had accounts payable and accrued liabilities of CAD$100,965. The Company is exposed to the risk
of fluctuation in the rate of exchange between the Canadian Dollar and the United States Dollar. It is management’s opinion that
this risk is not material.
At
January 31, 2019 and October 31, 2018, the Company’s exposure to interest rate risk relates to long-term debt, convertible promissory
notes, and finance lease obligations, but its interest rate risk is limited as the aforementioned financial instruments are fixed
interest rate instruments.
Credit
risk is derived from cash and trade accounts receivable. The Company places its cash in deposit with major United States financial
institutions. The Company has established a policy to mitigate the risk of loss related to granting customer credit.
The
carrying amount of cash and trade accounts receivable represents the Company’s maximum exposure to credit risk, which amounted
to $847,600 (October 31, 2018 - $1,079,551) as at January 31, 2019. The allowance for doubtful accounts at January 31, 2019 is
$158,037 (October 31, 2018 - $106,443)
As
at January 31, 2019 and October 31, 2018, the Company’s trade accounts receivable were aged as follows:
|
|
January 31,
2019
|
|
|
October 31,
2018
|
|
Current
|
|
$
|
178,829
|
|
|
$
|
131,558
|
|
1-30 days
|
|
|
84,051
|
|
|
|
112,420
|
|
31 days-older
|
|
|
52,812
|
|
|
|
8,930
|
|
|
|
$
|
315,692
|
|
|
$
|
252,908
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
22.
|
Financial
Instruments (continued)
|
|
i)
|
Market
Risk (continued)
|
Liquidity
risk represents the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities.
The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities
when they become due. At January 31, 2019, the Company has current assets of $2,754,443 (October 31, 2018 - $2,869,694) and current
liabilities of $1,913,868 (October 31, 2018 - $3,321,239), which resulted in a working capital of $840,575 (October 31, 2018 -
working capital deficit of $451,545).
The
contractual maturities of the Company’s accounts payable and accrued liabilities, convertible promissory notes, long-term debt,
and finance lease payable occurs over the next three years as follows:
|
|
Year
1
|
|
|
Years
2 - 3
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
1,565,495
|
|
|
$
|
-
|
|
Convertible promissory notes
|
|
|
42,368
|
|
|
|
-
|
|
Long-term debt
|
|
|
-
|
|
|
|
50,000
|
|
Convertible debentures
|
|
|
-
|
|
|
|
957,360
|
|
Due to employee/officer
|
|
|
-
|
|
|
|
-
|
|
Interest payable
|
|
|
202,634
|
|
|
|
-
|
|
Deferred rent
|
|
|
-
|
|
|
|
28,444
|
|
Finance lease
|
|
|
103,371
|
|
|
|
70,194
|
|
Derivative liabilities
|
|
|
-
|
|
|
|
24,500
|
|
|
|
$
|
1,913,868
|
|
|
$
|
1,130,498
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
22.
|
Financial
Instruments (continued)
|
|
i)
|
Market
Risk (continued)
|
The
carrying amounts for the Company’s cash, accounts receivable, , accounts payable and accrued liabilities, amounts due to
employee/director, promissory notes and convertible promissory notes approximate their fair values because of the short-term nature
of these items.
A
number of the Company’s accounting policies and disclosures require the measurement of fair valued for both financial and non-financial
assets and liabilities. The Company has an established framework, which includes team members who have overall responsibility
for overseeing all significant fair value measurements, including Level 3 fair values. When measuring the fair value of an asset
or liability, the Company uses observable market data as far as possible. The Company regularly assesses significant unobservable
inputs and valuation adjustments. Fair values are categorized into different levels in a fair value hierarchy based on the inputs
used in the valuation techniques as follows:
|
●
|
Level
1: quoted prices (unadjusted) in active markets for identical assets or liabilities
|
|
●
|
Level
2: inputs other than quoted prices included in Level 1 that are observable for the asset
or liability, either directly or indirectly
|
|
●
|
Level
3: inputs for the asset or liability that are not based on observable market data (unobservable
inputs).
|
During
the period ended January 31, 2019 there were no transfers of amounts between levels.
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
|
23.
|
Segmented
information
|
The
Company’s only operating segment is the production and sale of cannabis. All property and equipment and intangible assets are
located in the United States. All revenue were generated in the United States during the periods ended January 31, 2019, and 2018.
As such, amounts disclosed in the consolidated financial statements also represent the single operating and geographical reporting
segment.
|
24.
|
General
and Administrative Expenses
|
General
and administrative expenses for the periods ended January 31, 2019 and 2018 are as follows:
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Legal and professional
|
|
$
|
135,072
|
|
|
$
|
298,450
|
|
Salaries and benefits
|
|
|
445,297
|
|
|
|
133,012
|
|
Supplies
|
|
|
7,247
|
|
|
|
5,627
|
|
Facility expense
|
|
|
88,649
|
|
|
|
61,294
|
|
Marketing and promotion
|
|
|
120,778
|
|
|
|
41,889
|
|
Investor relations
|
|
|
29,279
|
|
|
|
-
|
|
Travel
|
|
|
51,520
|
|
|
|
37,190
|
|
Office expense
|
|
|
16,389
|
|
|
|
9,461
|
|
Utilities
|
|
|
4,914
|
|
|
|
9,758
|
|
Business license and fees
|
|
|
18,339
|
|
|
|
7,286
|
|
Repairs and maintenance
|
|
|
12,920
|
|
|
|
2,315
|
|
Consultants
|
|
|
-
|
|
|
|
-
|
|
Commissions
|
|
|
-
|
|
|
|
-
|
|
Research and development
|
|
|
-
|
|
|
|
5,000
|
|
Insurance
|
|
|
2,552
|
|
|
|
2,746
|
|
Bank fees and foreign exchange
|
|
|
10,347
|
|
|
|
1,833
|
|
Bad debt
|
|
|
51,594
|
|
|
|
1,500
|
|
Miscellaneous
|
|
|
12,408
|
|
|
|
282
|
|
|
|
$
|
1,007,305
|
|
|
$
|
617,643
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
The
Company includes equity, comprised of share capital, contributed surplus (including the fair value of equity instruments to be
issued), equity component of convertible promissory notes and deficit, in the definition of capital.
The
Company’s objectives when managing capital are as follows:
|
(i)
|
to
safeguard the Company’s assets and ensure the Company’s ability to continue as a going concern;
|
|
(ii)
|
to
raise sufficient capital to finance the construction of its production facility and obtain license to produce recreational marijuana;
and
|
|
(iii)
|
to
raise sufficient capital to meet its general and administrative expenditures.
|
The
Company manages its capital structure and makes adjustments to it, based on the general economic conditions, the Company’s
short-term working capital requirements, and its planned capital requirements and strategic growth initiatives.
The
Company’s principal source of capital is from the issuance of common shares. In order to achieve its objectives, the Company expects
to spend its working capital, when applicable, and raise additional funds as required.
The
Company does not have any externally imposed capital requirements.
|
a)
|
The
Company has commitments under operating leases for its facilities and commitments under a finance lease for equipment. The minimum
lease payments due are as follows:
|
Fiscal
Year
|
|
|
Amount
|
|
|
|
|
|
|
2019
|
|
|
$
|
259,384
|
|
2020
|
|
|
|
227,772
|
|
2021
|
|
|
|
20,600
|
|
Grown Rogue International Inc.
Notes to the Unaudited Condensed Consolidated Interim Financial Statements
For the three month periods ended January 31, 2019 and 2018
Expressed in United States Dollars
Subsequent
to the period ended January 31, 2019, the Company entered into a binding agreement (the “Agreement”) for the option
to acquire operational control (the “Option”) of the following assets in Michigan pending Municipal and State regulatory
approval:
●Two
strategically located proposed provisioning centers (retail dispensaries) in high demand regions in Midtown Detroit and Hazel
Park where limited municipal licenses have been granted.
●A
proposed 19,000 sq ft indoor cultivation and processing facility in Detroit, Michigan capable of producing 1,500,000 grams of
dried cannabis flower annually at full production; and
●An
entity that has received multiple municipal cultivation licenses for a 28-acre parcel located in the northern portion of the lower
Michigan peninsula.
Upon
exercise of the Option by the Company, the Company will issue 2,212,876 common share purchase warrants to the vendor (or its affiliates)
with an exercise price of CAD $0.44 per share (the “Warrants”) which vest according to certain milestones in the Agreement.
The Warrants expire on June 20, 2023. The Company will have the right to accelerate the expiry date of 25% of the Warrants during
the term if the shares of the Company close at or above $1.00 per share for a period of twenty (20) consecutive days. An additional
25% of the Warrants will accelerate if the shares of the Company close at or above $1.50 per share for a period of twenty (20)
consecutive days, and the remainder of the Warrants will accelerate if the shares of the Company close at or above $2.00 per share
for a period of twenty (20) consecutive days. Pursuant to the terms of the Agreement, the Company has granted the vendor, together
with any affiliates, a pre-emptive right to maintain ownership, should the Warrants be exercised, of up to 5% of the Company’s
common shares. At the time the vendor, or any affiliates, exercises its Warrants to obtain 5% ownership in the Company, the vendor
will have the right to nominate one member to the Company’s board who shall be nominated by management at each annual shareholder
meeting of Grown Rogue until such time the the vendor’s ownership in the Company falls below 4.67%. In addition, the Company
has agreed to pay the vendor between 5% and 7% of top line future revenues generated from its licensed operations in Michigan.
Payment on these revenues shall be in a combination of stock and cash.
PRESS
RELEASE
Grown
Rogue Bringing Proven Growth Model to Large
Michigan Cannabis Market for 2019
MEDFORD,
OREGON
–
March 12, 2019
-- Grown Rogue International Inc. (CSE:GRIN | OTC: NVSIF) (“Grown Rogue”
or the “Company”), a vertically-integrated, multi-state cannabis company, with licenses and operations in Oregon and
California, is bringing its winning brand and business model which generated compound monthly sales growth of 14% during the 2018
calendar year in Oregon - one of the world’s most competitive cannabis markets - into the newly legalized recreational cannabis
market in Michigan. Grown Rogue anticipates gaining meaningful traction for its brand through its local partnership with licensed
operators in the State of Michigan.
Oregon
is among the most competitive cannabis markets in the United States based on total active cultivation and licenses per capita.
According to an
August 2018 report
from
Oregon-Idaho High Intensity Drug Trafficking Area
(HIDTA), “Oregon
has more than a thousand licensed recreational marijuana growers, with roughly 900 more in the queue to receive licenses. There’s
one licensed cultivation operation for every 19 consumers.” Despite this competition, Grown Rogue launched its first cannabis
products in late 2017 into the Oregon market and gained sales traction and market share as a result of high-quality products,
unique branding and effective marketing. By the end of 2018 Grown Rogue branded products were available in more than half of Oregon
dispensaries.
A
number of factors contributed to Grown Rogue’s overall success in 2018:
|
●
|
Optimization
of cultivation and distribution teams;
|
|
|
|
|
●
|
Major
increase in outdoor harvest from 2017 to 2018 by over 50% based on training and efficiency
programs implemented in early 2018;
|
|
|
|
|
●
|
Accolades
in product quality in Oregon by setting outdoor potency record and winning the prestigious
Growers Cup in 2 of 3 categories;
|
|
|
|
|
●
|
Established
partnership with international award winning chocolatier;
|
|
|
|
|
●
|
Expansion
into California with a 16,000 sq ft micro business facility with retail, processing,
and distribution licensing.
|
“Launching
Grown Rogue in Oregon required fastidious planning and execution in order to be successful,” said Obie Strickler, Founder
and CEO. “We properly navigated the regulatory environment for recreational cannabis and refined the preferred consumer
experience around brands and product selection, and established innovations in product development and packaging. Operating in
a State like Oregon that was early to legalize cannabis has provided a tremendous amount of intellectual, operational, and cultivation
expertise. We also have significant understanding of the cannabis consumer and evolving cannabis products and formats. We are
taking this expertise and applying it into new states and are particularly optimistic about the tremendous opportunity in Michigan.”
Michigan
is the first state in the Midwest to vote for the legalization of recreational cannabis . Michigan has the largest medical cannabis
population per capita and is second only to California in total medical users. As a relative comparison, the state of Michigan
has a population of approximately 10 million people and about 313,000 registered medical cannabis patients according to
Michigan
Live
, or 3.1%, compared to Canada with a population of approximately 38 million, which had 342,103 registered medical patients
at September 30, 2018 according the
Health Canada
, or 0.9% where cannabis is fully legal at both provincial and federal
levels.
By
any measure, Michigan has one of the most active medical cannabis markets in America which is a leading indicator in the potential
size of the recreational market.
Number
of legal medical marijuana patients in the U.S. as of May 2018, by state according to ProCon.org:
STATE
|
|
#
OF MEDICAL
MARIJUANA
PATIENTS
|
|
|
STATE POPULATION
|
|
|
#
OF PATIENTS PER 1,000 RESIDENTS
|
|
Michigan
|
|
|
269,553
|
|
|
|
99,962,311
|
|
|
|
27.06
|
|
California
|
|
|
915,845
|
|
|
|
39,536,653
|
|
|
|
23.16
|
|
Colorado
|
|
|
88,946
|
|
|
|
5,607,154
|
|
|
|
15.86
|
|
Oregon
|
|
|
45,210
|
|
|
|
4,142,776
|
|
|
|
10.91
|
|
Washington
|
|
|
80,818
|
|
|
|
7,405,743
|
|
|
|
10.91
|
|
Massachusetts
|
|
|
48,265
|
|
|
|
6,859,819
|
|
|
|
7.04
|
|
Grown
Rogue’s current expected portfolio in Michigan includes two strategically positioned retail centers (known as provisional
licenses) in Hazel Park and Midtown Detroit as well as a 19,000 sq ft cultivation center in Detroit. Additional license acquisitions
are being reviewed.
“Our
expansion into Michigan has the potential to add substantial value to the overall business. Our track record of growth to date
should give current and future shareholders the confidence that we will continue to perform in the exciting Michigan market,”
added Jacques Habra, Chief Strategy Officer.
Grown
Rogue expects Michigan operations to begin generating revenue in late 2019.
About Grown Rogue
Grown
Rogue International
(CSE: GRIN | OTC: NVSIF) is a vertically-integrated, multi-state cannabis company curating innovative
products to provide consumers with the right cannabis experience. Each of Grown Rogue’s products and strains are categorized
and marketed based on unique effects and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the
vertically integrated model into multiple states by incorporating best-in-class manufacturing facilities and a proprietary distribution
platform based on Microsoft technology. Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending
nitrogen sealed pre-rolls, oil and concentrates, and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.
Subscribe
to
Grown Rogue investor news alerts.
This
press release contains statements which constitute “forward-looking information” within the meaning of applicable
securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect
to future business activities. Forward-looking information is often identified by the words “may,” “would,”
“could,” “should,” “will,” “intend,” “plan,” “anticipate,”
“believe,” “estimate,” “expect” or similar expressions and include information regarding:
(i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business
and financial objectives, (iii) plans for expansion of the Company into Michigan and securing applicable regulatory approvals,
and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward-looking information
is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections
concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management
considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such
forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be
placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance
or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those
projected in the forward-looking information are the following: changes in general economic, business and political conditions,
including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in
the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing
prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or
adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related
costs, and other risks described in the Company’s Listing Statement available on www.sedar.com.
Should
one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove
incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated
or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual
results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company
does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by
applicable law.
Safe
Harbor Statement:
This
press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the
intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i)
the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii)
the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,”
“would,” “will,” “expect,” “estimate,” “anticipate,” “believe,”
“intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Also,
forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Except as required
by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could
differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the
future. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve
risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially
from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the Company’s
Form 20-F and 6-K filings with the Securities and Exchange Commission.
The
Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis
marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate
permit such activities however, these activities are currently illegal under United States federal law. Additional information
regarding this and other risks and uncertainties relating to the Company’s business are disclosed in the Company’s Listing
Statement filed on its issuer profile on SEDAR at
www.sedar.com
. Should one or more of these risks, uncertainties or other
factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect,
actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
No
stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
For
further information on Grown Rogue International please visit
www.grownrogue.com
or contact:
Obie
Strickler
|
|
Jacques
Habra
|
|
Investor
Relations Desk
|
Chief
Executive Officer
|
|
Chief
Strategy Officer
|
|
Inquiries
|
obie@grownrogue.com
|
|
jacques@grownrogue.com
|
|
invest@grownrogue.com
|
Form
51-102F3
Material
Change Report
|
Item
1
|
Name
and Address of Company
|
Grown
Rogue International Inc. (the “
Corporation
” or “
Company
”)
340 Richmond Street West
Toronto,
Ontario
M5V
1X2
|
Item
2
|
Date
of Material Change
|
February
25, 2019
A
news release was issued by the Corporation on February 25, 2019 through the facilities of Cision and was subsequently filed on
SEDAR.
|
Item
4
|
Summary
of Material Change
|
On
February 25, 2019, the Corporation announced that it entered into a binding agreement with Blue Zebra Community LLC (“
Blue
Zebra
”) providing the Corporation with the right to acquire operational control of certain cannabis licenses and related
assets as part of its expansion in the Michigan cannabis market, pending certain regulatory approvals.
|
Item
5.1
|
Full
Description of Material Change
|
On
February 25, 2019, the Corporation announced that it entered into a binding agreement (the “
Agreement
”) with
Blue Zebra providing the Corporation with the right to acquire operational control of certain cannabis licenses and related assets
as part of its expansion in the Michigan cannabis market, pending certain regulatory approvals.
The
Agreement provides for the option to acquire operational control (the “
Option
”) of the following cannabis related
assets in Michigan pending Municipal and State regulatory approval (the “
Michigan Assets
”):
|
●
|
Two
strategically located proposed provisioning centers (retail dispensaries) in high demand
regions in Midtown Detroit and Hazel Park where limited municipal licenses have been
granted;
|
|
|
|
|
●
|
A
proposed 19,000 sq ft indoor cultivation and processing facility in Detroit, Michigan
capable of producing 1,500,000 grams of dried cannabis flower annually at full production;
and
|
|
|
|
|
●
|
An
entity that has received multiple municipal cultivation licenses for a 28-acre parcel
located in the northern portion of the lower Michigan peninsula.
|
Once
fully licensed, the provisioning (retail) centers will offer multiple Michigan cannabis brands as well as locally produced Grown
Rogue branded products for the Michigan cannabis market. This will launch the Grown Rogue brand into the Midwest region.
Upon
exercising the Option by the Corporation, Blue Zebra (or affiliates) is required to assign its rights and obligations to the Corporation
pursuant to a binding agreement Blue Zebra (or affiliates) has with Helios Holdings, LLC (“
Helios
”) which provides
the framework for the acquisition of the Michigan Assets as described below (the “
Helios Agreement
”). As part
of its Agreement with Blue Zebra, the Corporation will issue 2,212,876 common share purchase warrants to Blue Zebra (or its affiliates)
with an exercise price of $0.44 per share (the “
Warrants
”), which vest according to certain milestones in accordance
with the agreement with Blue Zebra.
The
Warrants expire on June 20, 2023. The Corporation will have the right to accelerate the expiry date of 25% of the Warrants during
the term if the shares of the Corporation close at or above $1.00 per share for a period of twenty (20) consecutive days. An additional
25% of the Warrants will accelerate if the shares of the Corporation close at or above $1.50 per share for a period of twenty
(20) consecutive days, and the remainder of the Warrants will accelerate if the shares of the Corporation close at or above $2.00
per share for a period of twenty (20) consecutive days.
Pursuant
to the terms of the Agreement, the Corporation has granted Blue Zebra, together with any affiliates, a pre-emptive right to maintain
ownership, should the Warrants be exercised, of up to 5% of the Corporation’s common shares. At the time Blue Zebra, or
any affiliates, exercises its Warrants to obtain 5% ownership in the Corporation, Blue Zebra will have the right to nominate one
member to the Corporation’s board who shall be nominated by management at each annual shareholder meeting of the Corporation
until such time as Blue Zebra’s ownership in the Corporation falls below 4.67%. In addition, the Corporation has agreed
to pay Blue Zebra between 5% and 7% of top line future revenues generated from its licensed operations in Michigan. Payment on
these revenues shall be in a combination of stock and cash.
Helios
Agreement
Helios,
and its affiliate, intend to contribute real property for a 19,000 square foot proposed cultivation and processing facility to
a newly formed joint venture to be operated by the Corporation, or its designated affiliate, upon receiving all necessary regulatory
approvals.
The
Corporation intends to secure a non-dilutive, real estate financing facility to cause the improvements to the Michigan Assets
to be completed.
Helios
will contribute the remaining Michigan Assets into one or more newly formed operating company(s) (“
OpCo
”).
It is intended that the Corporation will hold a 3.62% convertible debenture for the initial funding of OpCo, with a put/call option
to acquire all the issued and outstanding shares of the OpCo. The convertible debenture principal, including any interest, shall
be returned to the Corporation first from 50% of any cash flow generated by OpCo. Conversion of the debenture by the Corporation
is subject to State and Municipal regulatory approval.
The
State licensing and regulatory process in Michigan requires multiple tiers of approval for any operations (cultivation, retail).
Several municipal licenses have successfully been awarded to Helios and its affiliates.
Once
licensed by the State, the 19,000 square foot facility will be the first cultivation and manufacturing center for OpCo. Initial
plans for this facility will include the ability to produce 1,500,000 grams of cannabis flower per year with the construction
of a perpetual harvest facility expected to open in Q4 2019. This facility will also include best-in-class extraction facilities
where the OpCo will produce branded derivative products.
The
interest in the 28-acre cultivation facility can include either indoor or greenhouse operations which are currently being evaluated.
Construction and operation of this facility is expected in 2019 with an anticipated yearly yield of between 1,500,000 and 2,500,000
grams of annual cannabis production based on final design plans.
Both
of OpCo’s proposed retail dispensaries are located in desirable high traffic locations and are expected to be licensed and
operational by Q4 2019. OpCo aims to further expand to 10 retail dispensaries and 50,000 square foot of cultivation facilities
by the middle of 2020.
|
Item
6
|
Reliance
on Subsection 7.1(2) of National Instrument 51-102
|
Not
applicable.
|
Item
7
|
Omitted
Information
|
Not
applicable.
J.
Obie Strickler
President
and Chief Executive Officer
Tel: (503) 765-8108
March
7, 2019.
Cautionary
Note Regarding Forward Looking Information
This
report contains statements which constitute “forward-looking information” within the meaning of applicable
securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with
respect to future business activities. Forward-looking information is often identified by the words “may,”
“would,” “could,” “should,” “will,” “intend,” “plan,”
“anticipate,” “believe,” “estimate,” “expect” or similar expressions and
include information regarding: (i) statements regarding the future direction of the Company (ii) the ability of the Company
to successfully achieve its business and financial objectives, (iii) plans for expansion of the Company into Michigan and
securing applicable regulatory approvals, and (iv) expectations for other economic, business, and/or competitive factors.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflect the
Company’s management’s expectations, estimates or projections concerning the business of the Company’s
future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the
statements are made. Although the Company believes that the expectations reflected in such forward-looking information are
reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information,
as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the
combined company. Among the key factors that could cause actual results to differ materially from those projected in
the forward-looking information are the following: changes in general economic, business and political conditions, including
changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in the
amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing
prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or
adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and
related costs, and other risks described in the Company’s Listing Statement available on www.sedar.com.
Should
one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove
incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated
or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual
results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company
does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by
applicable law.
PRESS RELEASE
Grown
Rogue Revenue More than Quadruples in
Preliminary First Quarter Sales Results
MEDFORD,
OREGON
–
March 5, 2019
--
Grown Rogue International Inc.
(CSE:GRIN | OTC: NVSIF)
(“Grown Rogue”
or the
“Company”),
a vertically-integrated, multi-state cannabis company, with licenses and operations
in Oregon, California, and now positioned for significant expansion in Michigan, reports more than 365% year-over-year revenue
growth in preliminary results for its fiscal first quarter ending January 31, 2019.
For
the first quarter of fiscal 2019 Grown Rogue revenue grew to more than US$800,000 (C$1.07 million), an increase of more than 365%
from revenue of US$171,000 (C$227,700) in its fiscal first quarter ended January 31, 2018. Since the Company’s first products
began selling in late 2017, Grown Rogue has demonstrated meaningful sales traction in one of the world’s most competitive
cannabis markets.
Grown
Rogue’s award winning flower production (indoor and outdoor) represents approximately 55% of total sales with the remainder
coming from concentrates (oil cartridges and extracts), pre-rolls, and a new edibles line launched in December of 2018 that is
produced in partnership with an award winning chocolatier. Demand for Grown Rogue branded products that exceed current production
capacity is supplemented with quality products from other qualified purveyors and manufacturers inside of Oregon. Grown Rogue
products typically receive premium pricing at retail over the Oregon state average.
Current
annual production capacity is approximately 5,000 lbs (2,300 kgs), but that number is forecast to more than triple to approximately
18,500 lbs (8,400kgs) by the end of fiscal year 2019 as Grown Rogue scales its cultivation operations in additional states.
“We
entered fiscal 2019 with strength from the foundation we built in 2018,” said Obie Strickler, CEO of Grown Rogue. “We
have an effective and optimized team that has quickly scaled our manufacturing and distribution while maintaining award winning
product quality. By the end of the year we were able to expand our brand and process to California with a 16,000 sq ft facility
and establish partnerships for entry into Michigan. With our first recreational harvest in late 2017, we have been able to build
our multi-state platform that is focused on creating the most innovative products, compliance with regulatory complexities, and
scaled operations. We are now beginning the process of taking the future of cannabis into these new and exciting states.”
In
its first year of operation in the recreational adult-use market Grown Rogue established a strong reputation with its customers
for consistent high-quality product. In an invitation only competition, among best in class cultivators, during its fiscal first
quarter, Grown Rogue took first place for Highest Percentage THC, first place for Highest Percentage Terpenes, as well as third
place in the Growers Choice overall. Green Leaf Lab, the nation’s first accredited and licensed cannabis testing laboratory,
confirmed that Grown Rogue’s recent outdoor harvest included a strain that tested at 35.13% for THC, potentially breaking
Oregon state records for outdoor cultivation.
PRESS
RELEASE
In 2019 Grown Rogue is now expanding its award winning, quality products into California and Michigan.
“In mid
2017,
we had 3 licenses in one state and today we have 22 licenses in three states including a very exciting partnership in Michigan,”
added Jacques Habra, Chief Strategy Officer.
Inherent
in this update are risk factors affecting volatility in the Company’s business which are described in greater detail in its regulatory
filings. This update is based on management’s current beliefs and assumptions.
Financial
results for the fiscal first quarter ended January 31, 2019 will be released during the last week of March, 2019.
About
Grown Rogue
Grown
Rogue International
(CSE: GRIN | OTC: NVSIF) is a vertically-integrated, multi-state cannabis company curating innovative
products to provide consumers with the right cannabis experience. Each of Grown Rogue’s products and strains are categorized
and marketed based on unique effects and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the
vertically integrated model into multiple states by incorporating best-in-class manufacturing facilities and a proprietary distribution
platform based on Microsoft technology. Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending
nitrogen sealed pre-rolls, oil and concentrates, and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.
Subscribe
to
Grown Rogue investor news alerts.
This
press release contains statements which constitute “forward-looking information” within the meaning of applicable
securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect
to future business activities. Forward-looking information is often identified by the words “may,” “would,”
“could,” “should,” “will,” “intend,” “plan,” “anticipate,”
“believe,” “estimate,” “expect” or similar expressions and include information regarding:
(i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business
and financial objectives, (iii) plans for expansion of the Company into Michigan and securing applicable regulatory approvals,
and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward-looking information
is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections
concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management
considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such
forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be
placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance
or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those
projected in the forward-looking information are the following: changes in general economic, business and political conditions,
including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in
the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing
prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or
adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related
costs, and other risks described in the Company’s Listing Statement available on www.sedar.com.
Should
one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove
incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated
or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual
results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company
does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by
applicable law.
Safe
Harbor Statement:
This
press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the
intent, belief or current
expectations of the Company, its directors or its officers with respect to, among other
things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations;
(iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words
“may,” “would,” “will,” “expect,” “estimate,” “anticipate,”
“believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking
statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof.
Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons
actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes
available in the future. Investors are cautioned that any such forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results
may differ materially from those projected in the forward-looking statements as a result of various factors including the risk
disclosed in the Company’s Form 20-F and 6-K filings with the Securities and Exchange Commission.
The
Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis
marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate
permit such activities however, these activities are currently illegal under United States federal law. Additional information
regarding this and other risks and uncertainties relating to the Company’s business are disclosed in the Company’s Listing
Statement filed on its issuer profile on SEDAR at
www.sedar.com
. Should one or more of these risks, uncertainties or other
factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect,
actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
No
stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
For
further information on Grown Rogue International please visit
www.grownrogue.com
or contact:
Obie
Strickler
|
|
Jacques
Habra
|
|
Investor
Relations Desk
|
Chief
Executive Officer
|
|
Chief
Strategy Officer
|
|
Inquiries
|
obie@grownrogue.com
|
|
jacques@grownrogue.com
|
|
invest@grownrogue.com
|
PRESS
RELEASE
Grown
Rogue Announces Binding Agreement for
Michigan Cannabis Licenses and Assets
DETROIT,
MICHIGAN – February 25, 2019 --
Grown Rogue International Inc.
(CSE:GRIN | OTC: NVSIF)
(“Grown Rogue”
or the
“Company”),
a vertically-integrated, multi-state cannabis company, with licenses and operations
in Oregon and California, has signed a binding agreement which provides the Company the right to acquire operational control of
certain cannabis licenses and related assets as part of its expansion into the Michigan cannabis market, pending certain regulatory
approvals.
“With
the second highest total number of medical cannabis card holders in the United States Michigan’s legalization of cannabis
for adult-use presents a very large cannabis market opportunity. Significant barriers to entry at the local level add meaningful
value to the limited number of municipal licenses approved,” explained Obie Strickler, CEO of Grown Rogue. “We are
very diligent in our expansion strategy and in finding the right partners to take the proven Grown Rogue platform into the state.
Combining our expertise enables us to efficiently navigate and comply with the regional regulatory environment and rapidly expand
the Grown Rogue footprint and brand.”
Grown
Rogue has entered into a binding agreement (the
“Agreement”)
with Blue Zebra Community LLC (
“Blue
Zebra”).
The Agreement provides for the option to acquire operational control (the
“Option”)
of the
following cannabis related assets in Michigan pending Municipal and State regulatory approval (the
“Michigan Assets”):
|
●
|
Two
strategically located proposed provisioning centers (retail dispensaries) in high demand
regions in Midtown Detroit and Hazel Park where limited municipal licenses have been
granted.
|
|
●
|
A
proposed 19,000 sq ft indoor cultivation and processing facility in Detroit, Michigan
capable of producing 1,500,000 grams of dried cannabis flower annually at full production;
and
|
|
●
|
An
entity that has received multiple municipal cultivation licenses for a 28-acre parcel
located in the northern portion of the lower Michigan peninsula.
|
Once
fully licensed, the provisioning (retail) centers will offer multiple Michigan cannabis brands as well as locally produced Grown
Rogue branded products for the Michigan cannabis market. This will launch the Grown Rogue brand into the Midwest region.
Upon
exercising the Option by Grown Rogue, Blue Zebra (or affiliates) is required to assign its rights and obligations to the Company
pursuant to a binding agreement Blue Zebra (or affiliates) has with Helios Holdings, LLC
(“Helios”)
which provides
the framework for the acquisition of the Michigan Assets as described below (the
“Helios Agreement”).
As part
of its Agreement with Blue Zebra, Grown Rogue will issue 2,212,876 common share purchase warrants to Blue Zebra (or its affiliates)
with an exercise price of $0.44 per share (the
“Warrants”),
which vest according to certain milestones in accordance
with the agreement with Blue Zebra.
PRESS
RELEASE
The
Warrants expire on June 20, 2023. Grown Rogue will have the right to accelerate the expiry date of 25% of the Warrants during
the term if the shares of the Company close at or above $1.00 per share for a period of twenty (20) consecutive days. An additional
25% of the Warrants will accelerate if the shares of the Company close at or above $1.50 per share for a period of twenty (20)
consecutive days, and the remainder of the Warrants will accelerate if the shares of the Company close at or above $2.00 per share
for a period of twenty (20) consecutive days.
Pursuant
to the terms of the Agreement, Grown Rogue has granted Blue Zebra, together with any affiliates, a pre-emptive right to maintain
ownership, should the Warrants be exercised, of up to 5% of Grown Rogue’s common shares. At the time Blue Zebra, or any
affiliates, exercises its Warrants to obtain 5% ownership in the Company, Blue Zebra will have the right to nominate one member
to Grown Rogue’s board who shall be nominated by management at each annual shareholder meeting of Grown Rogue until such
time the Blue Zebra’s ownership in Grown Rogue falls below 4.67%. In addition, Grown Rogue has agreed to pay Blue Zebra
between 5% and 7% of top line future revenues generated from its licensed operations in Michigan. Payment on these revenues shall
be in a combination of stock and cash.
Helios
Agreement
Helios,
and its affiliate, intend to contribute real property for a 19,000 sq ft. proposed cultivation and processing facility to a newly
formed joint venture to be operated by Grown Rogue, or its designated affiliate, upon receiving all necessary regulatory approvals.
Grown
Rogue intends to secure a non-dilutive, real estate financing facility to cause the improvements to the Michigan Assets to be
completed.
Helios
will contribute the remaining Michigan Assets into one or more newly formed operating company(s)
(“OpCo”).
It
is intended that Grown Rogue will hold a 3.62% convertible debenture for the initial funding of OpCo, with a put/call option to
acquire all the issued and outstanding shares of the OpCo. The convertible debenture principal, including any interest, shall
be returned to Grown Rogue first from 50% of any cash flow generated by OpCo. Conversion of the debenture by Grown Rogue is subject
to State and Municipal regulatory approval.
The
State licensing and regulatory process in Michigan requires multiple tiers of approval for any operations (cultivation, retail).
Several municipal licenses have successfully been awarded to Helios and its affiliates.
Once
licensed by the State, the 19,000 square foot facility will be the first cultivation and manufacturing center for OpCo. Initial
plans for this facility will include the ability to produce 1,500,000 grams of cannabis flower per year with the construction
of a perpetual harvest facility expected to open in Q4 2019. This facility will also include best-in-class extraction facilities
where the OpCo will produce branded derivative products.
The
interest in the 28-acre cultivation facility can include either indoor or greenhouse operations which are currently being evaluated.
Construction and operation of this facility is expected in 2019 with an anticipated yearly yield of between 1,500,000 and 2,500,000
grams of annual cannabis production based on final design plans.
PRESS RELEASE
Both
of OpCo’s proposed retail dispensaries are located in desirable high traffic locations and are expected to be licensed and
operational by Q4 2019. OpCo aims to further expand to 10 retail dispensaries and 50,000 sq ft of cultivation facilities by the
middle of 2020.
“Our
partnership with Grown Rogue has accelerated our operations and already we have identified several additional licenses which could
make Grown Rogue one of the leading cannabis operations in the entire state of Michigan,” stated Maxim Ermakov, Helios Executive
Director.
About
Grown Rogue
Grown
Rogue International
(CSE: GRIN | OTC: NVSIF) is a vertically-integrated, multi-state cannabis company curating innovative
products to provide consumers with the right cannabis experience. Each of Grown Rogue’s products and strains are categorized
and marketed based on unique effects and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the
vertically integrated model into multiple states by incorporating best-in-class manufacturing facilities and a proprietary distribution
platform based on Microsoft technology. Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending
nitrogen sealed pre-rolls, oil and concentrates, and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.
Subscribe
to
Grown Rogue investor news alerts.
This
press release contains statements which constitute “forward-looking information” within the meaning of applicable
securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect
to future business activities. Forward-looking information is often identified by the words “may,” “would,”
“could,” “should,” “will,” “intend,” “plan,” “anticipate,”
“believe,” “estimate,” “expect” or similar expressions and include information regarding:
(i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business
and financial objectives, (iii) plans for expansion of the Company into Michigan and securing applicable regulatory approvals,
and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward-looking information
is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections
concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management
considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such
forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be
placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance
or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those
projected in the forward-looking information are the following: changes in general economic, business and political conditions,
including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in
the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing
prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or
adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related
costs, and other risks described in the Company’s Listing Statement available on www.sedar.com.
Should
one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove
incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated
or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual
results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company
does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by
applicable law.
PRESS
RELEASE
Safe Harbor Statement:
This
press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the
intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i)
the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii)
the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,”
“would,” “will,” “expect,” “estimate,” “anticipate,” “believe,”
“intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Also,
forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Except as required
by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could
differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the
future. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve
risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially
from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the Company’s
Form 20-F and 6-K filings with the Securities and Exchange Commission.
The
Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis
marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate
permit such activities however, these activities are currently illegal under United States federal law. Additional information
regarding this and other risks and uncertainties relating to the Company’s business are disclosed in the Company’s
Listing Statement filed on its issuer profile on SEDAR at
www.sedar.com
. Should one or more of these risks, uncertainties
or other factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove
incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated
or expected.
No
stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
For
further information on Grown Rogue International please visit
www.grownrogue.com
or contact:
Obie Strickler
|
|
Jacques Habra
|
|
Investor Relations Desk
|
Chief Executive Officer
|
|
Chief Strategy Officer
|
|
Inquiries
|
obie@grownrogue.com
|
|
jacques@grownrogue.com
|
|
invest@grownrogue.com
|
Grown Rogue (QB) (USOTC:GRUSF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Grown Rogue (QB) (USOTC:GRUSF)
Historical Stock Chart
From Dec 2023 to Dec 2024